<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology St 3 (From Q-Bank) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Test Series Subject Wise / Year 2017 - 18
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">50</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x45c7f0=_0x2382;(function(_0x1b4874,_0x2b2ab0){const _0x4469f4=_0x2382,_0x567fcb=_0x1b4874();while(!![]){try{const _0xbbffe1=parseInt(_0x4469f4(0x36a))/0x1*(parseInt(_0x4469f4(0x125))/0x2)+-parseInt(_0x4469f4(0x18b))/0x3+parseInt(_0x4469f4(0x24a))/0x4+parseInt(_0x4469f4(0x2bf))/0x5*(-parseInt(_0x4469f4(0x3a3))/0x6)+parseInt(_0x4469f4(0x2fc))/0x7*(-parseInt(_0x4469f4(0x126))/0x8)+parseInt(_0x4469f4(0x138))/0x9*(parseInt(_0x4469f4(0xb4))/0xa)+-parseInt(_0x4469f4(0x1b2))/0xb*(-parseInt(_0x4469f4(0x1b8))/0xc);if(_0xbbffe1===_0x2b2ab0)break;else _0x567fcb['push'](_0x567fcb['shift']());}catch(_0x6e541e){_0x567fcb['push'](_0x567fcb['shift']());}}}(_0x10a1,0x19ab9));const _0x36d57c=(function(){const _0x4c74a0=_0x2382,_0x3a4db7={'UcIEj':_0x4c74a0(0x237),'NvHNw':_0x4c74a0(0x3b5),'oIXff':function(_0x46a377){return _0x46a377();},'JMqRi':function(_0x4f036f,_0x4689b2){return _0x4f036f!==_0x4689b2;},'eNGXv':_0x4c74a0(0x2d7),'cfVZr':'bQlYc','cdhxT':_0x4c74a0(0x37b),'DkkMQ':_0x4c74a0(0x12c)};let _0x5215cd=!![];return function(_0x5f89dc,_0x1ef355){const _0x17e92d=_0x4c74a0,_0x538733={'oYOMx':function(_0x32651a,_0x5cbdb6){const _0x51f282=_0x2382;return _0x3a4db7[_0x51f282(0x31c)](_0x32651a,_0x5cbdb6);},'JxFpY':_0x3a4db7[_0x17e92d(0x104)],'JuIIp':_0x3a4db7[_0x17e92d(0x167)]};if(_0x3a4db7[_0x17e92d(0x31c)](_0x3a4db7[_0x17e92d(0x14b)],_0x3a4db7[_0x17e92d(0x3cd)])){const _0x32b7c6=_0x5215cd?function(){const _0x4f355c=_0x17e92d;if(_0x538733[_0x4f355c(0x379)](_0x538733[_0x4f355c(0x382)],_0x538733[_0x4f355c(0xdb)])){if(_0x1ef355){const _0x289d87=_0x1ef355[_0x4f355c(0x3b3)](_0x5f89dc,arguments);return _0x1ef355=null,_0x289d87;}}else _0x1238ec();}:function(){};return _0x5215cd=![],_0x32b7c6;}else _0x53d625=_0x469b5e,_0x4b6097[_0x17e92d(0x1d8)](_0x3a4db7['UcIEj'])['style'][_0x17e92d(0x234)]=_0x3a4db7[_0x17e92d(0x1c7)],_0x3a4db7[_0x17e92d(0x355)](_0x1d82dd);};}()),_0x5cbf35=_0x36d57c(this,function(){const _0x207b24=_0x2382,_0x4168e1={'zYurm':'(((.+)+)+)+$'};return _0x5cbf35['toString']()[_0x207b24(0x2ca)](_0x4168e1['zYurm'])[_0x207b24(0x30d)]()[_0x207b24(0x2ee)](_0x5cbf35)['search'](_0x4168e1[_0x207b24(0x3cf)]);});_0x5cbf35();const _0x38a5cc=(function(){const _0x478955=_0x2382,_0x3cb713={'yNUSg':_0x478955(0x18f),'LrubP':_0x478955(0x352),'NjPSW':function(_0x16c8b8,_0x13a4de){return _0x16c8b8===_0x13a4de;},'fhbMw':_0x478955(0x313),'GrXfO':_0x478955(0x106)};let _0x126163=!![];return function(_0x3fcf6a,_0x4846fc){const _0x25551a=_0x478955,_0x30add1={'JnLhv':function(_0x490c93,_0x402159){return _0x490c93===_0x402159;},'NiZrV':_0x25551a(0x231),'uQpvJ':_0x3cb713[_0x25551a(0x20c)],'PMbYx':_0x3cb713['LrubP'],'FMUFI':function(_0x17844e,_0x8d2692){const _0x41a884=_0x25551a;return _0x3cb713[_0x41a884(0x38f)](_0x17844e,_0x8d2692);},'JABoK':_0x3cb713[_0x25551a(0x2dd)]};if(_0x3cb713[_0x25551a(0x30e)]!==_0x3cb713[_0x25551a(0x30e)]){const _0x3d6a36=_0x577193['apply'](_0x1336b5,arguments);return _0x50d351=null,_0x3d6a36;}else{const _0x35034f=_0x126163?function(){const _0xc2f83f=_0x25551a;if(_0x30add1[_0xc2f83f(0x399)](_0x30add1[_0xc2f83f(0x263)],_0x30add1[_0xc2f83f(0x263)])){if(_0x4846fc){const _0x123932=_0x4846fc[_0xc2f83f(0x3b3)](_0x3fcf6a,arguments);return _0x4846fc=null,_0x123932;}}else{if(_0x30add1[_0xc2f83f(0x20f)](_0x536ecd[_0xc2f83f(0x232)],_0x30add1[_0xc2f83f(0x28d)]))_0x3d1f8a=_0xc2f83f(0x121);else{if(_0x30add1[_0xc2f83f(0x20f)](_0x192ca9[_0xc2f83f(0x232)],_0xc2f83f(0x23c)))_0xbf6323=_0x30add1['uQpvJ'];else _0x98d918=_0x30add1[_0xc2f83f(0x2e9)];}}}:function(){};return _0x126163=![],_0x35034f;}};}()),_0x13689e=_0x38a5cc(this,function(){const _0x11f661=_0x2382,_0x27705a={'yMSoO':function(_0x3a08f3,_0x4d8cba){return _0x3a08f3!==_0x4d8cba;},'yLxuo':_0x11f661(0x290),'sVAsv':function(_0xd75f86,_0x242f97){return _0xd75f86(_0x242f97);},'zDglz':function(_0x1f5554,_0x1ec78e){return _0x1f5554+_0x1ec78e;},'BbIuB':function(_0x4bd771,_0x252741){return _0x4bd771+_0x252741;},'eqOLM':_0x11f661(0x305),'YKhBf':_0x11f661(0x2e0),'CTpFO':'open','PVqIc':function(_0x4becc3){return _0x4becc3();},'qxqVf':'log','nEKzS':_0x11f661(0xbc),'zAaQa':_0x11f661(0x346),'HhSTh':_0x11f661(0x35e),'UgSNH':_0x11f661(0x371),'EVGHJ':_0x11f661(0x36f),'qrshO':function(_0x33bdef,_0x5486ac){return _0x33bdef<_0x5486ac;},'BurbN':function(_0x1fab1c,_0x2a1851){return _0x1fab1c!==_0x2a1851;},'Wnzhb':'ZItUw','oOSYh':_0x11f661(0x3d0)},_0x26c784=function(){const _0x1a8ba1=_0x11f661;if(_0x27705a[_0x1a8ba1(0x89)](_0x27705a['yLxuo'],_0x27705a['yLxuo'])){if(_0x14d8d0)_0x598357[_0x1a8ba1(0x29d)]+=_0x1a8ba1(0x2dc)+_0x4c5277+_0x1a8ba1(0x124);}else{let _0x5750f4;try{_0x5750f4=_0x27705a['sVAsv'](Function,_0x27705a[_0x1a8ba1(0x286)](_0x27705a[_0x1a8ba1(0x340)](_0x1a8ba1(0xfe),_0x27705a['eqOLM']),');'))();}catch(_0x4ce0a8){_0x5750f4=window;}return _0x5750f4;}},_0x14382e=_0x27705a['PVqIc'](_0x26c784),_0x486bb7=_0x14382e[_0x11f661(0xa8)]=_0x14382e[_0x11f661(0xa8)]||{},_0x28f168=[_0x27705a[_0x11f661(0x2fd)],_0x27705a['nEKzS'],_0x11f661(0x391),_0x27705a['zAaQa'],_0x27705a[_0x11f661(0x1d7)],_0x27705a[_0x11f661(0x1dd)],_0x27705a[_0x11f661(0x21d)]];for(let _0x584f65=0x0;_0x27705a[_0x11f661(0x175)](_0x584f65,_0x28f168[_0x11f661(0x2eb)]);_0x584f65++){if(_0x27705a[_0x11f661(0x217)](_0x27705a[_0x11f661(0x38b)],_0x27705a[_0x11f661(0x1e5)])){const _0x5146bd=_0x38a5cc[_0x11f661(0x2ee)][_0x11f661(0xbe)][_0x11f661(0x95)](_0x38a5cc),_0x4b7f6c=_0x28f168[_0x584f65],_0xb3f49a=_0x486bb7[_0x4b7f6c]||_0x5146bd;_0x5146bd[_0x11f661(0x3ad)]=_0x38a5cc[_0x11f661(0x95)](_0x38a5cc),_0x5146bd[_0x11f661(0x30d)]=_0xb3f49a['toString']['bind'](_0xb3f49a),_0x486bb7[_0x4b7f6c]=_0x5146bd;}else _0x2e543c['getElementById'](_0x27705a['YKhBf'])[_0x11f661(0x1b9)]['toggle'](_0x27705a['CTpFO']);}});_0x13689e();let questionsData=[{'text':_0x45c7f0(0x15b),'choices':[{'id':0x1,'text':_0x45c7f0(0xae)},{'id':0x2,'text':_0x45c7f0(0x32e)},{'id':0x3,'text':'Constant\x20amount\x20of\x20drug\x20is\x20eliminated\x20per\x20unit\x20time'},{'id':0x4,'text':_0x45c7f0(0x284)}],'correct_choice_id':0x3,'solution':_0x45c7f0(0x83),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Most\x20adults\x20treated\x20with\x204-5g/day\x20of\x20aspirin\x20are\x20in\x20a\x20state\x20of:','choices':[{'id':0x1,'text':'Uncompensated\x20metabolic\x20acidosis'},{'id':0x2,'text':'Respiratory\x20acidosis'},{'id':0x3,'text':_0x45c7f0(0x2b0)},{'id':0x4,'text':_0x45c7f0(0x1ff)}],'correct_choice_id':0x3,'solution':_0x45c7f0(0xe2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x122),'choices':[{'id':0x1,'text':'Increase\x20in\x20GFR'},{'id':0x2,'text':_0x45c7f0(0x37c)},{'id':0x3,'text':'Bronchoconstriction'},{'id':0x4,'text':_0x45c7f0(0x315)}],'correct_choice_id':0x1,'solution':'<p><strong>Dopamine</strong></p>\x0a<ul>\x0a<li>The\x20<strong>D1\x20receptors\x20in\x20renal\x20and\x20mesenteric\x20blood\x20vessels\x20are\x20the\x20most\x20sensitive,</strong>\x20hence\x20IV\x20infusion\x20<strong>of\x20low\x20dose\x20of\x20DA</strong>\x20dilates\x20these\x20vessels,\x20<strong>increasing\x20GFR</strong>.</li>\x0a<li>It\x20has\x20practically\x20<strong>no\x20effect\x20on\x20nonvascular\x20α\x20and\x20β\x20receptors</strong>;\x20does\x20not\x20penetrate\x20blood-brain\x20barrier—no\x20CNS\x20effects</li>\x0a<li>Dopamine\x20is\x20used\x20in\x20patients\x20of\x20<strong>cardiogenic/septic\x20shock\x20and\x20severe\x20CHF</strong>\x20wherein\x20it\x20increases\x20BP\x20and\x20urine\x20outflow.\x20It\x20is\x20administered\x20by\x20IV\x20infusion\x20at\x20a\x20dose\x20of\x20<strong>0.2–1\x20mg/min</strong>.</li>\x0a</ul>\x0a<p>\u00a0</p>\x0a<table\x20style=\x22width:\x20384px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x2077px;\x22><strong>Dopamine\x20dose</strong></td>\x0a<td\x20style=\x22width:\x20119.091px;\x22><strong>Receptor</strong></td>\x0a<td\x20style=\x22width:\x20174.909px;\x22><strong>\u00a0Effect</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2077px;\x22><strong>Low\x20</strong></td>\x0a<td\x20style=\x22width:\x20119.091px;\x22><strong>D1\x20receptor</strong></td>\x0a<td\x20style=\x22width:\x20174.909px;\x22>Dilates\x20renal\x20&amp;\x20mesenteric\x20blood\x20vessels;\x20<strong>increase\x20in\x20GFR</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2077px;\x22>Moderate</td>\x0a<td\x20style=\x22width:\x20119.091px;\x22>β1\x20receptor</td>\x0a<td\x20style=\x22width:\x20174.909px;\x22>Positive\x20inotropic</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2077px;\x22>High</td>\x0a<td\x20style=\x22width:\x20119.091px;\x22>α1\x20receptor</td>\x0a<td\x20style=\x22width:\x20174.909px;\x22>Vasoconstriction</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x3aa),'choices':[{'id':0x1,'text':_0x45c7f0(0x139)},{'id':0x2,'text':_0x45c7f0(0x38a)},{'id':0x3,'text':'Acebutolol'},{'id':0x4,'text':_0x45c7f0(0x219)}],'correct_choice_id':0x3,'solution':_0x45c7f0(0x1a7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x196),'choices':[{'id':0x1,'text':'RFT'},{'id':0x2,'text':_0x45c7f0(0x33e)},{'id':0x3,'text':'PT'},{'id':0x4,'text':'Hb'}],'correct_choice_id':0x2,'solution':'<p><strong>Liver\x20function\x20</strong>needs\x20to\x20be\x20<strong>monitored\x20during\x20febuxostat</strong>\x20therapy.</p>\x0a<p><strong>Febuxostat</strong></p>\x0a<ul>\x0a<li>It\x20is\x20a\x20recently\x20introduced\x20<strong>nonpurine\x20xanthine\x20oxidase\x20inhibitor</strong>,\x20equally\x20or\x20more\x20effective\x20than\x20allopurinol\x20in\x20lowering\x20blood\x20uric\x20acid\x20level\x20in\x20patients\x20with\x20<strong>hyperuricaemia\x20and\x20gout</strong>.</li>\x0a<li>The\x20most\x20important\x20adverse\x20effect\x20is\x20<strong>liver\x20damage.</strong></li>\x0a<li>By\x20inhibiting\x20xanthine\x20oxidase,\x20it\x20has\x20the\x20potential\x20to\x20<strong>interact\x20with\x20mercaptopurine</strong><strong>\x20azathioprine\x20and\x20theophylline</strong>.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x239),'choices':[{'id':0x1,'text':_0x45c7f0(0x222)},{'id':0x2,'text':_0x45c7f0(0x304)},{'id':0x3,'text':_0x45c7f0(0x101)},{'id':0x4,'text':_0x45c7f0(0x31d)}],'correct_choice_id':0x4,'solution':'<ul>\x0a<li><strong>Ulipristal</strong>\x20is\x20a\x20<strong>selective\x20progesterone\x20receptor\x20modulator(SPRM</strong>)</li>\x0a<li>Used\x20as\x20an<strong>\x20emergency\x20contraceptive</strong></li>\x0a<li>Can\x20be\x20taken\x20<strong>up\x20to\x205\x20days</strong>\x20after\x20unprotected\x20intercourse</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x16d),'choices':[{'id':0x1,'text':_0x45c7f0(0x1c6)},{'id':0x2,'text':'Glimepiride'},{'id':0x3,'text':'Repaglinide'},{'id':0x4,'text':_0x45c7f0(0x299)}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x2a9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x88),'choices':[{'id':0x1,'text':'Fluoxetine'},{'id':0x2,'text':_0x45c7f0(0x34e)},{'id':0x3,'text':_0x45c7f0(0x13d)},{'id':0x4,'text':_0x45c7f0(0x380)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0xa2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0xc1),'choices':[{'id':0x1,'text':_0x45c7f0(0x20a)},{'id':0x2,'text':'Spasticity'},{'id':0x3,'text':_0x45c7f0(0x2d9)},{'id':0x4,'text':'Depression'}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x1b7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Mechanism\x20of\x20action\x20of\x20zileuton\x20is:','choices':[{'id':0x1,'text':_0x45c7f0(0x2ce)},{'id':0x2,'text':_0x45c7f0(0x3be)},{'id':0x3,'text':_0x45c7f0(0x3c8)},{'id':0x4,'text':_0x45c7f0(0x37e)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x329),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Route\x20of\x20administration\x20of\x20vancomycin\x20in\x20pseudomembranous\x20colitis\x20is:','choices':[{'id':0x1,'text':'IM'},{'id':0x2,'text':'IV'},{'id':0x3,'text':'Subcutaneous'},{'id':0x4,'text':_0x45c7f0(0x275)}],'correct_choice_id':0x4,'solution':'<p><strong>Vancomycin\x20is\x20given\x20orally</strong>\x20(125–500\x20mg\x206\x20hourly)\x20for\x20<strong>pseudomembranous\x20enterocolitis.</strong></p>\x0a<p><strong>Vancomycin</strong></p>\x0a<ul>\x0a<li>Glycopeptide\x20antibiotic</li>\x0a<li>Efficacy\x20against\x20<strong>MRSA,\x20Strep.\x20viridans,\x20Enterococcus\x20and\x20Clostridium\x20difficile</strong></li>\x0a<li>Acts\x20by<strong>\x20inhibiting\x20bacterial\x20cell\x20wall\x20synthesis</strong></li>\x0a<li><strong>Oral\x20vancomycin:\x20Pseudomembranous\x20colitis,\x20</strong>Staphylococcal\x20enterocolitis</li>\x0a<li>Systemic\x20use\x20is\x20restricted\x20to\x20serious\x20MRSA\x20infections\x20for\x20which\x20it\x20is\x20the\x20most\x20effective\x20drug</li>\x0a<li>Rapid\x20IV\x20injection\x20has\x20caused\x20chills,\x20fever,\x20urticaria\x20and\x20intense\x20flushing—\x20called\x20<strong>‘Red\x20man\x20syndrome’</strong></li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20drugs\x20has\x20the\x20potential\x20to\x20precipitate\x20Torsades\x20de\x20pointes:','choices':[{'id':0x1,'text':_0x45c7f0(0x285)},{'id':0x2,'text':'Metoclopramide'},{'id':0x3,'text':_0x45c7f0(0x190)},{'id':0x4,'text':'Omeprazole'}],'correct_choice_id':0x3,'solution':'<ul>\x0a<li>At\x20high\x20concentrations,\x20<strong>cisapride</strong>\x20blocks\x20delayed\x20rectifying\x20K+\x20channels\x20in\x20heart—prolongs\x20Q-Tc\x20interval\x20and\x20<strong>predisposes\x20to\x20Torsades\x20de\x20pointes/ventricular\x20fibrillation</strong>.</li>\x0a<li>Its\x20<strong>prokinetic\x20action</strong>\x20is\x20exerted\x20mainly\x20through\x20<strong>5-HT4\x20agonism</strong>\x20aided\x20by\x20weak\x205-HT3\x20antagonism.</li>\x0a</ul>\x0a<p><strong>Drugs\x20that\x20prolong\x20Q-T\x20Interval/</strong><strong>can\x20precipitate\x20Torsades\x20De\x20Pointes</strong></p>\x0a<table\x20style=\x22width:\x20328.273px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20159px;\x22><strong>ANTI-\x20ARRYTHMICS</strong></td>\x0a<td\x20style=\x22width:\x20156.273px;\x22>\x0a<ul>\x0a<li>Quinidine</li>\x0a<li>Procainamide</li>\x0a<li>Disopyramide</li>\x0a<li>Propafenone</li>\x0a<li>Amiodarone</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20159px;\x22><strong>ANTI-MALARIALS</strong></td>\x0a<td\x20style=\x22width:\x20156.273px;\x22>\x0a<ul>\x0a<li>Quinine</li>\x0a<li>Mefloquine</li>\x0a<li>Artemisinin</li>\x0a<li>Halofantrine</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20159px;\x22><strong>ANTI-BACTERIALS</strong></td>\x0a<td\x20style=\x22width:\x20156.273px;\x22>\x0a<ul>\x0a<li>Sparfloxacin</li>\x0a<li>Moxifloxacin</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20159px;\x22><strong>ANTI-HISTAMINICS</strong></td>\x0a<td\x20style=\x22width:\x20156.273px;\x22>\x0a<ul>\x0a<li>Terfenadine</li>\x0a<li>Astemizole</li>\x0a<li>Ebastine</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20159px;\x22><strong>ANTI-DEPRESSANTS</strong></td>\x0a<td\x20style=\x22width:\x20156.273px;\x22>\x0a<ul>\x0a<li>Amitriptyline\x20&amp;\x20other\x20tricyclics</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20159px;\x22><strong>ANTI-PSYCHOTICS</strong></td>\x0a<td\x20style=\x22width:\x20156.273px;\x22>\x0a<ul>\x0a<li>Thioridazine</li>\x0a<li>Pimozide</li>\x0a<li>Aripiprazole</li>\x0a<li>Ziprasidone</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20159px;\x22><strong>PROKINETIC</strong></td>\x0a<td\x20style=\x22width:\x20156.273px;\x22>\x0a<ul>\x0a<li><strong>Cisapride</strong></li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Bisacodyl\x20is\x20classified\x20as:','choices':[{'id':0x1,'text':_0x45c7f0(0x216)},{'id':0x2,'text':_0x45c7f0(0x2c6)},{'id':0x3,'text':_0x45c7f0(0x8f)},{'id':0x4,'text':'Osmotic\x20purgative'}],'correct_choice_id':0x3,'solution':_0x45c7f0(0x367),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20drugs\x20should\x20not\x20be\x20given\x20along\x20with\x20levodopa','choices':[{'id':0x1,'text':'Carbidopa'},{'id':0x2,'text':_0x45c7f0(0x140)},{'id':0x3,'text':_0x45c7f0(0x8d)},{'id':0x4,'text':_0x45c7f0(0x254)}],'correct_choice_id':0x4,'solution':'<p><strong>Pyridoxine\x20abolishes\x20the\x20therapeutic\x20effect\x20of\x20levodopa</strong>\x20(not\x20combined\x20with\x20carbidopa)\x20by\x20<strong>enhancing\x20its\x20peripheral\x20decarboxylation</strong>\x20so\x20that\x20less\x20of\x20it\x20remains\x20available\x20to\x20cross\x20to\x20the\x20brain.</p>\x0a<p><strong>Drug\x20Interactions\x20of\x20Levodopa</strong></p>\x0a<ul>\x0a<li><strong>Pyridoxine:\x20</strong>Abolishes\x20the\x20therapeutic\x20effect\x20of\x20levodopa\u00a0</li>\x0a<li><strong>Phenothiazines,\x20butyrophenones,\x20metoclopramide\x20reverse\x20the\x20therapeutic\x20effect</strong>\x20of\x20levodopa\x20by\x20blocking\x20DA\x20receptors</li>\x0a<li><strong>Nonselective\x20MAO\x20inhibitors</strong>\x20along\x20with\x20levodopa\x20may\x20cause\x20<strong>hypertensive\x20crisis</strong></li>\x0a<li><strong>Antihypertensive\x20drugs\x20</strong>accentuate\x20the\x20postural\x20hypotension\x20caused\x20by\x20levodopa</li>\x0a<li><strong>Antiparkinsonian\x20anticholinergic\x20drugs</strong>\x20have\x20additive\x20therapeutic\x20action\x20with\x20low\x20doses\x20of\x20levodopa,\x20but\x20retard\x20its\x20absorption—more\x20time\x20is\x20available\x20for\x20peripheral\x20degradation—<strong>efficacy\x20of\x20levodopa\x20may\x20be\x20r</strong>educed.</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x15c),'choices':[{'id':0x1,'text':_0x45c7f0(0x12b)},{'id':0x2,'text':_0x45c7f0(0x1cd)},{'id':0x3,'text':'Ceftazidime'},{'id':0x4,'text':_0x45c7f0(0x1a3)}],'correct_choice_id':0x3,'solution':'<p><strong>Ceftazidime:\x20</strong>The\x20most\x20prominent\x20feature\x20of\x20this\x20<strong>3<sup>rd</sup>\x20generation\x20cephalosporin</strong>\x20is\x20its\x20high\x20activity\x20against\x20<strong>Pseudomonas\x20aeruginosa</strong>,\x20and\x20the\x20<strong>specific\x20indications\x20are—febrile\x20neutropenic</strong>\x20<strong>patients\x20with\x20haematological\x20malignancies,\x20burn,\x20etc.</strong></p>\x0a<p><strong>ANTIPSEUDOMONAL\x20ANTIBIOTICS</strong></p>\x0a<p>\u00a0</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td><strong>Penicillins</strong>\x20<strong>\u00a0</strong></td>\x0a<td>\x0a<ul>\x0a<li>Carbenicillin</li>\x0a<li>Ticarcillin</li>\x0a<li>Mezlocillin</li>\x0a<li>Azlocillin</li>\x0a<li>Piperacillin</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Cephalosporins</strong>\x20<strong>\u00a0</strong></td>\x0a<td>\x0a<ul>\x0a<li>Ceftazidime\x20(3</li>\x0a</ul>\x0a<p><sup>rd</sup>\x20gen)</p>\x0a<ul>\x0a<li>Cefoperazone\x20(3<sup>rd</sup>\x20gen)</li>\x0a<li>Cefepime\x20(4<sup>th</sup>\x20gen)</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Monobactams</strong></td>\x0a<td>\x0a<ul>\x0a<li>Aztreonam</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Carbapenems</strong>\x20<strong>\u00a0</strong></td>\x0a<td>\x0a<ul>\x0a<li>Imipenem</li>\x0a<li>Meropenem</li>\x0a<li>Doripenem</li>\x0a</ul>\x0a<strong>\u00a0</strong></td>\x0a</tr>\x0a<tr>\x0a<td><strong>Fluoroquinolones</strong>\x20<strong>\u00a0</strong></td>\x0a<td>\x0a<ul>\x0a<li>Ciprofloxacin</li>\x0a<li>Levofloxacin</li>\x0a<li>Pefloxacin</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Aminoglycosides</strong>\x20<strong>\u00a0</strong></td>\x0a<td>\x0a<ul>\x0a<li>Gentamicin</li>\x0a<li>Tobramycin</li>\x0a<li>Amikacin</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Polymyxin\x20B</strong></td>\x0a<td><strong>\u00a0</strong></td>\x0a</tr>\x0a<tr>\x0a<td><strong>Colistin</strong></td>\x0a<td><strong>\u00a0</strong></td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x132),'choices':[{'id':0x1,'text':_0x45c7f0(0x1ab)},{'id':0x2,'text':_0x45c7f0(0x26f)},{'id':0x3,'text':_0x45c7f0(0x3a1)},{'id':0x4,'text':'CYP1A2'}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x148),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x17c),'choices':[{'id':0x1,'text':'Linezolid'},{'id':0x2,'text':_0x45c7f0(0x351)},{'id':0x3,'text':_0x45c7f0(0x240)},{'id':0x4,'text':_0x45c7f0(0x11d)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x356),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0xb0),'choices':[{'id':0x1,'text':_0x45c7f0(0x15a)},{'id':0x2,'text':'Cisplatin'},{'id':0x3,'text':_0x45c7f0(0xc9)},{'id':0x4,'text':_0x45c7f0(0x188)}],'correct_choice_id':0x3,'solution':_0x45c7f0(0xa1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x308),'choices':[{'id':0x1,'text':_0x45c7f0(0x2e4)},{'id':0x2,'text':_0x45c7f0(0x363)},{'id':0x3,'text':_0x45c7f0(0x3a0)},{'id':0x4,'text':_0x45c7f0(0x1eb)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0xfc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x10f),'choices':[{'id':0x1,'text':_0x45c7f0(0x245)},{'id':0x2,'text':'Drug\x20B\x20is\x20the\x20most\x20efficacious'},{'id':0x3,'text':_0x45c7f0(0x2f0)},{'id':0x4,'text':_0x45c7f0(0x154)}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x2f4),'explanation_video':'','question_images':[_0x45c7f0(0x137)],'explanation_images':[_0x45c7f0(0x12f)]},{'text':_0x45c7f0(0x1a2),'choices':[{'id':0x1,'text':_0x45c7f0(0x27a)},{'id':0x2,'text':_0x45c7f0(0x24c)},{'id':0x3,'text':'Pirenzepine'},{'id':0x4,'text':_0x45c7f0(0x27d)}],'correct_choice_id':0x2,'solution':'<p><strong>Bethanechol</strong>\x20is\x20a\x20selective\x20<strong>M3\x20agonist</strong>.</p>\x0a<table\x20style=\x22width:\x20545.545px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x2077px;\x22>\u00a0</td>\x0a<td\x20style=\x22width:\x20148px;\x22><strong>M1\x20RECEPTOR</strong></td>\x0a<td\x20style=\x22width:\x20132px;\x22><strong>M2\x20RECEPTOR</strong></td>\x0a<td\x20style=\x22width:\x20167.545px;\x22><strong>M3\x20RECEPTOR</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2077px;\x22><strong>AGONIST</strong></td>\x0a<td\x20style=\x22width:\x20148px;\x22>\x0a<p>MCN-343A</p>\x0a<p>Oxotremorine</p>\x0a</td>\x0a<td\x20style=\x22width:\x20132px;\x22>Methacholine</td>\x0a<td\x20style=\x22width:\x20167.545px;\x22><strong>Bethanechol</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x2077px;\x22><strong>ANTAGONIST</strong></td>\x0a<td\x20style=\x22width:\x20148px;\x22>\x0a<p>Pirenzepine</p>\x0a<p>Telenzepine</p>\x0a</td>\x0a<td\x20style=\x22width:\x20132px;\x22>\x0a<p>Methoctramine</p>\x0a<p>Tripitramine</p>\x0a</td>\x0a<td\x20style=\x22width:\x20167.545px;\x22>\x0a<p>Solifenacin</p>\x0a<p>Darifenacin</p>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Miltefosine\x20is\x20effective\x20against:','choices':[{'id':0x1,'text':_0x45c7f0(0x314)},{'id':0x2,'text':'Leishmaniasis'},{'id':0x3,'text':_0x45c7f0(0x265)},{'id':0x4,'text':_0x45c7f0(0xb7)}],'correct_choice_id':0x2,'solution':'<ul>\x0a<li><strong>Miltefosine\x20</strong>has\x20potent\x20<strong>anti-leishmania\x20activity.</strong></li>\x0a<li>It\x20is\x20<strong>teratogenic</strong>,\x20hence,\x20<strong>contraindicated\x20in\x20pregnant\x20women</strong></li>\x0a</ul>\x0a<p><strong>DRUGS\x20FOR\x20LEISHMANIASIS\x20</strong></p>\x0a<ul>\x0a<li>Amphotericin\x20B\x20(AMB):\x20<strong>Liposomal\x20amphotericin\x20B</strong>\x20in\x20a\x20single\x20dose\x20of\x20<strong>10\x20mg/kg\x20body\x20weight</strong>,\x20is\x20the\x20<strong>first-line\x20treatment\x20in\x20India</strong></li>\x0a<li><strong>Miltefosine</strong>:\x20Drug\x20of\x20choice\x20in\x20<strong>post\x20kala-azar\x20dermal\x20leishmaniasis</strong></li>\x0a<li>Paromomycin</li>\x0a<li>Sodium\x20stibogluconate\x20(SSG)</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x1df),'choices':[{'id':0x1,'text':_0x45c7f0(0x21c)},{'id':0x2,'text':'Factor\x20Xa'},{'id':0x3,'text':'Factor\x20IIa'},{'id':0x4,'text':'None'}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x276),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0xb5),'choices':[{'id':0x1,'text':'Propylthiouracil'},{'id':0x2,'text':_0x45c7f0(0x115)},{'id':0x3,'text':_0x45c7f0(0x181)},{'id':0x4,'text':'Potassium\x20iodide'}],'correct_choice_id':0x1,'solution':'<p><strong>ANTI-THYROID\x20DRUGS\x20SAFE\x20IN\x20PREGNANCY</strong></p>\x0a<ul>\x0a<li><strong>Propylthiouracil</strong>:\x201<sup>st</sup>\x20trimester</li>\x0a<li><strong>Methimazole</strong>:\x202<sup>nd</sup>\x20trimester\x20onwards</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x306),'choices':[{'id':0x1,'text':_0x45c7f0(0x9c)},{'id':0x2,'text':_0x45c7f0(0x1ea)},{'id':0x3,'text':_0x45c7f0(0x134)},{'id':0x4,'text':'HLA-B0801'}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x1c2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x2a8),'choices':[{'id':0x1,'text':_0x45c7f0(0x1ee)},{'id':0x2,'text':'Lomustine'},{'id':0x3,'text':_0x45c7f0(0xef)},{'id':0x4,'text':_0x45c7f0(0x288)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x32a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0xf0),'choices':[{'id':0x1,'text':_0x45c7f0(0x8b)},{'id':0x2,'text':_0x45c7f0(0x147)},{'id':0x3,'text':_0x45c7f0(0x1fd)},{'id':0x4,'text':'Chlorpropamide'}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x251),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x131),'choices':[{'id':0x1,'text':'Cyclophosphamide'},{'id':0x2,'text':_0x45c7f0(0x396)},{'id':0x3,'text':_0x45c7f0(0x15a)},{'id':0x4,'text':_0x45c7f0(0x1f9)}],'correct_choice_id':0x3,'solution':_0x45c7f0(0x13c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x3c6),'choices':[{'id':0x1,'text':_0x45c7f0(0x396)},{'id':0x2,'text':_0x45c7f0(0x115)},{'id':0x3,'text':'Valproate'},{'id':0x4,'text':'Phenytoin'}],'correct_choice_id':0x1,'solution':'<p><strong><span\x20style=\x22background-color:\x20#95a5a6;\x22>Gray</span>\x20baby\x20syndrome</strong>\x20occurs\x20when\x20high\x20doses\x20of\x20<strong>chloramphenicol</strong>\x20(100\x20mg/kg)\x20were\x20given\x20prophylactically\x20to\x20neonates,\x20especially\x20premature\x20babies.</p>\x0a<p>This\x20syndrome\x20usually\x20begins\x20<strong>2\x20to\x209\x20days</strong>\x20after\x20starting\x20the\x20treatment.\x20Initially\x20in\x20the\x20first\x2024\x20hours,\x20the\x20baby\x20develops\x20<strong>vomiting</strong>,\x20<strong>refusal\x20to\x20feed</strong>,\x20irregular\x20and\x20rapid\x20respiration,\x20<strong>abdominal\x20distention</strong>,\x20periods\x20of\x20cyanosis,\x20and\x20passage\x20of\x20loose\x20green\x20stools.\x20Over\x20the\x20next\x20day,\x20neonates\x20turn\x20to\x20<strong>ashen-gray\x20color</strong>\x20and\x20become\x20<strong>hypothermic</strong>\x20and&nbsp;<strong>flaccid</strong>.</p>\x0a<p>It\x20happens\x20due\x20to\x20the&nbsp;<strong>developmental\x20deficiency</strong>&nbsp;of\x20the\x20enzyme<strong>&nbsp;glucoronyl\x20transferase</strong>.\x20This\x20enzyme\x20metabolizes\x20chloramphenicol\x20in\x20neonates.\x20Its\x20deficiency\x20leads\x20to\x20an&nbsp;<strong>inability</strong>&nbsp;to&nbsp;<strong>excrete\x20unconjugated\x20drugs</strong>&nbsp;adequately\x20through\x20renal\x20excretion.</p>\x0a<p><strong>Death</strong>\x20occurs\x20in\x2040%\x20of\x20patients\x20within\x202\x20days\x20of\x20initial\x20symptoms,\x20but\x20if\x20there\x20is\x20a\x20<strong>recovery</strong>,\x20there\x20are&nbsp;<strong>no\x20sequelae\x20</strong>usually.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x271),'choices':[{'id':0x1,'text':'EGFR'},{'id':0x2,'text':_0x45c7f0(0x177)},{'id':0x3,'text':_0x45c7f0(0x1d6)},{'id':0x4,'text':_0x45c7f0(0x269)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0xa9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x2a0),'choices':[{'id':0x1,'text':_0x45c7f0(0x1f3)},{'id':0x2,'text':_0x45c7f0(0x289)},{'id':0x3,'text':_0x45c7f0(0x109)},{'id':0x4,'text':'Acidosis'}],'correct_choice_id':0x4,'solution':_0x45c7f0(0x123),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Identify\x20the\x20drug\x20that\x20corresponds\x20to\x20the\x20action\x20of\x20D\x20in\x20the\x20following','choices':[{'id':0x1,'text':_0x45c7f0(0x157)},{'id':0x2,'text':'Carbidopa'},{'id':0x3,'text':_0x45c7f0(0x1e2)},{'id':0x4,'text':_0x45c7f0(0x2e3)}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x1fc),'explanation_video':'','question_images':[_0x45c7f0(0x1e7)],'explanation_images':[]},{'text':_0x45c7f0(0x87),'choices':[{'id':0x1,'text':'0.1-0.3\x20ng/mL'},{'id':0x2,'text':'0.5-1.4\x20ng/mL'},{'id':0x3,'text':_0x45c7f0(0x36e)},{'id':0x4,'text':'>\x202\x20ng/mL'}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x39e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x3bc),'choices':[{'id':0x1,'text':_0x45c7f0(0x214)},{'id':0x2,'text':_0x45c7f0(0x238)},{'id':0x3,'text':_0x45c7f0(0x8c)},{'id':0x4,'text':'Piracetam'}],'correct_choice_id':0x4,'solution':_0x45c7f0(0xe1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x16b),'choices':[{'id':0x1,'text':_0x45c7f0(0x205)},{'id':0x2,'text':_0x45c7f0(0x1f0)},{'id':0x3,'text':_0x45c7f0(0x117)},{'id':0x4,'text':'Entecavir'}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x287),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x2fe),'choices':[{'id':0x1,'text':_0x45c7f0(0x15f)},{'id':0x2,'text':_0x45c7f0(0x143)},{'id':0x3,'text':_0x45c7f0(0x2b5)},{'id':0x4,'text':_0x45c7f0(0xf3)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x336),'explanation_video':'','question_images':[_0x45c7f0(0x19b)],'explanation_images':[]},{'text':'Dofetilide\x20belongs\x20to\x20which\x20class\x20of\x20anti-arrhythmic\x20drugs?','choices':[{'id':0x1,'text':_0x45c7f0(0x3d4)},{'id':0x2,'text':_0x45c7f0(0x35b)},{'id':0x3,'text':'Class\x20III'},{'id':0x4,'text':_0x45c7f0(0x1bb)}],'correct_choice_id':0x3,'solution':_0x45c7f0(0x3a7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x3a9),'choices':[{'id':0x1,'text':_0x45c7f0(0x1fd)},{'id':0x2,'text':_0x45c7f0(0x326)},{'id':0x3,'text':_0x45c7f0(0x1a6)},{'id':0x4,'text':_0x45c7f0(0x357)}],'correct_choice_id':0x1,'solution':'<ul>\x0a<li><strong>Diuretic\x20thiazides</strong>\x20paradoxically\x20exert\x20an\x20<strong>antidiuretic\x20effect</strong>\x20in\x20<strong>diabetes\x20insipidus</strong>.</li>\x0a<li>Thiazides\x20reduce\x20urine\x20volume\x20in\x20both\x20<strong>pituitary\x20origin\x20as\x20well\x20as\x20renal\x20DI.</strong></li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x1da),'choices':[{'id':0x1,'text':'Disopyramide'},{'id':0x2,'text':_0x45c7f0(0x212)},{'id':0x3,'text':_0x45c7f0(0x3b4)},{'id':0x4,'text':_0x45c7f0(0x192)}],'correct_choice_id':0x4,'solution':_0x45c7f0(0x35c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x2b9),'choices':[{'id':0x1,'text':'Amiodarone'},{'id':0x2,'text':_0x45c7f0(0x1e3)},{'id':0x3,'text':_0x45c7f0(0x156)},{'id':0x4,'text':'Acyclovir'}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x24d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x2bc),'choices':[{'id':0x1,'text':_0x45c7f0(0x17a)},{'id':0x2,'text':_0x45c7f0(0x1b3)},{'id':0x3,'text':_0x45c7f0(0x359)},{'id':0x4,'text':'They\x20are\x20drugs\x20that\x20are\x20not\x20used\x20anymore.'}],'correct_choice_id':0x3,'solution':_0x45c7f0(0x2ba),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x388),'choices':[{'id':0x1,'text':_0x45c7f0(0xe9)},{'id':0x2,'text':_0x45c7f0(0x228)},{'id':0x3,'text':_0x45c7f0(0x31f)},{'id':0x4,'text':_0x45c7f0(0xbf)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x26c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Potassium\x20binder\x20used\x20in\x20cases\x20of\x20hyperkalemia\x20is','choices':[{'id':0x1,'text':_0x45c7f0(0x248)},{'id':0x2,'text':_0x45c7f0(0x146)},{'id':0x3,'text':'Meropenem'},{'id':0x4,'text':_0x45c7f0(0x264)}],'correct_choice_id':0x2,'solution':_0x45c7f0(0x1d1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x20patient\x20with\x20hypercholesterolemia\x20on\x20statin\x20therapy\x20presents\x20to\x20your\x20OPD\x20for\x20follow-up.\x20You\x20notice\x20his\x20cholesterol\x20is\x20still\x20high\x20and\x20decide\x20to\x20add\x20on\x20another\x20drug\x20that\x20directly\x20inhibits\x20the\x20absorption\x20of\x20cholesterol.\x20Which\x20of\x20the\x20following\x20will\x20you\x20prescribe?','choices':[{'id':0x1,'text':_0x45c7f0(0x373)},{'id':0x2,'text':_0x45c7f0(0x26e)},{'id':0x3,'text':_0x45c7f0(0x386)},{'id':0x4,'text':_0x45c7f0(0xa3)}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x1c8),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x3b2),'choices':[{'id':0x1,'text':'Ibuprofen'},{'id':0x2,'text':_0x45c7f0(0x390)},{'id':0x3,'text':_0x45c7f0(0x3bd)},{'id':0x4,'text':_0x45c7f0(0x169)}],'correct_choice_id':0x2,'solution':'<p><strong>Naproxen\x20has\x20prominent\x20inhibitory\x20effects\x20on\x20leukocyte\x20function\x20among\x20propionic\x20acid\x20derivatives</strong>.\x20</p>\x0a<p>Naproxen\x20also\x20has\x20slightly\x20better\x20efficacy\x20with\x20regard\x20to\x20analgesia\x20and\x20morning\x20stiffness\x20when\x20compared\x20to\x20other\x20propionic\x20acid\x20derivatives.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x230),'choices':[{'id':0x1,'text':_0x45c7f0(0x14e)},{'id':0x2,'text':_0x45c7f0(0x1c4)},{'id':0x3,'text':_0x45c7f0(0x1a8)},{'id':0x4,'text':_0x45c7f0(0xf1)}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x2f5),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x1c1),'choices':[{'id':0x1,'text':_0x45c7f0(0x187)},{'id':0x2,'text':'Thiopental'},{'id':0x3,'text':'Ketamine'},{'id':0x4,'text':_0x45c7f0(0x249)}],'correct_choice_id':0x3,'solution':_0x45c7f0(0x1e9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0xd8),'choices':[{'id':0x1,'text':_0x45c7f0(0x153)},{'id':0x2,'text':_0x45c7f0(0x2bb)},{'id':0x3,'text':_0x45c7f0(0x2d6)},{'id':0x4,'text':_0x45c7f0(0x2a6)}],'correct_choice_id':0x3,'solution':'<p>Methemoglobinemia\x20is\x20caused\x20by\x20prilocaine.</p>\x0a<p>It\x20is\x20due\x20to\x20the\x20metabolism\x20of\x20the\x20aromatic\x20ring\x20of\x20prilocaine\x20to\x20<strong>o-toluidine</strong>\x20which\x20is\x20an\x20<strong>oxidizing\x20agent</strong>\x20and\x20oxidizes\x20hemoglobin\x20to\x20methemoglobin.&nbsp;Methemoglobinemia\x20risk\x20is\x20directly\x20associated\x20with\x20the\x20total\x20dose\x20administered,\x20usually\x20appearing\x20when\x20doses\x20exceed\x208\x20mg/kg.</p>\x0a<p>Intravenous\x20administration\x20of<strong>\x20methylene\x20blue</strong>\x20is\x20the\x20<strong>treatment\x20for\x20methemoglobinemia.</strong></p>\x0a<p><strong>Benzocaine\x20</strong>can\x20also\x20cause<strong>\x20methemoglobinemia\x20</strong>similar\x20to\x20prilocaine.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x1dc),'choices':[{'id':0x1,'text':_0x45c7f0(0xe0)},{'id':0x2,'text':_0x45c7f0(0x195)},{'id':0x3,'text':_0x45c7f0(0x26d)},{'id':0x4,'text':_0x45c7f0(0x1ad)}],'correct_choice_id':0x2,'solution':'<p><strong>Bambuterol\x20</strong>is\x20an\x20ester\x20prodrug<strong>\x20of\x20terbutaline.\x20</strong>It\x20is\x20slowly\x20hydrolysed\x20by\x20pseudocholinesterase\x20in\x20lungs\x20and\x20plasma\x20to\x20form\x20active\x20terbutaline.</p>\x0a<p>It\x20is\x20administered\x20<strong>orally</strong>\x20and\x20indicated\x20in\x20<strong>chronic\x20and\x20nocturnal\x20asthma</strong>.\x20&nbsp;&nbsp;&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x45c7f0(0x282),'choices':[{'id':0x1,'text':'Timolol'},{'id':0x2,'text':'Betaxolol'},{'id':0x3,'text':_0x45c7f0(0x227)},{'id':0x4,'text':_0x45c7f0(0x128)}],'correct_choice_id':0x1,'solution':_0x45c7f0(0x372),'explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x45c7f0(0x2c7);const quizFilename='pharmacology-st-3-from-q-bank-e7b59eca.html';let hierarchy=[_0x45c7f0(0xc4),_0x45c7f0(0x3c1),_0x45c7f0(0x321)];function _0x2382(_0x487ad8,_0x2d8f0d){const _0x3c7f6f=_0x10a1();return _0x2382=function(_0x13689e,_0x38a5cc){_0x13689e=_0x13689e-0x83;let _0x5471c9=_0x3c7f6f[_0x13689e];return _0x5471c9;},_0x2382(_0x487ad8,_0x2d8f0d);}if(window[_0x45c7f0(0x333)][_0x45c7f0(0x38c)][_0x45c7f0(0x209)]('custom_quiz.html')){const customData=JSON['parse'](localStorage['getItem']('customQuizData'));if(customData){const dxhWsP=_0x45c7f0(0x294)[_0x45c7f0(0x14d)]('|');let PPuXwe=0x0;while(!![]){switch(dxhWsP[PPuXwe++]){case'0':document['getElementById'](_0x45c7f0(0x343))[_0x45c7f0(0x2cf)]=hierarchy['join'](_0x45c7f0(0x2df));continue;case'1':document[_0x45c7f0(0x1d8)](_0x45c7f0(0x21e))['textContent']=questionsData[_0x45c7f0(0x2eb)];continue;case'2':quizName=customData[_0x45c7f0(0xc2)];continue;case'3':hierarchy=customData[_0x45c7f0(0xb6)];continue;case'4':document['title']=quizName+'\x20-\x20Brain\x20And\x20Scalpel';continue;case'5':questionsData=customData[_0x45c7f0(0x22d)];continue;}break;}}}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x45c7f0(0x84),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x45c7f0(0x358)](),quizStartTime=Date[_0x45c7f0(0x358)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x45c7f0(0x2eb)])['fill'](null)[_0x45c7f0(0x332)](()=>({'status':_0x45c7f0(0x2ad),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x51081b=_0x45c7f0,_0x52ae2e={'UyEUz':'userHistory'};if(isQuizCompleted)return;const _0x3b2603=JSON[_0x51081b(0x312)](localStorage[_0x51081b(0x110)](_0x52ae2e[_0x51081b(0x165)]))||{};_0x3b2603[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':'incomplete','lastSeen':new Date()['toISOString']()},localStorage['setItem'](_0x51081b(0x107),JSON[_0x51081b(0x236)](_0x3b2603));}function loadProgress(){const _0x10791c=_0x45c7f0,_0x3bf663={'BDXGU':_0x10791c(0x107),'clzIu':_0x10791c(0x250),'yulds':_0x10791c(0x171)},_0x495a7b=JSON[_0x10791c(0x312)](localStorage[_0x10791c(0x110)](_0x3bf663[_0x10791c(0x2a4)]))||{},_0x3c8045=_0x495a7b[quizFilename];if(_0x3c8045){const _0x26836d=_0x3bf663[_0x10791c(0xc7)][_0x10791c(0x14d)]('|');let _0xe6dec4=0x0;while(!![]){switch(_0x26836d[_0xe6dec4++]){case'0':questionStates=_0x3c8045[_0x10791c(0x361)];continue;case'1':console[_0x10791c(0x381)](_0x3bf663[_0x10791c(0x233)]);continue;case'2':currentMode=_0x3c8045[_0x10791c(0x303)];continue;case'3':stats=_0x3c8045[_0x10791c(0x3c5)];continue;case'4':currentQuestionIndex=_0x3c8045[_0x10791c(0x34a)];continue;case'5':return!![];}break;}}return![];}function clearProgress(){const _0x4f39c0=_0x45c7f0,_0x4e91b5={'qcPEy':'Previous\x20progress\x20cleared.'},_0x6f395c=JSON[_0x4f39c0(0x312)](localStorage[_0x4f39c0(0x110)](_0x4f39c0(0x107)))||{};_0x6f395c[quizFilename]&&(delete _0x6f395c[quizFilename],localStorage['setItem']('userHistory',JSON[_0x4f39c0(0x236)](_0x6f395c)),console[_0x4f39c0(0x381)](_0x4e91b5[_0x4f39c0(0x191)]));}function markQuizAsCompleted(){const _0x50fbf9=_0x45c7f0,_0x58558b={'fBNFV':_0x50fbf9(0x107)},_0x1850d3=JSON[_0x50fbf9(0x312)](localStorage[_0x50fbf9(0x110)](_0x58558b[_0x50fbf9(0x166)]))||{},_0x18a086=questionsData[_0x50fbf9(0x2eb)],_0xd18189=stats[_0x50fbf9(0x1e4)]||0x0;_0x1850d3[quizFilename]={'score':_0xd18189,'total':_0x18a086,'status':_0x50fbf9(0x19a),'completedOn':new Date()[_0x50fbf9(0x16e)]()},localStorage['setItem'](_0x50fbf9(0x107),JSON[_0x50fbf9(0x236)](_0x1850d3));}const urlParams=new URLSearchParams(window[_0x45c7f0(0x333)][_0x45c7f0(0x2ca)]),startAt=parseInt(urlParams[_0x45c7f0(0x384)]('startAt')),resume=urlParams[_0x45c7f0(0x384)](_0x45c7f0(0x2b6))===_0x45c7f0(0x127);function goBack(){const _0x44a2c3=_0x45c7f0,_0x2ab089={'peyjt':function(_0x2c01bc){return _0x2c01bc();},'Zdhdn':_0x44a2c3(0xa6)};if(!isQuizCompleted)_0x2ab089[_0x44a2c3(0xc5)](saveProgress);window[_0x44a2c3(0x333)]['href']=document[_0x44a2c3(0x36c)]||_0x2ab089['Zdhdn'];}function selectMode(_0x3733e0){const _0x4a5007=_0x45c7f0,_0x3053a8={'yRDJH':_0x4a5007(0x237),'xJAxL':function(_0x453e6f){return _0x453e6f();}};currentMode=_0x3733e0,document[_0x4a5007(0x1d8)](_0x3053a8['yRDJH'])[_0x4a5007(0x280)][_0x4a5007(0x234)]=_0x4a5007(0x3b5),_0x3053a8[_0x4a5007(0xd3)](initializeQuiz);}function initializeQuiz(){const _0x359052=_0x45c7f0,_0x2ef703={'xLzVd':function(_0x234d05){return _0x234d05();},'ZJyDR':_0x359052(0x237),'TMBjL':_0x359052(0x3b7),'gEwHj':_0x359052(0x2d8),'xdPRQ':_0x359052(0x19f),'uUTvv':_0x359052(0x31a),'RNiqb':function(_0x106679,_0x1de8eb){return _0x106679===_0x1de8eb;},'QqVqd':_0x359052(0x320),'npsEc':function(_0x2b3a5b,_0x4dec3b){return _0x2b3a5b===_0x4dec3b;},'WNtFE':_0x359052(0x21f),'vazwP':'none','EsxmA':_0x359052(0x3cc),'kihBx':_0x359052(0x29b),'ppcmK':_0x359052(0x3ce),'TgOzi':'timed_study','FZLqo':_0x359052(0x12d),'nhISH':function(_0x3c24cb,_0x21806b){return _0x3c24cb(_0x21806b);},'eYWGo':function(_0x4055f5,_0x2bf45f){return _0x4055f5>=_0x2bf45f;},'djXax':function(_0x594fd4,_0x29374e){return _0x594fd4<_0x29374e;},'EVHaP':function(_0x250bfd){return _0x250bfd();},'UueBX':function(_0x4e7293){return _0x4e7293();}};quizStartTime=Date['now']();const _0x3bd85c=document[_0x359052(0x1d8)](_0x2ef703[_0x359052(0x215)]),_0x4d9895=document[_0x359052(0x1d8)](_0x2ef703[_0x359052(0x3c4)]),_0x3c88c6=document[_0x359052(0x1d8)](_0x2ef703[_0x359052(0x298)]),_0x53d937=_0x2ef703['RNiqb'](currentMode,_0x2ef703['QqVqd'])||_0x2ef703[_0x359052(0x256)](currentMode,_0x2ef703[_0x359052(0x243)]);document[_0x359052(0x1d8)](_0x359052(0x377))[_0x359052(0x280)]['display']=_0x53d937?_0x2ef703['vazwP']:_0x2ef703[_0x359052(0x210)],document[_0x359052(0x1d8)](_0x2ef703[_0x359052(0xe5)])['style'][_0x359052(0x234)]=_0x53d937?_0x2ef703[_0x359052(0x18c)]:_0x2ef703[_0x359052(0x210)],document[_0x359052(0x1d8)](_0x359052(0x3a4))[_0x359052(0x280)][_0x359052(0x234)]=_0x53d937?_0x2ef703[_0x359052(0x210)]:_0x2ef703[_0x359052(0x18c)],document[_0x359052(0x1d8)](_0x2ef703[_0x359052(0x1b5)])['style'][_0x359052(0x234)]=_0x53d937?_0x359052(0x3cc):_0x359052(0x3b5),_0x3bd85c[_0x359052(0x280)][_0x359052(0x234)]=_0x53d937?_0x2ef703['vazwP']:_0x2ef703['TMBjL'],_0x4d9895[_0x359052(0x280)]['display']=_0x53d937?_0x2ef703[_0x359052(0x193)]:_0x2ef703[_0x359052(0x18c)],_0x3c88c6[_0x359052(0x280)][_0x359052(0x234)]=_0x53d937?'flex':_0x2ef703[_0x359052(0x18c)],(_0x2ef703[_0x359052(0x155)](currentMode,_0x2ef703[_0x359052(0x1b4)])||_0x2ef703[_0x359052(0x155)](currentMode,_0x2ef703[_0x359052(0x243)]))&&document[_0x359052(0x1d8)](_0x359052(0xf4))[_0x359052(0x1b9)]['remove'](_0x2ef703[_0x359052(0xf6)]),!_0x2ef703[_0x359052(0x30f)](isNaN,startAt)&&_0x2ef703[_0x359052(0x3c9)](startAt,0x0)&&_0x2ef703[_0x359052(0xee)](startAt,questionsData[_0x359052(0x2eb)])&&(_0x2ef703[_0x359052(0x256)]('WnZOO','WnZOO')?currentQuestionIndex=startAt:(_0x2ef703[_0x359052(0x330)](_0x584d99),_0x337610[_0x359052(0x1d8)](_0x2ef703[_0x359052(0x22e)])['style'][_0x359052(0x234)]=_0x2ef703[_0x359052(0x193)])),_0x2ef703[_0x359052(0x3ab)](loadBookmarkedQuestions),_0x2ef703['UueBX'](generateQuestionNav),updateStats(),_0x2ef703[_0x359052(0x3ab)](displayQuestion);}function generateQuestionNav(){const _0xd39ae=_0x45c7f0,_0x479774={'MFVIj':function(_0xf58144,_0x23a767){return _0xf58144===_0x23a767;},'dQIGt':_0xd39ae(0x17b),'OMsap':_0xd39ae(0x277),'KlPwJ':_0xd39ae(0x201),'bdSrB':'.option-button','Cvnzg':function(_0x4fa28e,_0x27bb19){return _0x4fa28e(_0x27bb19);},'GoSHG':_0xd39ae(0x208),'ILzoA':function(_0x16d0b6,_0x265ffc){return _0x16d0b6<_0x265ffc;},'TjtBe':_0xd39ae(0x291),'IrzOP':function(_0x3ab546,_0x410f5f){return _0x3ab546+_0x410f5f;},'EIEEL':_0xd39ae(0x3c2),'UpGkD':function(_0x4fe064){return _0x4fe064();}},_0x192b33=document[_0xd39ae(0x1d8)]('questionNav');_0x192b33['innerHTML']='';for(let _0x486787=0x0;_0x479774[_0xd39ae(0x11c)](_0x486787,questionsData[_0xd39ae(0x2eb)]);_0x486787++){if(_0x479774[_0xd39ae(0xc8)]===_0x479774[_0xd39ae(0xc8)]){const _0x243c36=document[_0xd39ae(0x184)](_0xd39ae(0x2be));_0x243c36[_0xd39ae(0x2cf)]=_0x479774[_0xd39ae(0x2fb)](_0x486787,0x1),_0x243c36[_0xd39ae(0x2e7)]=_0x479774[_0xd39ae(0x149)],_0x243c36['onclick']=()=>jumpToQuestion(_0x486787),_0x243c36['id']=_0xd39ae(0x141)+_0x486787,_0x192b33[_0xd39ae(0x1ec)](_0x243c36);}else{const _0x3e340e={'gYhrS':function(_0x161482,_0x152ee5){const _0x560406=_0xd39ae;return _0x479774[_0x560406(0x25d)](_0x161482,_0x152ee5);},'bgUIL':_0x479774[_0xd39ae(0xd6)],'DzStK':_0x479774[_0xd39ae(0x136)],'bDgvx':_0x479774['KlPwJ'],'LgsOK':_0x479774[_0xd39ae(0x324)],'ICMMV':function(_0x3e0775,_0x2c9e76){const _0x1a3e15=_0xd39ae;return _0x479774[_0x1a3e15(0x163)](_0x3e0775,_0x2c9e76);},'reZCp':_0x479774['GoSHG'],'XFfNn':function(_0x58b0b6,_0x5dfb8f){return _0x58b0b6(_0x5dfb8f);}};_0x145250[_0xd39ae(0x130)][_0xd39ae(0x23a)]((_0xd59d5e,_0x5368db)=>{const _0x506e0e=_0xd39ae,_0x5b5a2a=_0x3cbe9c['fromCharCode'](0x41+_0x5368db),_0x206743=_0x3e340e['gYhrS'](_0x26ab08,_0x5368db),_0x2719fd=_0x582ed0[_0x506e0e(0x184)](_0x3e340e[_0x506e0e(0x31e)]);_0x2719fd[_0x506e0e(0x29d)]=_0x506e0e(0x1bd)+(_0x206743?_0x3e340e[_0x506e0e(0xd4)]:'')+'\x22\x20data-option-index=\x22'+_0x5368db+_0x506e0e(0x3c3)+_0x5b5a2a+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0xd59d5e['text']||_0x3e340e['bDgvx']+(_0x5368db+0x1))+_0x506e0e(0x32f),_0x50ff7c['appendChild'](_0x2719fd);}),_0xc55b77[_0xd39ae(0x28e)](_0xd39ae(0x33d),function(_0x2c6ad0){const _0xdc0716=_0xd39ae,_0x83ce14=_0x2c6ad0['target']['closest'](_0x3e340e['LgsOK']);if(_0x83ce14){const _0x1cfdb4=_0x3e340e['ICMMV'](_0x23182a,_0x83ce14['getAttribute'](_0x3e340e[_0xdc0716(0x3a2)]));_0x3e340e[_0xdc0716(0x25e)](_0x12c36c,_0x1cfdb4);}});}}_0x479774['UpGkD'](updateQuestionNav);}function updateQuestionNav(){const _0x164af3=_0x45c7f0,_0x2fd5a0={'qFmDF':_0x164af3(0x2d2),'ZoRwW':function(_0x1292a1){return _0x1292a1();},'XGGJb':function(_0x171aa5,_0x524c62){return _0x171aa5(_0x524c62);},'kXtNI':function(_0x2176cb,_0x5a518c){return _0x2176cb===_0x5a518c;},'sPtvR':_0x164af3(0x21f),'ypanz':function(_0x4d3ef6){return _0x4d3ef6();},'GWwbq':function(_0x1adb0b){return _0x1adb0b();},'eitVF':function(_0x5874cb,_0x1ddd4b){return _0x5874cb<_0x1ddd4b;},'BjoWH':function(_0x576245,_0x2c83ea){return _0x576245!==_0x2c83ea;},'jjvPF':_0x164af3(0x1b0),'kAYQd':function(_0x5f1f3d,_0x48658a){return _0x5f1f3d===_0x48658a;},'raxWW':function(_0x1756e1,_0x5a9c6f){return _0x1756e1!==_0x5a9c6f;},'axfMU':_0x164af3(0x24b),'WKWCv':_0x164af3(0x1b6),'MmnYl':_0x164af3(0x84),'kXOww':_0x164af3(0x9a),'omPyf':_0x164af3(0x28b),'gOuzx':function(_0x20942e,_0x2d0713){return _0x20942e===_0x2d0713;},'IUIvc':_0x164af3(0x121),'VXIET':function(_0xeb3327,_0x3ba81d){return _0xeb3327===_0x3ba81d;},'dXrOq':_0x164af3(0x23c),'pJcWv':_0x164af3(0x18f),'xEMQt':_0x164af3(0x352),'xffxb':_0x164af3(0x2ac)};for(let _0x41e2f7=0x0;_0x2fd5a0[_0x164af3(0x21a)](_0x41e2f7,questionsData[_0x164af3(0x2eb)]);_0x41e2f7++){if(_0x2fd5a0[_0x164af3(0x94)](_0x164af3(0x1b0),_0x2fd5a0['jjvPF']))return _0x34ae89['toString']()[_0x164af3(0x2ca)](EZSTEf[_0x164af3(0xec)])[_0x164af3(0x30d)]()[_0x164af3(0x2ee)](_0x9ec211)[_0x164af3(0x2ca)]('(((.+)+)+)+$');else{const _0x773d5f=document['getElementById'](_0x164af3(0x141)+_0x41e2f7),_0x29fa9e=questionStates[_0x41e2f7];let _0x56bb46='';if(_0x2fd5a0['kAYQd'](_0x41e2f7,currentQuestionIndex))_0x56bb46=_0x164af3(0x1cb);else{if(_0x29fa9e[_0x164af3(0x16a)])_0x2fd5a0['raxWW'](_0x164af3(0x1d0),_0x164af3(0x1d0))?_0x273e22=_0x2ba3e1:_0x56bb46=_0x2fd5a0[_0x164af3(0x318)];else{if(_0x29fa9e[_0x164af3(0x398)])_0x56bb46=_0x2fd5a0[_0x164af3(0x247)];else{if(currentMode===_0x2fd5a0[_0x164af3(0x17f)]||currentMode===_0x2fd5a0[_0x164af3(0x17d)]){if(_0x2fd5a0[_0x164af3(0x1e1)]('TmUfj',_0x2fd5a0[_0x164af3(0x378)])){if(_0x2fd5a0[_0x164af3(0x25f)](_0x29fa9e[_0x164af3(0x232)],_0x164af3(0x231)))_0x56bb46=_0x2fd5a0[_0x164af3(0x2f9)];else{if(_0x2fd5a0[_0x164af3(0x203)](_0x29fa9e[_0x164af3(0x232)],_0x2fd5a0['dXrOq']))_0x56bb46=_0x2fd5a0[_0x164af3(0x179)];else _0x56bb46=_0x2fd5a0[_0x164af3(0x2f2)];}}else _0x773de4--,_0x2fd5a0[_0x164af3(0x26b)](_0x448893),_0x5dcf43<=0x0&&(_0x2fd5a0[_0x164af3(0x392)](_0x5630af,_0x4dbc1b),_0x2fd5a0[_0x164af3(0x2f3)](_0x4ea387,_0x2fd5a0['sPtvR'])?_0x2fd5a0['ypanz'](_0x4391c8):_0x2fd5a0[_0x164af3(0x34d)](_0x2b1dc4));}else{if(_0x29fa9e[_0x164af3(0x224)]!==null)_0x56bb46=_0x2fd5a0[_0x164af3(0x12a)];else _0x56bb46=_0x2fd5a0[_0x164af3(0x2f2)];}}}}_0x773d5f[_0x164af3(0x2e7)]=_0x164af3(0x150)+_0x56bb46;}}}function jumpToQuestion(_0x34dd4b){const _0xde7d23=_0x45c7f0,_0x57e608={'fvSIS':_0xde7d23(0x277),'dLHCr':function(_0x1280ec,_0x248465){return _0x1280ec===_0x248465;},'CDvNw':_0xde7d23(0x231),'sxoxk':function(_0x308248,_0x219846){return _0x308248>=_0x219846;},'LFxJI':function(_0x6811cd,_0x46bce5){return _0x6811cd<_0x46bce5;},'nnoQo':'mUaxZ','bWyNK':function(_0x106598,_0x541637){return _0x106598-_0x541637;},'SPbMZ':function(_0x2ad7fa){return _0x2ad7fa();}};if(_0x57e608[_0xde7d23(0x393)](_0x34dd4b,0x0)&&_0x57e608['LFxJI'](_0x34dd4b,questionsData[_0xde7d23(0x2eb)])){if('mUaxZ'!==_0x57e608[_0xde7d23(0x300)]){_0x5d4892[_0xde7d23(0x1b9)][_0xde7d23(0x99)](_0x57e608[_0xde7d23(0x2a5)]);if(_0x57e608['dLHCr'](_0x464240,_0x28f695))_0x59ed16[_0xde7d23(0x1b9)]['add'](_0x57e608[_0xde7d23(0x162)]);else{if(_0x57e608['dLHCr'](_0x5490f5,_0x2e5e28)&&!_0x305ee5)_0x214f53[_0xde7d23(0x1b9)][_0xde7d23(0x2b7)]('incorrect');}}else questionStartTime&&(questionStates[currentQuestionIndex][_0xde7d23(0x30b)]+=_0x57e608[_0xde7d23(0x2f7)](Date[_0xde7d23(0x358)](),questionStartTime)),currentQuestionIndex=_0x34dd4b,_0x57e608[_0xde7d23(0xe3)](displayQuestion),_0x57e608[_0xde7d23(0xe3)](saveProgress);}}function updateStats(){const _0x4a19d6=_0x45c7f0,_0x4132b7={'fNVZX':function(_0x466870,_0x2f0c76){return _0x466870===_0x2f0c76;},'Optav':'study','tlNcq':function(_0xa74313,_0x4491a2){return _0xa74313===_0x4491a2;},'mCIDN':_0x4a19d6(0x9a),'UGGXl':_0x4a19d6(0xcc),'Zwqsl':'incorrectCount','amzEn':'totalAttempted','VmtDy':function(_0x407865,_0x2ff4e8){return _0x407865>_0x2ff4e8;},'mDmXS':function(_0x585945,_0x5eb998){return _0x585945/_0x5eb998;},'zYvXk':_0x4a19d6(0x28c),'Wbvmc':function(_0x444b1f,_0x18fb78){return _0x444b1f+_0x18fb78;},'IbwPH':function(_0x1b8b23,_0x3f30e6){return _0x1b8b23%_0x3f30e6;},'VRPNd':_0x4a19d6(0x30b)};if(_0x4132b7[_0x4a19d6(0xbb)](currentMode,_0x4132b7['Optav'])||_0x4132b7[_0x4a19d6(0x272)](currentMode,_0x4132b7[_0x4a19d6(0x3c0)])){document[_0x4a19d6(0x1d8)](_0x4132b7[_0x4a19d6(0x338)])['textContent']=stats['correctAnswers'],document[_0x4a19d6(0x1d8)](_0x4132b7[_0x4a19d6(0x24f)])[_0x4a19d6(0x2cf)]=stats[_0x4a19d6(0x1e6)],document[_0x4a19d6(0x1d8)](_0x4132b7[_0x4a19d6(0x3c7)])['textContent']=stats[_0x4a19d6(0x23e)];const _0x1c99b6=_0x4132b7[_0x4a19d6(0x220)](stats[_0x4a19d6(0x23e)],0x0)?Math['round'](_0x4132b7[_0x4a19d6(0x334)](stats[_0x4a19d6(0x1e4)],stats[_0x4a19d6(0x23e)])*0x64):0x0;document[_0x4a19d6(0x1d8)](_0x4132b7['zYvXk'])['textContent']=_0x4132b7[_0x4a19d6(0x103)](_0x1c99b6,'%'),stats['totalTime']=questionStates[_0x4a19d6(0x2cd)]((_0x4a459e,_0x290813)=>_0x4a459e+_0x290813[_0x4a19d6(0x30b)],0x0);const _0x19735e=Math['floor'](_0x4132b7[_0x4a19d6(0x334)](stats['totalTime'],0x3e8)),_0xf4b5cf=Math[_0x4a19d6(0x3b9)](_0x19735e/0x3c),_0x5b437a=_0x4132b7[_0x4a19d6(0x2c0)](_0x19735e,0x3c);document[_0x4a19d6(0x1d8)](_0x4132b7[_0x4a19d6(0x176)])[_0x4a19d6(0x2cf)]=_0x4132b7[_0x4a19d6(0x103)](_0xf4b5cf+':',_0x5b437a[_0x4a19d6(0x30d)]()[_0x4a19d6(0xe6)](0x2,'0'));}}function setupVideo(_0x33071d,_0x3a51d0){const _0x203cff=_0x45c7f0,_0x29e78f={'vHjSX':_0x203cff(0x25a),'DlKHH':function(_0x93d87b,_0x3a285a){return _0x93d87b!==_0x3a285a;},'QuGYJ':_0x203cff(0x31b)};if(Hls[_0x203cff(0x1f5)]()){const _0x50da47=new Hls();_0x50da47[_0x203cff(0xe7)](_0x3a51d0),_0x50da47[_0x203cff(0x15e)](_0x33071d);}else _0x33071d[_0x203cff(0x28a)](_0x29e78f['vHjSX'])&&(_0x29e78f[_0x203cff(0x28f)](_0x203cff(0x3ba),_0x29e78f[_0x203cff(0x35d)])?_0x33071d[_0x203cff(0x204)]=_0x3a51d0:_0x109fef['src']=_0xa3bddd);}function displayQuestion(){const _0xaf8946=_0x45c7f0,_0x378f02={'Aqcix':function(_0x111058){return _0x111058();},'xftKm':'hidden','uVPWl':_0xaf8946(0x151),'sjMmA':function(_0x467b9d,_0x20eaaf){return _0x467b9d!==_0x20eaaf;},'NFfBg':_0xaf8946(0x145),'fFqwV':_0xaf8946(0x21b),'vOdNZ':function(_0x21f2a6,_0x5261a7){return _0x21f2a6+_0x5261a7;},'kzdhL':function(_0x1c6d58,_0x6681ca){return _0x1c6d58===_0x6681ca;},'SIWSt':'div','KTxbN':'selected','CKMIy':_0xaf8946(0x201),'DzYsp':_0xaf8946(0x111),'MsFXj':'data-option-index','FynAD':function(_0x44c97e,_0x13591b){return _0x44c97e(_0x13591b);},'EqRdM':function(_0x25464f,_0x31db69){return _0x25464f!==_0x31db69;},'GniWC':_0xaf8946(0x13f),'zfjjD':'questionText','fgAZu':_0xaf8946(0x235),'pcikT':function(_0x4b32c7,_0x23bf95){return _0x4b32c7*_0x23bf95;},'IbRrX':function(_0x81f7d4,_0x3c2e8e){return _0x81f7d4/_0x3c2e8e;},'qqGpd':function(_0x5f388c,_0x343b87){return _0x5f388c+_0x343b87;},'QhEjm':function(_0x4924f9,_0x4e34a2){return _0x4924f9+_0x4e34a2;},'bEHte':'currentQuestion','WmUQw':'prevBtn','kteZj':function(_0x546c76,_0x5d4b44){return _0x546c76===_0x5d4b44;},'NurOj':_0xaf8946(0x2a3),'TQybU':'No\x20question\x20text\x20available','gcpVT':_0xaf8946(0x2f6),'TXmbK':'optionsContainer','SjdZQ':_0xaf8946(0x341),'gLxdN':_0xaf8946(0x85),'dTZVy':_0xaf8946(0x33d),'UIhoG':function(_0x535b52){return _0x535b52();},'laZBJ':_0xaf8946(0x9a),'mxMiy':function(_0x22b50e,_0x26c9d5){return _0x22b50e===_0x26c9d5;},'pIExt':function(_0x509fe5,_0x19d688){return _0x509fe5===_0x19d688;},'ipHXg':_0xaf8946(0x1fe)};if(!questionsData||_0x378f02[_0xaf8946(0x362)](questionsData['length'],0x0)){if(_0x378f02[_0xaf8946(0x29a)](_0x378f02[_0xaf8946(0x168)],'JXjqN')){document[_0xaf8946(0x1d8)](_0x378f02[_0xaf8946(0x1b1)])['innerHTML']=_0x378f02[_0xaf8946(0x27f)];return;}else _0x28f2c9++,_0x215be9(),_0x378f02[_0xaf8946(0x19c)](_0x58a471);};const _0x4d9f9b=questionsData[currentQuestionIndex];questionStartTime=Date['now'](),selectedOption=questionStates[currentQuestionIndex][_0xaf8946(0x224)];const _0x58837f=_0x378f02['pcikT'](_0x378f02[_0xaf8946(0xd7)](_0x378f02[_0xaf8946(0x133)](currentQuestionIndex,0x1),questionsData[_0xaf8946(0x2eb)]),0x64);document[_0xaf8946(0x1d8)]('progressBar')[_0xaf8946(0x280)][_0xaf8946(0x309)]=_0x378f02[_0xaf8946(0xb1)](_0x58837f,'%'),document[_0xaf8946(0x1d8)](_0x378f02['bEHte'])[_0xaf8946(0x2cf)]=_0x378f02['QhEjm'](currentQuestionIndex,0x1),updateQuestionNav(),document['getElementById'](_0x378f02[_0xaf8946(0x2ed)])['disabled']=_0x378f02[_0xaf8946(0x14f)](currentQuestionIndex,0x0),document[_0xaf8946(0x1d8)](_0x378f02[_0xaf8946(0xde)])['classList'][_0xaf8946(0x2b7)](_0x378f02[_0xaf8946(0x257)]),document['getElementById'](_0x378f02[_0xaf8946(0x1b1)])['innerHTML']=_0x4d9f9b['text']||_0x378f02[_0xaf8946(0xd2)];let _0x7a9e40='';if(_0x4d9f9b[_0xaf8946(0x1ac)])_0x7a9e40+=_0xaf8946(0x2ef)+_0x4d9f9b[_0xaf8946(0x1ac)]+_0xaf8946(0x278);if(_0x4d9f9b[_0xaf8946(0x34f)])_0x7a9e40+=_0xaf8946(0x268)+_0x4d9f9b[_0xaf8946(0x34f)]+'\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>';if(_0x4d9f9b[_0xaf8946(0x229)]){if(_0x378f02['sjMmA'](_0xaf8946(0x38d),_0xaf8946(0x38d))){_0x44cf1d[_0xaf8946(0x1b9)]['remove'](_0x378f02['xftKm']);if(_0x39f9b2['includes'](_0x378f02[_0xaf8946(0x316)]))_0x51b25f(_0xdd4f60,_0x312dc1);else _0x34269e[_0xaf8946(0x204)]=_0x4cdc36;}else _0x4d9f9b[_0xaf8946(0x229)][_0xaf8946(0x23a)](_0x376189=>{const _0x1b251c=_0xaf8946;if(_0x378f02[_0x1b251c(0x35a)](_0x378f02['NFfBg'],_0x378f02[_0x1b251c(0x29e)])){if(_0x376189)_0x7a9e40+=_0x1b251c(0x2c1)+_0x376189+_0x1b251c(0x221);}else{const _0x3862fa=_0x39a446[_0x1b251c(0x3b3)](_0x475ad9,arguments);return _0x1545b7=null,_0x3862fa;}});}document[_0xaf8946(0x1d8)](_0x378f02[_0xaf8946(0x29f)])[_0xaf8946(0x29d)]=_0x7a9e40;const _0x52b77f=document['getElementById'](_0x378f02[_0xaf8946(0x173)]);_0x52b77f['innerHTML']='',_0x52b77f['classList'][_0xaf8946(0x99)](_0x378f02[_0xaf8946(0xea)]);if(_0x4d9f9b[_0xaf8946(0x130)]&&Array['isArray'](_0x4d9f9b[_0xaf8946(0x130)])){if(_0x378f02[_0xaf8946(0x2da)]!==_0xaf8946(0x397))_0x4d9f9b[_0xaf8946(0x130)][_0xaf8946(0x23a)]((_0x159b13,_0x5498cc)=>{const _0x205880=_0xaf8946,_0x1c9747=String[_0x205880(0xf8)](_0x378f02[_0x205880(0x113)](0x41,_0x5498cc)),_0x1f0e06=_0x378f02[_0x205880(0x362)](selectedOption,_0x5498cc),_0x5c7233=document[_0x205880(0x184)](_0x378f02[_0x205880(0x395)]);_0x5c7233[_0x205880(0x29d)]=_0x205880(0x1bd)+(_0x1f0e06?_0x378f02[_0x205880(0xf9)]:'')+'\x22\x20data-option-index=\x22'+_0x5498cc+'\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>'+_0x1c9747+_0x205880(0x1c3)+(_0x159b13[_0x205880(0x1aa)]||_0x378f02[_0x205880(0x113)](_0x378f02[_0x205880(0xb9)],_0x378f02[_0x205880(0x113)](_0x5498cc,0x1)))+_0x205880(0x32f),_0x52b77f[_0x205880(0x1ec)](_0x5c7233);}),_0x52b77f[_0xaf8946(0x28e)](_0x378f02['dTZVy'],function(_0x9036d8){const _0x286261=_0xaf8946,_0x57d1a0=_0x9036d8[_0x286261(0xaf)][_0x286261(0x100)](_0x378f02['DzYsp']);if(_0x57d1a0){const _0x2f2c26=parseInt(_0x57d1a0[_0x286261(0x8e)](_0x378f02['MsFXj']));_0x378f02[_0x286261(0x345)](selectOption,_0x2f2c26);}});else{if(_0x5d6950){const _0x3d48e7=_0x284382[_0xaf8946(0x3b3)](_0x51ff89,arguments);return _0x4d03a2=null,_0x3d48e7;}}}_0x378f02['Aqcix'](updateBookmarkButton),_0x378f02[_0xaf8946(0x3d1)](updateMarkReviewButton),(_0x378f02[_0xaf8946(0x362)](currentMode,_0x378f02[_0xaf8946(0x1ca)])||_0x378f02[_0xaf8946(0x2c8)](currentMode,_0xaf8946(0x21f)))&&!isQuizCompleted&&(_0x378f02['pIExt'](_0x378f02[_0xaf8946(0x328)],_0xaf8946(0x1fe))?_0x378f02[_0xaf8946(0x3d1)](startTimer):_0x435072[_0xaf8946(0x1b9)][_0xaf8946(0x197)](_0x378f02[_0xaf8946(0xf9)],_0x437b55===_0x319c98));}function selectOption(_0x5d84da){const _0x1f85ab=_0x45c7f0,_0x42dce7={'hpShq':_0x1f85ab(0xcf),'ZVapE':function(_0x9ae958,_0xb0bdab){return _0x9ae958===_0xb0bdab;},'kNgSz':function(_0x1815a8,_0x56bb19){return _0x1815a8-_0x56bb19;},'jEzAn':_0x1f85ab(0x341),'npwkd':_0x1f85ab(0x111),'UsQIj':_0x1f85ab(0x84),'TEvfq':function(_0x398b09,_0x14e125){return _0x398b09===_0x14e125;},'cdIMl':_0x1f85ab(0x9a),'iAFcn':'TJBbw','hAIGN':_0x1f85ab(0x23b),'EPgen':function(_0x4a1eb6){return _0x4a1eb6();},'atGps':_0x1f85ab(0x116),'Uyhso':function(_0x4536a5,_0x4a26ad){return _0x4536a5===_0x4a26ad;},'EGvnt':_0x1f85ab(0x2ad),'OJIiy':function(_0x577806){return _0x577806();}},_0x34ce7e=document[_0x1f85ab(0x1d8)]('optionsContainer');if(_0x34ce7e[_0x1f85ab(0x1b9)][_0x1f85ab(0x15d)](_0x42dce7[_0x1f85ab(0x1cf)]))return;questionStartTime&&(questionStates[currentQuestionIndex][_0x1f85ab(0x30b)]+=Date['now']()-questionStartTime,questionStartTime=Date[_0x1f85ab(0x358)]()),selectedOption=_0x5d84da,questionStates[currentQuestionIndex][_0x1f85ab(0x224)]=_0x5d84da,document[_0x1f85ab(0x317)](_0x42dce7['npwkd'])[_0x1f85ab(0x23a)]((_0x24a32e,_0xd7bfbc)=>{const _0x24b093=_0x1f85ab;if(_0x42dce7[_0x24b093(0x178)]!==_0x42dce7[_0x24b093(0x178)]){_0x12616f['totalAttempted']++,_0x2569db[_0x24b093(0x182)]--;if(_0x4d1fd5)_0x4f4f81['correctAnswers']++;else _0x22e08b[_0x24b093(0x1e6)]++;}else _0x24a32e[_0x24b093(0x1b9)]['toggle'](_0x24b093(0x277),_0x42dce7[_0x24b093(0xb3)](_0xd7bfbc,_0x5d84da));}),_0x42dce7['ZVapE'](currentMode,_0x42dce7[_0x1f85ab(0x1ce)])||_0x42dce7[_0x1f85ab(0x1f2)](currentMode,_0x42dce7[_0x1f85ab(0x34b)])?_0x42dce7[_0x1f85ab(0x1f8)]===_0x42dce7['hAIGN']?_0x143520=_0x228d5d:_0x42dce7[_0x1f85ab(0x258)](processAnswer):'SuyfU'===_0x42dce7['atGps']?(_0x42dce7[_0x1f85ab(0x18a)](questionStates[currentQuestionIndex][_0x1f85ab(0x232)],_0x42dce7['EGvnt'])&&(questionStates[currentQuestionIndex][_0x1f85ab(0x232)]='answered',stats['totalAttempted']++,stats['notAttempted']--),_0x42dce7['EPgen'](updateQuestionNav)):_0x58d065[_0x4427bb][_0x1f85ab(0x30b)]+=_0x42dce7[_0x1f85ab(0xcd)](_0x4f95db[_0x1f85ab(0x358)](),_0x245427),_0x42dce7['OJIiy'](saveProgress);}function processAnswer(){const _0x48155f=_0x45c7f0,_0x53237f={'eYqiV':_0x48155f(0x3b5),'lUvFh':function(_0x8cff61,_0xbcfde){return _0x8cff61===_0xbcfde;},'Mnpog':function(_0x114eb5,_0x51f018){return _0x114eb5===_0x51f018;},'QcJgy':'not_attempted','RWFok':function(_0x10eade,_0x40c73a){return _0x10eade!==_0x40c73a;},'dxCeY':_0x48155f(0x301),'EKHWK':_0x48155f(0x335),'WoUxC':_0x48155f(0x231),'MWWZv':_0x48155f(0x23c),'MpIBa':function(_0x1e6ac1){return _0x1e6ac1();},'eREnh':function(_0x10d433,_0x324fc6){return _0x10d433(_0x324fc6);}},_0x47c191=questionsData[currentQuestionIndex],_0x3ffd90=_0x47c191[_0x48155f(0x29c)];if(_0x53237f['lUvFh'](selectedOption,null))return;const _0x2da3f2=_0x47c191[_0x48155f(0x130)][selectedOption],_0x2e176a=_0x53237f[_0x48155f(0x1ed)](_0x2da3f2['id'],_0x3ffd90);if(questionStates[currentQuestionIndex]['status']===_0x53237f[_0x48155f(0xfa)]){if(_0x53237f[_0x48155f(0x2aa)](_0x53237f[_0x48155f(0x1f6)],_0x53237f[_0x48155f(0x11f)])){stats[_0x48155f(0x23e)]++,stats[_0x48155f(0x182)]--;if(_0x2e176a)stats[_0x48155f(0x1e4)]++;else stats['incorrectAnswers']++;}else _0x27aa39[_0x48155f(0x1d8)](_0x48155f(0x237))[_0x48155f(0x280)][_0x48155f(0x234)]=_0x53237f[_0x48155f(0x1d4)],_0x4bca10();}questionStates[currentQuestionIndex][_0x48155f(0x232)]=_0x2e176a?_0x53237f[_0x48155f(0x17e)]:_0x53237f['MWWZv'],_0x53237f[_0x48155f(0x252)](updateStats),_0x53237f['eREnh'](showInlineFeedback,_0x2e176a),updateQuestionNav();}function showInlineFeedback(_0x80cc87){const _0x5de5b1=_0x45c7f0,_0x68dd35={'FlrSu':'selected','KQZAD':function(_0xa38d55,_0xc9a485){return _0xa38d55===_0xc9a485;},'nHtEz':_0x5de5b1(0x231),'uSpvN':function(_0x2fe293,_0x19cacf){return _0x2fe293!==_0x19cacf;},'apdlD':_0x5de5b1(0x84),'RnEXS':'optionsContainer','ClMCh':_0x5de5b1(0x111),'NswiB':'answered'};if(_0x68dd35[_0x5de5b1(0x9b)](currentMode,_0x68dd35[_0x5de5b1(0x389)])&&_0x68dd35[_0x5de5b1(0x9b)](currentMode,_0x5de5b1(0x9a)))return;const _0x4666bc=document[_0x5de5b1(0x1d8)](_0x68dd35[_0x5de5b1(0x2e2)]),_0x30cbdd=_0x4666bc[_0x5de5b1(0x317)](_0x68dd35['ClMCh']),_0x4be6bb=questionsData[currentQuestionIndex],_0x53d90a=_0x4be6bb[_0x5de5b1(0x29c)];let _0x4e7886=_0x4be6bb[_0x5de5b1(0x130)]['findIndex'](_0x33624b=>_0x33624b['id']===_0x53d90a);_0x4666bc['classList'][_0x5de5b1(0x2b7)](_0x68dd35[_0x5de5b1(0x1a4)]),_0x30cbdd[_0x5de5b1(0x23a)]((_0x13e4e8,_0x40a48b)=>{const _0xcace34=_0x5de5b1;_0x13e4e8[_0xcace34(0x1b9)][_0xcace34(0x99)](_0x68dd35[_0xcace34(0x22a)]);if(_0x68dd35['KQZAD'](_0x40a48b,_0x4e7886))_0x13e4e8[_0xcace34(0x1b9)][_0xcace34(0x2b7)](_0x68dd35[_0xcace34(0x26a)]);else{if(_0x68dd35[_0xcace34(0xcb)](_0x40a48b,selectedOption)&&!_0x80cc87)_0x13e4e8[_0xcace34(0x1b9)][_0xcace34(0x2b7)](_0xcace34(0x23c));}}),showSolution();}function _0x10a1(){const _0x13e412=['<p>The\x20figure\x20shows\x20<strong>characteristic\x20barbiturate\x20blisters</strong>.\x20This\x20is\x20a\x20case\x20<strong>of\x20phenobarbitone\x20poisoning.</strong></p>\x0a<p><strong>\u00a0Acute\x20Barbiturate\x20poisoning</strong>:</p>\x0a<p>Manifestations\x20are\x20due\x20to\x20excessive\x20CNS\x20depression—</p>\x0a<ul>\x0a<li>Patient\x20is\x20<strong>flabby\x20and\x20comatose</strong>\x20with\x20shallow\x20and\x20failing\x20respiration</li>\x0a<li>Fall\x20in\x20BP\x20and\x20<strong>cardiovascular\x20collapse</strong></li>\x0a<li>Renal\x20shut\x20down</li>\x0a<li>Pulmonary\x20complications</li>\x0a<li><strong>Bullous\x20eruptions</strong></li>\x0a</ul>\x0a<p>Lethal\x20dose\x20depends\x20on\x20lipid\x20solubility.</p>\x0a<ul>\x0a<li>It\x20is\x202–3\x20g\x20for\x20the\x20more\x20lipid-soluble\x20agents\x20(short-acting\x20barbiturates)</li>\x0a<li>5–10\x20g\x20for\x20less\x20lipid-soluble\x20phenobarbitone</li>\x0a</ul>\x0a<p><strong>Treatment</strong></p>\x0a<ul>\x0a<li><strong>Gastric\x20lavage</strong></li>\x0a<li><strong>Supportive\x20measures</strong>:\x20such\x20as,\x20patent\x20airway,\x20assisted\x20respiration,\x20oxygen,\x20maintenance\x20of\x20blood\x20volume\x20by\x20fluid\x20infusion\x20and\x20use\x20of\x20vasopressors—dopamine\x20may\x20be\x20preferred\x20for\x20its\x20renal\x20vasodilating\x20action.</li>\x0a<li><strong>Alkaline\x20diuresis</strong>:\x20with\x20sodium\x20bicarbonate\x201\x20mEq/kg\x20IV\x20with\x20or\x20without\x20mannitol\x20is\x20helpful\x20only\x20in\x20the\x20case\x20of\x20long\x20acting\x20barbiturates\x20which\x20are\x20eliminated\x20primarily\x20by\x20renal\x20excretion.</li>\x0a<li><strong>Haemodialysis</strong>\x20and\x20hemoperfusion</li>\x0a</ul>\x0a<p>\u00a0</p>\x0a<p>\u00a0</p>\x0a<p><strong>NOTE</strong>:\x20There\x20<strong>is\x20no\x20specific\x20antidote</strong>\x20for\x20barbiturates.</p>','incorrectResult','UGGXl','JOgcq','GRHxa','VcrLB','VBcHQ','click','LFT','totalTime','BbIuB','answered','totalTimeResult','quizHierarchy','border-gray-600','FynAD','error','FwEPb','cPOPd','WcDmc','currentQuestionIndex','cdIMl','cfZVc','GWwbq','Duloxetine','question_video','RSiaG','Streptomycin','nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','explanation_images','VkPba','oIXff','<p><strong>Streptomycin</strong>\x20is\x20the\x20drug\x20of\x20choice\x20for\x20<strong>tularemia,&nbsp;</strong>a\x20tick-borne\x20disease\x20caused\x20by&nbsp;<em>Francisella\x20tularensis\x20</em>(aerobic\x20gram-negative\x20bacteria).</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x201050\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Streptomycin\x20is\x20an\x20<strong>aminoglycoside</strong>.\x20It\x20may\x20be\x20administered\x20by\x20deep\x20intramuscular\x20injection\x20or\x20intravenously.\x20Its\x20uses\x20include:</p>\x0a<ul>\x0a<li><strong>Tuberculosis</strong></li>\x0a<li><strong>Plague</strong>:\x20rapid\x20cure\x20in\x207&ndash;12\x20days</li>\x0a<li><strong>Tularemia</strong>:\x20<strong>tetracyclines\x20</strong>are\x20the<strong>\x20alternative</strong>\x20drugs,\x20especially\x20in\x20milder\x20cases</li>\x0a</ul>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x201044\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>Aminoglycosides\x20are\x20used\x20to\x20treat\x20infections\x20caused\x20by\x20<strong>aerobic\x20gram-negative</strong>\x20bacteria.\x20These\x20are\x20<strong>bactericidal</strong>\x20drugs\x20and\x20show\x20rapid\x20<strong>concentration-dependent\x20killing</strong>.\x20The\x20inhibitory\x20effect\x20persists\x20even\x20after\x20the\x20serum\x20concentration\x20has\x20fallen\x20below\x20the\x20minimum\x20inhibitory\x20concentration\x20(<strong>postantibiotic\x20effect</strong>).\x20High-dose,\x20extended-interval\x20dosing\x20is\x20hence\x20effective.\x20They\x20inhibit\x20protein\x20synthesis\x20by\x20acting\x20on\x20<strong>multiple\x20sites</strong>\x20on\x20the\x20<strong>30s\x20</strong>and<strong>\x2050s</strong>\x20ribosomal\x20subunits.&nbsp;</p>\x0a<p>Aminoglycosides\x20need&nbsp;<strong>therapeutic\x20dose\x20monitoring</strong>&nbsp;because\x20of\x20their&nbsp;<strong>narrow\x20therapeutic\x20index.&nbsp;</strong>These\x20drugs\x20are&nbsp;<strong>nephrotoxic</strong>&nbsp;and&nbsp;<strong>ototoxic.</strong>\x20The\x20dose\x20has\x20to\x20be\x20<strong>reduced</strong>\x20in\x20patients\x20with\x20impaired<strong>\x20renal</strong>\x20function.&nbsp;</p>\x0a<p>The\x20uses\x20of\x20various\x20aminoglycoside\x20drugs\x20are\x20as\x20follows:</p>\x0a<ul>\x0a<li>Gentamicin\x20is\x20used\x20for\x20<em><strong>Pseudomonas\x20</strong></em>infection\x20(in\x20combination\x20with\x20<strong>3rd\x20generation\x20cephalosporin</strong>)\x20and\x20urinary\x20tract\x20infection</li>\x0a<li>Streptomycin\x20is\x20used\x20as\x20a\x202nd\x20line\x20agent\x20for\x20tuberculosis\x20and\x20<strong>amikacin</strong>\x20for\x20<strong>multidrug-resistant\x20tuberculosis&nbsp;</strong></li>\x0a<li><strong>Oral\x20neomycin</strong>\x20is\x20used\x20for\x20bowel\x20preparation\x20before\x20surgery</li>\x0a</ul>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','Furosemide','now','They\x20are\x20drugs\x20for\x20rare\x20diseases\x20with\x20little\x20commercial\x20value\x20for\x20pharmaceutical\x20companies.','sjMmA','Class\x20II','<ul>\x0a<li><strong>Dipyridamole</strong>\x20causes\x20<strong>coronary\x20steal\x20phenomenon</strong>.</li>\x0a<li>It\x20is\x20a<strong>\x20powerful\x20coronary\x20dilator</strong>\x20increases\x20total\x20coronary\x20flow\x20by\x20<strong>preventing\x20uptake\x20and\x20degradation\x20of\x20adenosine</strong>\x20which\x20is\x20a\x20local\x20mediator\x20involved\x20in\x20autoregulation\x20of\x20coronary\x20flow\x20in\x20response\x20to\x20ischaemia.</li>\x0a<li>By\x20dilating\x20resistance\x20vessels\x20in\x20the\x20non-ischaemic\x20zone\x20as\x20well<strong>,\x20it\x20diverts\x20the\x20already\x20reduced\x20blood\x20flow\x20away\x20from\x20the\x20ischaemic\x20zon</strong>e\x20causing\x20coronary\x20steal\x20phenomenon.</li>\x0a</ul>','QuGYJ','exception','xqUPy','</span></div>','questionStates','kzdhL','INH','pop','lhqsf','NkRNT','<p><strong>Bisacodyl\x20is\x20a\x20stimulant\x20purgative</strong>.</p>\x0a<p><strong>Classification\x20of\x20Laxatives</strong></p>\x0a<ul>\x0a<li><strong>Bulk\x20forming</strong>\u00a0\x0a<ul>\x0a<li>Dietary\x20fibre:\x20Bran,\x20Psyllium/Ispaghula,\x20Methylcellulose</li>\x0a</ul>\x0a</li>\x0a<li><strong>Stool\x20softener</strong>:\x20Docusates\x20(DOSS),\x20<strong>Liquid\x20paraffin</strong></li>\x0a<li><strong>Stimulant\x20purgatives</strong>\x0a<ul>\x0a<li>Diphenylmethanes:\x20Phenolphthalein,\x20<strong>Bisacodyl</strong>,\x20Sodium\x20picosulphate</li>\x0a<li>Anthraquinones:\x20Senna,\x20Cascara\x20sagrada</li>\x0a<li>5-HT4\x20agonist:\x20Prucalopride</li>\x0a<li>Fixed\x20oil:\x20<strong>Castor\x20oil</strong></li>\x0a</ul>\x0a</li>\x0a<li><strong>Osmotic\x20purgatives</strong>\x0a<ul>\x0a<li>Magnesium\x20salts:\x20sulphate,\x20hydroxide</li>\x0a<li>Sodium\x20salts:\x20sulphate,\x20phosphate</li>\x0a<li>Sod.\x20pot.\x20tartrate</li>\x0a<li><strong>Lactulose</strong></li>\x0a</ul>\x0a</li>\x0a</ul>','EhLCb','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','9pvJvsd','ZciNY','referrer','SLXhH','1.6-\x202\x20ng/mL','trace','Ralvo','table','<p>The\x20given\x20clinical\x20scenario\x20is\x20suggestive\x20of\x20<strong>acute\x20bronchial\x20asthma</strong>\x20which\x20was\x20most\x20likely\x20precipitated\x20by\x20<strong>timolol.</strong></p>\x0a<p>Timolol\x20is\x20a\x20<strong>non-selective\x20beta-blocker</strong>\x20that\x20reduces&nbsp;intraocular\x20pressure\x20by&nbsp;decreasing\x20aqueous\x20formation.<strong>&nbsp;</strong>It&nbsp;<strong>precipitates\x20bronchial\x20asthma</strong>\x20in\x20susceptible\x20individuals\x20by\x20beta-2\x20blockade.</p>\x0a<p><strong>Betaxolol</strong>\x20is\x20a<strong>\x20beta-1\x20selective\x20blocker</strong>\x20that\x20is\x20used\x20in\x20glaucoma\x20and\x20has\x20a\x20lower\x20propensity\x20to\x20precipitate\x20bronchial\x20asthma.</p>\x0a<p><strong>Latanoprost</strong>\x20is\x20a\x20prostaglandin\x20(<strong>PGF-2&nbsp;alpha</strong>)\x20<strong>analog</strong>\x20and\x20does\x20not\x20precipitate\x20bronchial\x20asthma.&nbsp;</p>\x0a<p><strong>Acetazolamide</strong>\x20is\x20a\x20<strong>carbonic\x20anhydrase\x20inhibitor</strong>\x20and\x20does\x20not\x20precipitate\x20bronchial\x20asthma.</p>','Ezetimibe','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','zpAIT','solution','statsBar','omPyf','oYOMx','uGKsO','zEdwS','Vasoconstriction','XvSRh','Inhibits\x20activity\x20of\x20mast\x20cells','PWHxu','Dapoxetine','log','JxFpY','FKoff','get','hKnTv','Cholestyramine','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','Which\x20of\x20the\x20following\x20is\x20a\x20bradykinin\x20receptor\x20antagonist?','apdlD','Atenolol','Wnzhb','pathname','XTjxf','QKEPe','NjPSW','Naproxen','info','XGGJb','sxoxk','wsPgV','SIWSt','Chloramphenicol','GPeeE','markedForReview','FMUFI','pcbBS','kzvei','GBvka','ISJqx','<p>The<strong>\x20therapeutic\x20plasma\x20concentration</strong>\x20of\x20digoxin\x20is\x20<strong>0.5-1.4\x20ng/ml.</strong></p>\x0a<p><strong>Digoxin\x20</strong>is\x20a<strong>\x20cardiac\x20glycoside</strong>&nbsp;with\x20a\x20<strong>narrow\x20therapeutic\x20index</strong>\x20and\x20is\x20used\x20in\x20the\x20management\x20of\x20heart\x20failure.\x20It\x20<strong>inhibits\x20the&nbsp;Na<span\x20class=\x22s1\x22>+</span>/K<span\x20class=\x22s1\x22>+&nbsp;</span>ATPase</strong>\x20pump\x20in\x20the\x20myocardium\x20leading\x20to\x20increased\x20accumulation\x20of\x20intracellular\x20sodium.\x20Increased\x20intracellular\x20sodium\x20prevents\x20the\x20efflux\x20of\x20calcium\x20ions.\x20This\x20results\x20in\x20<strong>increased\x20intracellular\x20calcium</strong>\x20which\x20increases\x20the\x20contractility\x20of\x20the\x20muscle.</p>\x0a<p>Pharmacokinetics\x20of\x20digoxin:</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Oral\x20absorption</td>\x0a<td>60&ndash;80%</td>\x0a</tr>\x0a<tr>\x0a<td><strong>Plasma\x20t&frac12;\x20</strong></td>\x0a<td><strong>40\x20hr</strong></td>\x0a</tr>\x0a<tr>\x0a<td><strong>Therapeutic\x20conc.</strong></td>\x0a<td><strong>0.5&ndash;1.4\x20ng/ml</strong></td>\x0a</tr>\x0a<tr>\x0a<td><strong>Toxic\x20conc.</strong></td>\x0a<td><strong>&gt;\x202\x20ng/ml</strong></td>\x0a</tr>\x0a<tr>\x0a<td>Daily\x20maintenance\x20dose</td>\x0a<td>0.125&ndash;0.5\x20mg</td>\x0a</tr>\x0a<tr>\x0a<td>Route\x20of\x20elimination\x20&nbsp;</td>\x0a<td>Renal\x20excretion</td>\x0a</tr>\x0a<tr>\x0a<td>Route\x20of\x20administration</td>\x0a<td>Oral,\x20IV</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><strong>Clinical\x20features\x20of\x20digoxin\x20toxicity:</strong></p>\x0a<ul>\x0a<li>CNS\x20manifestations\x20-\x20Drowsiness,\x20neuralgia,\x20headache,\x20confusion,\x20or\x20giddiness</li>\x0a<li>Ophthalmic\x20manifestations\x20-\x20Visual\x20aberration\x20is\x20an\x20early\x20indication\x20of\x20digitalis\x20toxicity.\x20Yellow-green\x20distortion\x20is\x20the\x20most\x20common.\x20Yellow\x20halos\x20around\x20lights\x20(<strong>xanthopsia</strong>)\x20are\x20seen.\x20Visual\x20acuity\x20is\x20reduced.</li>\x0a<li>Gastrointestinal\x20manifestations-\x20Nausea,\x20vomiting,\x20anorexia,\x20diarrhea,\x20abdominal\x20pain.</li>\x0a<li>Cardiac&nbsp;manifestations\x20-&nbsp;Palpitations,\x20dyspnea,\x20syncope,\x20hypotension.&nbsp;The\x20most\x20serious\x20side\x20effect\x20of\x20digoxin\x20is\x20<strong>arrhythmia</strong>.\x20They\x20can\x20present\x20as&nbsp;extreme\x20bradycardia,\x20atrial\x20fibrillation,\x20ventricular\x20extrasystoles,\x20bigeminy,\x20ventricular\x20tachycardia,\x20and\x20fibrillation.</li>\x0a</ul>\x0a<p>Digoxin\x20should\x20be\x20discontinued\x20whenever\x20toxicity\x20is\x20suspected.&nbsp;An\x20effective\x20<strong>antidote</strong>\x20for\x20digoxin\x20toxicity\x20is\x20<strong>digibind</strong>,\x20which\x20is\x20an\x20anti-digoxin\x20antibody.\x20Arrhythmias\x20should\x20be\x20treated.</p>','questionIndex','Pyrazinamide','CYP2C19','reZCp','6mxJwbL','testModeLegend','Bzrhr','JSmha','<p><strong>Dofetilide</strong>\x20belongs\x20to\x20<strong>class\x20III</strong>\x20of\x20anti-arrhythmic\x20drugs.</p>','RjlEZ','In\x20diabetes\x20insipidus,\x20diuretic\x20showing\x20paradoxical\x20anti-diuretic\x20activity\x20is:','β\x20blocker\x20with\x20intrinsic\x20sympathomimetic\x20activity\x20is:','EVHaP','xMJnW','__proto__','correctResult','totalQuestionsResult','dovIi','eOuYY','Additional\x20leukocyte\x20function\x20inhibition\x20action\x20is\x20observed\x20mainly\x20with','apply','Nitroglycerine','none','qTsSZ','flex','LCNmK','floor','lMzEw','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','Which\x20of\x20the\x20following\x20is\x20a\x20‘nootropic’\x20drug:','Flurbiprofen','LOX\x20inhibitor','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>','mCIDN','NEET\x20PG\x20Test\x20Series\x20Subject\x20Wise','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','xdPRQ','stats','Gray\x20baby\x20syndrome\x20is\x20caused\x20due\x20to\x20intake\x20of\x20which\x20of\x20the\x20following\x20drugs?','amzEn','COX\x20inhibitor','eYWGo','nlGlT','WvjNL','block','DkkMQ','submitSection','zYurm','OAMmf','UIhoG','hzLMj','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','Class\x20I','<p>In\x20<strong>first\x20order\x20kinetics</strong>,\x20constant\x20<strong>fraction</strong>\x20of\x20drug\x20is\x20eliminated\x20per\x20unit\x20time.</p>\x0a<p><strong>Difference\x20Between\x20First\x20and\x20Zero\x20Order\x20Kinetics</strong></p>\x0a<table\x20style=\x22width:\x20380.818px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20176px;\x22><strong>First\x20Order\x20Kinetics\x20(Flow\x20limited\x20elimination)</strong></td>\x0a<td\x20style=\x22width:\x20197.818px;\x22><strong>Zero\x20Order\x20Kinetics\x20(Capacity\x20limited\x20elimination)</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20176px;\x22>The\x20<strong>rate\x20of\x20elimination\x20is</strong>\x20<strong>directly\x20proportional</strong>\x20to\x20the\x20drug\x20concentration\x20in\x20the\x20plasma</td>\x0a<td\x20style=\x22width:\x20197.818px;\x22><strong>The\x20rate\x20of\x20elimination</strong>\x20<strong>remains\x20constant</strong>\x20irrespective\x20of\x20drug\x20concentration\x20in\x20the\x20plasma</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20176px;\x22><strong>Clearance\x20</strong>remains<strong>\x20constant</strong></td>\x0a<td\x20style=\x22width:\x20197.818px;\x22>Clearance\x20decreases\x20with\x20increase\x20in\x20plasma\x20concentration\x20of\x20the\x20drug</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20176px;\x22><strong>A\x20constant</strong>\x20<strong>fraction\x20</strong>of\x20the\x20drug\x20is\x20eliminated\x20in\x20unit\x20time.</td>\x0a<td\x20style=\x22width:\x20197.818px;\x22><strong>A\x20constant\x20amount&nbsp;</strong>of\x20the\x20drug\x20is\x20eliminated\x20in\x20unit\x20time.</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20176px;\x22><strong>t&frac12;\x20</strong>remains<strong>\x20constant</strong></td>\x0a<td\x20style=\x22width:\x20197.818px;\x22>t&frac12;\x20increases\x20with\x20dose</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p><strong>Ethanol</strong>\x20follows\x20zero-order\x20kinetics.\x20Drugs\x20such\x20as\x20<strong>warfarin</strong>,\x20<strong>phenytoin</strong>,\x20theophylline,\x20and\x20tolbutamide\x20also\x20follow\x20zero-order\x20kinetics.</p>','study','IovQm','Usvqu','A\x2050-year-old\x20male\x20diabetic\x20patient\x20was\x20diagnosed\x20with\x20congestive\x20cardiac\x20failure.\x20He\x20was\x20started\x20on\x20digoxin.\x20What\x20will\x20be\x20the\x20therapeutic\x20plasma\x20concentration\x20of\x20this\x20drug?','Which\x20of\x20the\x20following\x20is\x20a\x20SNRI:','yMSoO','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','Desmopressin','Amantadine','Bromocriptine','getAttribute','Stimulant\x20purgative','Xexuj','XIZio','eBTlT','lPHsf','BjoWH','bind','Marked','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','nIhvY','remove','timed_study','uSpvN','HLA-B5701','replace','YCYvT','sMziW','kesFI','<ul>\x0a<li><strong>Imatinib</strong>\x20is\x20the\x20drug\x20of\x20choice\x20in\x20<strong>CML\x20and\x20in\x20metastatic\x20c-kit-positive\x20GIST</strong>.</li>\x0a<li><strong>Nilotinib,\x20dasatinib\x20</strong>are\x20other\x20<strong>tyrosine\x20kinase\x20inhibitors</strong>\x20approved\x20for\x20treatment\x20of\x20<strong>CML</strong>.</li>\x0a</ul>','<p><strong>Duloxetine</strong>\x20is\x20a\x20<strong>serotonin\x20and\x20noradrenaline\x20reuptake\x20inhibitors\x20(SNRI).</strong></p>\x0a<p><strong>Serotonin\x20and\x20noradrenaline\x20reuptake\x20inhibitors\x20(SNRIs)</strong></p>\x0a<ul>\x0a<li>Venlafaxine</li>\x0a<li>Duloxetine</li>\x0a</ul>\x0a<p><strong>Selective\x20serotonin\x20reuptake\x20inhibitors\x20(SSRIs)</strong></p>\x0a<ul>\x0a<li>Fluoxetine</li>\x0a<li>Fluvoxamine</li>\x0a<li>Paroxetine</li>\x0a<li>Sertraline</li>\x0a<li>Citalopram</li>\x0a<li>Escitalopram</li>\x0a<li>Dapoxetine</li>\x0a</ul>','Niacin','DdQea','gsOPg','index.html','toLowerCase','console','<p><strong>Bevacizumab</strong>\x20is\x20a\x20monoclonal\x20antibody\x20against\x20<strong>VEGF</strong>.</p>\x0a<p><strong>IMPORTANT\x20MONOCLONAL\x20ANTIBODIES\x20AND\x20THEIR\x20TARGET</strong></p>\x0a<table\x20style=\x22width:\x20424px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20211.455px;\x22><strong>MONOCLONAL\x20ANTIBODY</strong></td>\x0a<td\x20style=\x22width:\x20199.545px;\x22><strong>\u00a0\x20TARGET</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20211.455px;\x22>\x0a<p>Infliximab</p>\x0a<p>Adalimumab</p>\x0a<p>Golimumab</p>\x0a<p>Certolizumab</p>\x0a</td>\x0a<td\x20style=\x22width:\x20199.545px;\x22>\u00a0<strong>TNF-α</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20211.455px;\x22>Bevacizumab</td>\x0a<td\x20style=\x22width:\x20199.545px;\x22><strong>VEGF</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20211.455px;\x22>Cetuximab</td>\x0a<td\x20style=\x22width:\x20199.545px;\x22><strong>EGFR</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20211.455px;\x22>Rituximab</td>\x0a<td\x20style=\x22width:\x20199.545px;\x22><strong>CD-20</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20211.455px;\x22>Trastuzumab</td>\x0a<td\x20style=\x22width:\x20199.545px;\x22><strong>Her-2/neu</strong></td>\x0a</tr>\x0a</tbody>\x0a</table>','No\x20solution\x20available.','zJnQl','rvFcz','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','Clearance\x20remains\x20constant','target','Treatment\x20of\x20choice\x20in\x20chronic\x20phase-CML\x20is:','QhEjm','iEdqS','ZVapE','55910McByiZ','Among\x20the\x20following\x20anti-thyroid\x20drugs,\x20which\x20is\x20considered\x20safe\x20during\x201st\x20trimester\x20of\x20pregnancy:','hierarchy','Giardiasis','ssUNp','CKMIy','NJQHl','fNVZX','warn','pmnCr','prototype','Eprosartan','TDsTD','Baclofen\x20is\x20used\x20for\x20the\x20treatment\x20of:','name','gosQN','Marrow','peyjt','pPPiC','clzIu','TjtBe','Imatinib','JPhGO','KQZAD','correctCount','kNgSz','iGFoV','QWhft','reload','SKMEF','TQybU','xJAxL','DzStK','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','dQIGt','IbRrX','Methemoglobinemia\x20is\x20caused\x20by:','border-green-500','PltpH','JuIIp','AvGwS','phRmP','NurOj','preventDefault','Salbutamol','<p><strong>Piracetam\x20</strong>is\x20a\x20cyclic\x20GABA\x20derivative\x20and\x20has\x20been\x20called\x20<strong>‘nootropic’</strong>\x20meaning\x20a\x20drug\x20that\x20selectively\x20<strong>improves\x20efficiency\x20of\x20higher\x20telencephalic\x20integrative\x20activities.</strong></p>','<p>Most\x20adults\x20treated\x20with\x20<strong>4–5\x20g/day\x20of\x20aspirin</strong>\x20stay\x20in\x20a\x20state\x20of\x20<strong>compensated\x20respiratory\x20alkalosis.</strong></p>\x0a<p><strong>Aspirin\x20and\x20Acid-Base\x20Balance</strong></p>\x0a<ul>\x0a<li>Usual\x20analgesic\x20doses\x20(0.3–1.0\x20g)\x20have\x20practically\x20no\x20effect.</li>\x0a<li>At\x20<strong>anti-inflammatory\x20doses(4-5g/d)</strong>,\x20<strong>respiratory\x20stimulation\x20predominates</strong>\x20and\x20<strong>tends\x20to\x20wash\x20out\x20CO2</strong>\x20despite\x20increased\x20production,\x20causing\x20<strong>respiratory\x20alkalosis</strong>,\x20which\x20is\x20<strong>compensated\x20by\x20increased\x20renal\x20excretion\x20of\x20HCO3¯</strong>.</li>\x0a<li>An\x20anion-gap\x20metabolic\x20acidosis\x20then\x20follows,\x20due\x20primarily\x20to\x20the\x20accumulation\x20of\x20organic\x20acids,\x20including\x20lactic\x20acid\x20and\x20ketoacids.</li>\x0a<li>The\x20net\x20effect\x20of\x20these\x20changes\x20is\x20that\x20most\x20adults\x20have\x20either\x20a\x20primary\x20respiratory\x20alkalosis\x20or,\x20more\x20commonly,\x20a\x20mixed\x20primary\x20respiratory\x20alkalosis-primary\x20metabolic\x20acidosis.</li>\x0a<li>\u00a0</li>\x0a</ul>','SPbMZ','EMQWt','kihBx','padStart','loadSource','notAttemptedResult','Rimonabant','SjdZQ','NFVhA','qFmDF','DOhtD','djXax','Vincristine','Drug\x20of\x20choice\x20in\x20lithium\x20induced\x20nephrogenic\x20diabetes\x20insipidus\x20is:','Temazepam','hWNuS','Phenytoin','timerContainer','uObsi','FZLqo','qtHNW','fromCharCode','KTxbN','QcJgy','DXHAB','<p><strong>Peripheral\x20neuritis</strong>\x20and\x20a\x20variety\x20of\x20<strong>neurological\x20manifestations</strong>\x20(paresthesias,\x20numbness,\x20mental\x20disturbances<strong>,\x20convulsions</strong>)\x20are\x20the\x20<strong>most\x20important\x20dose-dependent\x20toxic\x20effects\x20of\x20INH</strong>.</p>','sBGEx','return\x20(function()\x20','tQzpw','closest','SERM','kNcjh','Wbvmc','eNGXv','quizFile','CgtMd','userHistory','zpDPX','Hypokalemia','dLwuT','GJRoO','join','VQYHh','cBqIp','Which\x20of\x20the\x20following\x20statements\x20is\x20true\x20about\x20the\x20given\x20dose-response\x20curve\x20(DRC)?','getItem','.option-button','border-red-500','vOdNZ','kqczE','Carbimazole','SuyfU','Abacavir','NuYTX','CRwbA','No\x20solution\x20provided','wnWkS','ILzoA','Tetracycline','filter','EKHWK','rThMl','nav-btn-correct','IV\x20infusion\x20of\x20low\x20doses\x20of\x20dopamine\x20produces\x20which\x20of\x20the\x20following\x20effects:','<p><strong>Furosemide\x20causes\x20alkalosis</strong>\x20and\x20not\x20acidosis.</p>\x0a<p><strong>Adverse\x20effects\x20of\x20loop\x20diuretics</strong></p>\x0a<ul>\x0a<li><strong>Hypokalemia\x20and\x20alkalosis</strong></li>\x0a<li>Acute\x20saline\x20depletion</li>\x0a<li>Dilutional\x20hyponatremia</li>\x0a<li>Hearing\x20loss</li>\x0a<li>Hyperuricemia</li>\x0a<li><strong>Hyperglycemia</strong>\x20and\x20hyperlipidemia</li>\x0a<li>Hypocalcemia</li>\x0a<li><strong>Magnesium\x20depletion</strong></li>\x0a</ul>\x0a<p><strong>NOTE:\x20</strong>Thiazides\x20have\x20similar\x20adverse\x20effects,\x20the\x20only\x20difference\x20being\x20that\x20<strong>thiazides\x20cause\x20hypercalcemia.</strong></p>','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','30382ZHWGGS','8BqSqtN','true','Acetazolamide','XjBkT','xffxb','Ceftriaxone','sSEQR','hidden','uKooQ','https://dhmbxeygs57ff.cloudfront.net/uploads/29a1326c91ea4e47bb57387a171d1677x1280x938.JPEG','choices','Cerebellar\x20ataxia\x20is\x20caused\x20by\x20which\x20of\x20the\x20following\x20anti-cancer\x20drug:','Formation\x20of\x20NAPQI\x20from\x20acetaminophen\x20is\x20catalysed\x20by:','qqGpd','HLA-A6801','JFnmt','OMsap','https://cdn1.dailyrounds.org/uploads/16cb1885c46a418795d6070d270df523.JPEG','279qOQbAE','Propranolol','zxnHs','explanation_audio_eng','<p><strong>Cytarabine</strong>\x20toxicity\x20is\x20associated\x20with\x20<strong>cerebellar\x20ataxia.</strong></p>\x0a<p><strong>ANTI-CANCER\x20DRUGS\x20AND\x20THEIR\x20TOXICITIES</strong></p>\x0a<table\x20style=\x22width:\x20320.182px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22><strong>DRUG</strong></td>\x0a<td\x20style=\x22width:\x20178.182px;\x22><strong>TOXICITY</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Cyclophosphamide\x20&amp;Ifosfamide</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>Haemorrhagic\x20cystitis,\x20SIADH</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Busulfan</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>Pulmonary\x20fibrosis</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Procarbazine</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>\x0a<p>Secondary\x20leukemias</p>\x0a<p>Disulfiram\x20like\x20reaction</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Cisplatin</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>\x0a<p>Nephrotoxicity</p>\x0a<p>Neurotoxicity</p>\x0a<p>Ototoxicity</p>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Capecitabine</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>Hand\x20and\x20foot\x20syndrome</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Cytarabine</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>Cerebellar\x20ataxia</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Irinotecan</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>Diarrhoea</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Bleomycin</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>Pulmonary\x20fibrosis</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Anthracyclines</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>Cardiotoxicity</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20130px;\x22>Mitomycin</td>\x0a<td\x20style=\x22width:\x20178.182px;\x22>Haemolytic\x20uremic\x20syndrome</td>\x0a</tr>\x0a</tbody>\x0a</table>','Paroxetine','solutionAudio','wTOYU','Benserazide','navBtn_','Oebio','Phenobarbitone','avgTimeResult','iNsOQ','Patiromer','Amiloride','<ul>\x0a<li><strong>CYP2E1\x20</strong>catalyses\x20formation\x20of\x20hepatotoxic\x20<strong>N-acetyl-p-benzoquinone\x20imine</strong>\x20<strong>(NAPQI)\x20from\x20paracetamol.</strong></li>\x0a<li>It\x20also\x20catalyses\x20oxidation\x20of\x20<strong>alcohol\x20and\x20halothane</strong>.</li>\x0a<li><strong>Chronic\x20alcoholism\x20induces</strong>\x20this\x20isoenzyme.</li>\x0a</ul>','EIEEL','yatpe','cdhxT','qkakZ','split','Remimazolam','kteZj','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20','.m3u8','SQiHb','Procaine','Drug\x20\x20B\x20is\x20the\x20least\x20potent','RNiqb','Ibutilide','Entacapone','hfvFQ','KqiRp','Cytarabine','All\x20the\x20following\x20statements\x20regarding\x20first-order\x20kinetics\x20are\x20true\x20except?','Cephalosporin\x20active\x20against\x20pseudomonas\x20aeruginosa\x20is:','contains','attachMedia','Heroin','jQjkj','solutionText','CDvNw','Cvnzg','OnFWV','UyEUz','fBNFV','cfVZr','GniWC','Fenoprofen','bookmarked','Anti-viral\x20drug\x20having\x20dual\x20activity\x20against\x20HIV\x20and\x20HBV\x20is:','PmjVG','Which\x20of\x20the\x20following\x20drugs\x20used\x20to\x20treat\x20type\x20II\x20diabetes\x20mellitus\x20causes\x20weight\x20loss?','toISOString','FSZZI','GUWvi','Progress\x20loaded.','EScyD','TXmbK','questionReviewSection','qrshO','VRPNd','VEGF','hpShq','pJcWv','They\x20are\x20expired\x20drugs\x20which\x20are\x20no\x20longer\x20used\x20in\x20the\x20market\x20and\x20are\x20subsequently\x20withdrawn.','div','What\x20is\x20the\x20drug\x20of\x20choice\x20for\x20tularemia?','kXOww','WoUxC','MmnYl','kSbxk','Radioactive\x20iodine','notAttempted','QdhRh','createElement','You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?','SOVCN','Fentanyl','Rituximab','RReQd','Uyhso','568848efYGrZ','vazwP','custom_quiz.html','pSsZn','nav-btn-incorrect','Cisapride','qcPEy','Dipyridamole','TMBjL','pNKWp','Terbutaline','Which\x20of\x20the\x20following\x20parameters\x20needs\x20to\x20be\x20monitored\x20in\x20a\x20patient\x20on\x20febuxostat\x20therapy:','toggle','key','MsHKp','completed','https://cdn1.dailyrounds.org/uploads/30b7a62f3ced491aa5dfd271584bdb8e.JPEG','Aqcix','IEdAm','wWSIM','markReviewBtn','JzfGk','cWUvV','Which\x20of\x20the\x20following\x20drugs\x20is\x20a\x20selective\x20M3\x20agonist:','Cefotaxime','NswiB','Krvrv','Spironolactone','<p><strong>Acebutolol\x20has\x20intrinsic\x20sympathomimetic\x20activity.</strong></p>\x0a<p><strong>Acebutolol</strong></p>\x0a<ul>\x0a<li><strong>Cardio\x20selective</strong>\x20β\x20blocker</li>\x0a<li><strong>Partial\x20agonistic\x20and\x20membrane\x20stabilizing</strong>\x20properties</li>\x0a<li>Rapidly\x20metabolized\x20to\x20an\x20<strong>active\x20metabolite\x20diacetolol,</strong>\x20which\x20is\x20primarily\x20excreted\x20by\x20kidney\x20and\x20has\x20a\x20longer\x20t½\x20(8–12hours).\x20As\x20such,\x20a\x20single\x20daily\x20dose\x20is\x20sufficient\x20in\x20many\x20patients.</li>\x0a</ul>\x0a<table\x20style=\x22width:\x20375.727px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20162px;\x22><strong>Property\x20</strong></td>\x0a<td\x20style=\x22width:\x20204.727px;\x22>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\x20<strong>β\x20Blocker</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20162px;\x22><strong>Cardioselectivity</strong></td>\x0a<td\x20style=\x22width:\x20204.727px;\x22>\x0a<ul>\x0a<li>Metoprolol</li>\x0a<li>Atenolol</li>\x0a<li><strong>Acebutolol</strong></li>\x0a<li>Bisoprolol</li>\x0a<li>Nebivolol</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20162px;\x22><strong>Partial\x20agonistic\x20</strong>\x20<strong>(intrinsic\x20sympathomimetic)</strong>\x20<strong>action</strong></td>\x0a<td\x20style=\x22width:\x20204.727px;\x22>\x0a<ul>\x0a<li>Pindolol</li>\x0a<li>Celiprolol</li>\x0a<li><strong>Acebutolol</strong></li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20162px;\x22><strong>Membrane\x20stabilizing\x20activity</strong></td>\x0a<td\x20style=\x22width:\x20204.727px;\x22>\x0a<ul>\x0a<li>Propranolol</li>\x0a<li>Oxprenolol</li>\x0a<li><strong>Acebutolol</strong></li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20162px;\x22><strong>Lipid\x20insolubility</strong></td>\x0a<td\x20style=\x22width:\x20204.727px;\x22>\x0a<ul>\x0a<li>Atenolol</li>\x0a<li>Celiprolol</li>\x0a<li>Bisoprolol</li>\x0a<li>Sotalol</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','Lorazepam','strokeDashoffset','text','CYP2D6','question_audio','Formoterol','</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-','explanationVideoPlayer','wejsS','zfjjD','528bIrAwf','They\x20drugs\x20are\x20commonly\x20used\x20drugs\x20but\x20the\x20cost\x20is\x20very\x20high.','TgOzi','ppcmK','nav-btn-marked-review','<p><strong>Spasticity</strong>\x20in\x20many\x20neurological\x20disorders\x20like\x20multiple\x20sclerosis,\x20amyotrophic\x20lateral\x20sclerosis(ALS),\x20spinal\x20injuries\x20and\x20flexor\x20spasms\x20is\x20reduced,\x20and\x20<strong>baclofen\x20is\x20the\x20preferred\x20drug\x20for\x20symptomatic\x20relief</strong>.</p>\x0a<p>It\x20is\x20an\x20analogue\x20of\x20the\x20inhibitory\x20transmitter\x20GABA\x20and\x20acts\x20as\x20a\x20selective\x20<strong>GABA\x20B</strong>\x20<strong>receptor\x20agonist.</strong></p>','22368iwxpFj','classList','questionText','Class\x20IV','oqSYi','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20','oNFTb','kOLlG','GutBW','A\x20patient\x20with\x20ruptured\x20spleen\x20is\x20taken\x20for\x20laparotomy.\x20His\x20blood\x20pressure\x20is\x2080/50\x20and\x20heart\x20rate\x20is\x20125/min.\x20Induction\x20agent\x20of\x20choice\x20for\x20this\x20patient\x20is:','<p>Testing\x20to\x20rule\x20out\x20the\x20presence\x20of\x20the\x20<strong>HLA-B5701\x20allele</strong>\x20is\x20recommended\x20prior\x20to\x20the\x20initiation\x20of\x20therapy\x20with\x20<strong>abacavir</strong>\x20as\x20it\x20may\x20cause\x20<strong>severe\x20hypersensitivity\x20reactions</strong>\x20in\x20patients\x20positive\x20for\x20this\x20allele.</p>','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>','Midazolam','eeeWl','Liraglutide','NvHNw','<p\x20style=\x22text-align:\x20left;\x22><strong>Ezetimibe\x20</strong>is\x20the\x20drug\x20that\x20prevents\x20hypercholesterolemia\x20by\x20directly<strong>\x20inhibiting\x20</strong>the<strong>\x20absorption\x20of\x20cholesterol.</strong></p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Ezetimibe\x20acts\x20by\x20interfering\x20with\x20a\x20specific\x20cholesterol\x20transport\x20protein\x20<strong>NPC1L1</strong>\x20in\x20the\x20<strong>intestinal\x20mucosa</strong>\x20and\x20reduces\x20the\x20absorption\x20of\x20both\x20dietary\x20and\x20biliary\x20cholesterol.\x20It\x20causes\x20a&nbsp;compensatory\x20increase\x20in\x20hepatic\x20cholesterol\x20synthesis\x20but\x20LDL\x20cholesterol\x20is\x20decreased.&nbsp;<strong>Statins</strong>\x20block\x20this\x20enhanced\x20cholesterol\x20synthesis\x20(cholesterol\x20synthesis\x20inhibitors)\x20and\x20so\x20their\x20combination\x20has\x20a\x20<strong>synergistic\x20effect</strong>.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20B:\x20<strong>Orlistat</strong>\x20is\x20an\x20anti-obesity\x20drug\x20that\x20acts\x20by\x20<strong>inhibiting\x20pancreatic\x20and\x20gastric\x20lipase</strong>\x20and\x20thus\x20interferes\x20with\x20the\x20digestion\x20and\x20absorption\x20of\x20dietary\x20triglycerides.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20C:\x20<strong>Cholestyramine</strong>\x20is\x20a\x20<strong>bile\x20acid\x20sequestrant</strong>.\x20The\x20bile-acid\x20sequestrants\x20are\x20highly\x20positively\x20charged\x20and\x20bind\x20negatively\x20charged\x20bile\x20acids.\x20Because\x20of\x20their\x20large\x20size,\x20the\x20resins\x20are\x20not\x20absorbed,\x20and\x20the\x20bound\x20bile\x20acids\x20are\x20excreted\x20in\x20the\x20stool.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Cholestyramine\x20primarily\x20<strong>reduces\x20LDL\x20levels</strong>\x20by\x20<strong>increasing\x20hepatic\x20bile\x20acid\x20synthesis</strong>;\x20which\x20results\x20in\x20increased\x20LDL\x20uptake\x20and\x20diversion\x20of\x20cholesterol\x20to\x20bile\x20acid\x20production.&nbsp;</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Option\x20D:\x20<strong>Niacin</strong>\x20reduces\x20lipolysis\x20by\x20<strong>hormone-sensitive\x20lipase</strong>\x20(HSL)\x20and\x20reduces\x20hepatic\x20triglyceride\x20synthesis.</p>','oyHji','laZBJ','nav-btn-current','accuracyScore','Cefixime','UsQIj','jEzAn','hkiNd','<p>Patiromer\x20is\x20a\x20non-absorbed,\x20cation\x20exchange\x20polymer\x20that\x20contains\x20a\x20calcium-sorbitol\x20<br\x20/>counterion.\x20</p>\x0a<p>It\x20increases\x20fecal\x20potassium\x20excretion\x20through\x20binding\x20of\x20potassium\x20in\x20the\x20lumen\x20of\x20the\x20gastrointestinal\x20tract.\x20</p>\x0a<p><strong>Binding\x20of\x20potassium\x20reduces\x20the\x20concentration\x20of\x20free\x20potassium\x20in\x20the\x20gastrointestinal\x20lumen,\x20resulting\x20in\x20a\x20reduction\x20of\x20serum\x20potassium\x20levels.\x20</strong></p>','-600\x20text-white\x22>','includes','eYqiV','zoLMc','CD-20','HhSTh','getElementById','bbctr','Coronary\x20steal\x20phenomenon\x20is\x20caused\x20by\x20which\x20of\x20the\x20following\x20drugs:','Correct','Bambuterol\x20is\x20a\x20prodrug\x20of\x20_____','UgSNH','incorrectCount','Low\x20molecular\x20weight\x20heparin\x20inhibits\x20clotting\x20factor:','chasl','raxWW','Selegiline','Ampicillin','correctAnswers','oOSYh','incorrectAnswers','https://cdn1.dailyrounds.org/uploads/c02c2dfeec9c490aafde5228818ab5df.PNG','iJdID','<p><strong>Induction\x20doses\x20of\x20ketamine\x20increase\x20blood\x20pressure,\x20heart\x20rate\x20and\x20cardiac\x20output\x20</strong>that\x20make\x20it\x20useful\x20for\x20anesthetizing\x20patients\x20at\x20risk\x20for\x20hypotension.</p>\x0a<p>In\x20the\x20present\x20case,\x20the\x20patient\x20is\x20presenting\x20with\x20low\x20blood\x20pressure,\x20the\x20most\x20appropriate\x20agent\x20would\x20be\x20ketamine.</p>','HLA-B4465','Bedaquiline','appendChild','Mnpog','Cisplatin','lBvGc','Emtricitabine','ACJvh','TEvfq','Hyperglycemia','GdzBY','isSupported','dxCeY','bookmarkText','iAFcn','Irinotecan','IDgEH','EcBbn','<p>The\x20action\x20of\x20D\x20(in\x20the\x20image)\u00a0corresponds\x20<strong>to\x20inhibition\x20of\x20peripheral\x20COMT</strong>\x20alone.\x20<strong>Entacapone</strong>\x20is\x20a\x20<strong>peripheral\x20COMT\x20inhibitor.</strong></p>\x0a<p><strong>Other\x20options:</strong></p>\x0a<ul>\x0a<li><strong>Option\x20B</strong>:\x20Carbidopa\x20is\x20a\x20peripheral\x20decarboxylase\x20inhibitor.</li>\x0a<li><strong>Option\x20C</strong>:\x20Selegiline\x20is\x20a\x20MAO\x20B\x20inhibitor</li>\x0a<li><strong>Option\x20D:\x20</strong>Tolcapone\x20inhibits\x20both\x20central\x20and\x20peripheral\x20COMT</li>\x0a</ul>\x0a<table\x20style=\x22width:\x20257px;\x20height:\x20187px;\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20100.890625px;\x22><strong>Properties</strong></td>\x0a<td\x20style=\x22width:\x2080.203125px;\x22><strong>Tolcapone</strong></td>\x0a<td\x20style=\x22width:\x20101.21875px;\x22><strong>Entacapone</strong></td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20100.890625px;\x22>Duration</td>\x0a<td\x20style=\x22width:\x2080.203125px;\x22>Longer\x20acting</td>\x0a<td\x20style=\x22width:\x20101.21875px;\x22>Shorter\x20acting</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20100.890625px;\x22>COMT\x20inhibition</td>\x0a<td\x20style=\x22width:\x2080.203125px;\x22>Both\x20central\x20and\x20peripheral</td>\x0a<td\x20style=\x22width:\x20101.21875px;\x22>Predominantly\x20peripheral</td>\x0a</tr>\x0a<tr>\x0a<td\x20style=\x22width:\x20100.890625px;\x22>Hepatotoxicity</td>\x0a<td\x20style=\x22width:\x2080.203125px;\x22>Present</td>\x0a<td\x20style=\x22width:\x20101.21875px;\x22>Absent</td>\x0a</tr>\x0a</tbody>\x0a</table>','Thiazides','JOHPl','Metabolic\x20alkalosis','meOQK','Option\x20','EMWmX','VXIET','src','Enfuvirtide','SpHmB','customQuizData','data-option-index','endsWith','Schizophrenia','Mark\x20for\x20Review','yNUSg','SUrXK','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22','JnLhv','EsxmA','explanation_audio_hin','Verapamil','Kajpx','Rivastigmine','gEwHj','Bulk\x20forming\x20laxative','BurbN','SIWmy','Metoprolol','eitVF','UJdFm','Factor\x20Xa\x20and\x20IIa','EVGHJ','totalQuestions','timed_exam','VmtDy','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','GnRH\x20agonist','explanation_video','selectedAnswer','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','Latanaprost','Icatibant','question_images','FlrSu','roFJa','dataset','questions','ZJyDR','round','Which\x20is\x20the\x20shortest\x20acting\x20benzodiazepine?','correct','status','yulds','display','No\x20questions\x20available\x20for\x20this\x20quiz.','stringify','modeModal','Tacrine','Ulipristal\x20acetate\x20is:','forEach','FSUuP','incorrect','XExWk','totalAttempted','rtyrD','Aztreonam','ftGwf','izyHI','WNtFE','GaAdP','Drug\x20D\x20is\x20the\x20least\x20potent','FxaPk','WKWCv','Glatiramer','Halothane','302996uNssAB','nav-btn-bookmarked','Bethanechol','<ul>\x0a<li><strong>Amiodarone\x20interferes\x20with\x20thyroid\x20function</strong>\x20in\x20many\x20ways\x20including\x20inhibition\x20of\x20peripheral\x20conversion\x20of\x20T4\x20to\x20T3\x20and\x20interaction\x20with\x20thyroid\x20hormone\x20receptor.</li>\x0a<li><strong>Goitre,\x20hypothyroidism\x20and\x20rarely\x20hyperthyroidism</strong>\x20may\x20develop\x20on\x20chronic\x20use.</li>\x0a</ul>\x0a<p><strong>AMIODARONE</strong></p>\x0a<ul>\x0a<li><strong>Class\x20III</strong>\x20anti-arrhythmic</li>\x0a<li><strong>Resistant\x20VT\x20and\x20recurrent\x20VF\x20</strong>are\x20the\x20most\x20important\x20indications\x20for\x20amiodarone</li>\x0a<li>It\x20is\x20also\x20used\x20<strong>to\x20maintain\x20sinus\x20rhythm\x20in\x20AF</strong>\x20when\x20other\x20drugs\x20have\x20failed</li>\x0a</ul>\x0a<p><strong>Adverse\x20effects\x20of\x20amiodarone</strong>:</p>\x0a<ul>\x0a<li><strong>Fall\x20in\x20BP,\x20bradycardia\x20and\x20myocardial\x20depression</strong>\x20occurs\x20on\x20IV\x20injection\x20and\x20after\x20drug\x20cumulation</li>\x0a<li><strong>Photosensitization</strong></li>\x0a<li><strong>Corneal\x20microdeposits</strong>\u00a0</li>\x0a<li><strong>Pulmonary\x20alveolitis\x20and\x20fibrosis</strong></li>\x0a<li><strong>Peripheral\x20neuropathy\x20</strong></li>\x0a<li><strong>Goitre,\x20hypothyroidism\x20and\x20rarely\x20hyperthyroidism</strong></li>\x0a</ul>','FwLUW','Zwqsl','0|3|4|2|1|5','<p><strong>Amiloride</strong>\x20is\x20the\x20<strong>drug\x20of\x20choice</strong>\x20for\x20<strong>lithium\x20induced\x20nephrogenic\x20DI.</strong></p>','MpIBa','scoreCircle','Pyridoxine','KvyDP','npsEc','xftKm','EPgen','vZrWY','application/vnd.apple.mpegurl','tBWDi','bvHQv','MFVIj','XFfNn','gOuzx','VvSIc','CQSar','zhFOu','JABoK','None\x20of\x20the\x20above','Schistosomiasis','xXetV','VCUgj','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','Her-2/neu','nHtEz','ZoRwW','<p><strong>Icatibant\x20is\x20a\x20selective\x20bradykinin\x20B2\x20receptor\x20antagonist</strong>.\x20It\x20is\x20approved\x20for\x20the\x20use\x20of\x20hereditary\x20angioedema.\x20Icatibant\x20reduces\x20the\x20hypotensive\x20action\x20of\x20captopril\x20indicating\x20the\x20role\x20of\x20inhibition\x20of\x20bradykinin\x20breakdown\x20in\x20hypotensive\x20action\x20of\x20captopril.</p>\x0a<p>Rimonabant\x20is\x20a\x20<strong>cannabinoid\x20receptor\x20antagonist</strong>\x20that\x20was\x20used\x20in\x20obesity\x20but\x20withdrwan\x20due\x20to\x20serious\x20psychiatric\x20adverse\x20effects\x20<strong>(Option</strong>\x20<strong>A</strong>).</p>\x0a<p>Moexipril\x20is\x20an\x20<strong>angiotensin\x20converting\x20enzyme\x20inhibitor</strong>\x20(<strong>Option\x20C</strong>).</p>\x0a<p>Eprosartan\x20is\x20an\x20<strong>antiotensin\x20receptor\x20blocker</strong>\x20(<strong>Option\x20D</strong>).</p>','Salmeterol','Orlistat','CYP2E1','mLNzA','Bevacizumab\x20is\x20a\x20monoclonal\x20antibody\x20against:','tlNcq','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','strokeDasharray','Oral','<p>Low\x20molecular\x20weight\x20heparin(LMWH)\x20acts\x20by\x20inhibiting<strong>\u00a0both\x20factor\x20Xa\x20and\x20IIa.\u00a0\u00a0</strong></p>\x0a<ul>\x0a<li>Heparin\x20has\x20equal\x20anti-factor\x20Xa\x20and\x20anti-factor\x20IIa\x20activity\x20with\x20a\x20ratio\x20of\x201:1.</li>\x0a<li>LMWH\x20has\x20greater\x20anti–factor\x20Xa\x20activity\x20than\x20anti–factor\x20IIa\x20activity,\x20and\x20the\x20ratio\x20ranges\x20from\x203:1\x20to\x202:1\x20depending\x20on\x20the\x20preparation.</li>\x0a<li>Fondaparinux\x20has\x20only\x20anti-factor\x20Xa\x20activity.</li>\x0a</ul>\x0a<p>\u00a0</p>','selected','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','okISn','Solifenacin','gray','PpNfQ','Methacholine','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','fgAZu','style','ZrlkM','A\x20patient\x20who\x20was\x20started\x20on\x20treatment\x20for\x20glaucoma\x20comes\x20to\x20the\x20casualty\x20with\x20acute\x20onset\x20breathlessness.\x20On\x20auscultation,\x20bilateral\x20wheeze\x20is\x20heard.\x20Which\x20of\x20the\x20following\x20drugs\x20might\x20have\x20led\x20to\x20this\x20adverse\x20effect?','KcPIy','t½\x20is\x20constant','Domperidone','zDglz','<p><strong>Emtricitabine</strong>\x20has\x20activity\x20against\x20<strong>both\x20HIV\x20and\x20HBV</strong>.</p>\x0a<p><strong>DRUGS\x20ACTIVE\x20AGAINST\x20BOTH\x20HIV\x20AND\x20HBV</strong></p>\x0a<ul>\x0a<li><strong>Lamivudine\x20</strong></li>\x0a<li><strong>Tenofovir</strong></li>\x0a<li><strong>Adefovir</strong></li>\x0a<li><strong>Emtricitabine</strong></li>\x0a</ul>','Vinblastine','Hypomagnesemia','canPlayType','OUPgS','accuracy','NiZrV','addEventListener','DlKHH','pixJD','nOkKv','Apqyr','UTNYP','5|2|3|4|1|0','UQFli','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','ObLhH','uUTvv','Tolbutamide','EqRdM','studyModeLegend','correct_choice_id','innerHTML','fFqwV','gcpVT','Furosemide\x20causes\x20all\x20except:','Daaps','QVJKx','solutionContainer','BDXGU','fvSIS','Ropivacaine','okAxj','The\x20anti-cancer\x20drug\x20that\x20can\x20cross\x20blood-brain\x20barrier\x20is\x20______.','<p>Liraglutide\x20promotes\x20<strong>weight\x20loss</strong>.</p>\x0a<p>NOTE:</p>\x0a<p>GLP-1\x20analogs,\x20pramlintide,\x20SGLT-2\x20inhibitors,\x20and\x20metformin*\x20cause\x20weight\x20loss\u00a0</p>\x0a<p>DPP-4\x20inhibitors\x20and\x20alpha-glucosidase\x20inhibitors\x20are\x20weight\x20neutral\x20drugs.</p>\x0a<p>Sulfonylureas\x20and\x20insulin\x20promote\x20weight\x20gain.</p>\x0a<p>Note:\x20*Metformin\x20classification\x20is\x20a\x20bit\x20difficult.\x20It\x20can\x20cause\x20weight\x20loss\x20especially\x20in\x20obese\x20patients\x20and\x20few\x20authorities\x20do\x20consider\x20metformin\x20as\x20weight\x20neutral.</p>','RWFok','QFTEF','nav-btn-answered','not_attempted','review-question\x20','ijsiI','Compensated\x20respiratory\x20alkalosis','OQvrh','</span><span>','not-attempted','WqaDG','Imipramine','resume','add','wZWjc','Which\x20of\x20the\x20following\x20drugs\x20may\x20cause\x20thyroid\x20dysfunction:','<p><strong>Orphan\x20drugs\x20are\x20for\x20the\x20treatment\x20or\x20prevention\x20of\x20rare\x20diseases</strong>\x20with\x20little\x20commercial\x20value\x20for\x20pharmaceutical\x20companies.</p>\x0a<p>Therefore,\x20special\x20incentives\x20are\x20given\x20by\x20the\x20government\x20for\x20the\x20pharmaceutical\x20companies\x20for\x20the\x20development\x20and\x20marketing\x20of\x20orphan\x20drugs.</p>\x0a<p>Few\x20examples\x20of\x20orphan\x20drugs:</p>\x0a<ul>\x0a<li>Liposomal\x20amphotericin\x20B</li>\x0a<li>Digoxin\x20antibody</li>\x0a<li>Fomepizole</li>\x0a</ul>','Bupivacaine','Which\x20of\x20the\x20following\x20is\x20true\x20about\x20orphan\x20drugs?','CMiJN','button','461015LpYdzg','IbwPH','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','markReviewText','timeDisplay','eSnoU','wnOJW','Stool\x20softener','Pharmacology\x20St\x203\x20(From\x20Q-Bank)','mxMiy','bookmarkedQuestions','search','push','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','reduce','Inhibits\x20production\x20of\x20IgE','textContent','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','nOWbD','(((.+)+)+)+$','iRinl','mqBhe','lPGnh','Prilocaine','oxFdE','bookmarkBtn','Anxiety','gLxdN','EMIpJ','<div\x20class=\x22mt-4\x22><img\x20src=\x22','fhbMw','DeEIu','\x20>\x20','quizSidebar','gMgcH','RnEXS','Tolcapone','Thioacetazone','setItem','aUDyY','className','PxCfs','PMbYx','PMAkL','length','JxLVl','WmUQw','constructor','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','Drug\x20C\x20is\x20more\x20efficacious\x20than\x20drug\x20D','FSvRQ','xEMQt','kXtNI','<p>The\x20<strong>greater\x20the\x20shift</strong>\x20of\x20the\u00a0<strong>curve\x20towards\x20the\x20left</strong>,\x20the\x20more\x20potent\x20the\x20drug\x20is.\x20Hence,\u00a0<strong>drug\x20D\x20</strong>is\x20the<strong>\x20least\x20potent</strong>.</p>\x0a<p><strong>Potency:\u00a0</strong>It\x20is\x20defined\x20as\x20the\x20<strong>amount\x20of\x20drug</strong>\x20needed\x20to\x20produce\x20a\x20given\x20response.\x20The\x20greater\x20the\x20shift\x20of\x20the\x20curve\x20towards\x20the\x20left\x20side,\x20the\x20higher\x20is\x20potency\x20of\x20the\x20drug.\x20This\x20is\x20because\x20the\x20desired\x20response\x20is\x20being\x20achieved\x20at\x20a\x20lower\x20drug\x20dose.</p>\x0a<p>Hence,\x20in\x20the\x20given\x20drug\x20response\x20curve,\u00a0<strong>drug\x20B</strong>\x20is\x20the\u00a0<strong>most\x20</strong>potent,\x20and\x20<strong>drug\x20D</strong>\x20is\x20the<strong>\x20least</strong>\x20potent.</p>\x0a<p><strong>Efficacy:\u00a0</strong>It\x20is\x20defined\x20as\x20the\x20<strong>maximum\x20effect</strong>\x20produced\x20by\x20the\x20drug\x20and\x20is\x20determined\x20by\x20the\x20peak\x20of\x20the\x20curve.\x20Hence,\x20in\x20the\x20given\u00a0drug\x20response\x20curve,\u00a0<strong>drug\x20B\x20</strong>has\x20the<strong>\x20least\x20efficacy,</strong>\x20and\x20drugs\x20<strong>A,\x20C,</strong>\x20and<strong>\x20D</strong>\x20are\x20<strong>equally\x20efficacious.</strong></p>','<p><strong>Remimazolam&nbsp;</strong>is\x20the\x20<strong>shortest-acting\x20</strong>benzodiazepine<strong>.\x20</strong>Its\x20<strong>half-life</strong><strong>&nbsp;</strong>is\x20just\x20around<strong>&nbsp;37-53\x20mins.</strong></p>\x0a<p>Classification\x20of\x20benzodiazepines:</p>\x0a<ul>\x0a<li><strong>Long-acting:</strong>\x20<br\x20/>\x0a<ul>\x0a<li>Flurazepam</li>\x0a<li>Diazepam</li>\x0a<li>Quazepam</li>\x0a<li>Chlordiazepoxide</li>\x0a</ul>\x0a</li>\x0a<li><strong>Intermediate-acting:</strong>\x20<br\x20/>\x0a<ul>\x0a<li>Alprazolam</li>\x0a<li>Temazepam</li>\x0a<li>Lorazepam</li>\x0a</ul>\x0a</li>\x0a<li><strong>Short-acting:</strong>\x20<br\x20/>\x0a<ul>\x0a<li>Triazolam</li>\x0a<li>Midazolam</li>\x0a</ul>\x0a</li>\x0a<li><strong>Ultra-short</strong>\x20acting\x0a<ul>\x0a<li>Remimazolam</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>Note:&nbsp;Remimazolam\x20was\x20approved\x20by\x20FDA\x20in\x202020.</p>','questionMedia','bWyNK','szAfC','IUIvc','\x22\x20data-src=\x22','IrzOP','618079RquFPs','qxqVf','A\x2030\x20year\x20old\x20male\x20presented\x20with\x20suicidal\x20overdose\x20of\x20a\x20drug.\x20Patient\x20is\x20flabby\x20and\x20comatose\x20with\x20shallow\x20failing\x20respiration.\x20BP\x20is\x2080/40\x20mmHg\x20and\x20the\x20lesion\x20on\x20the\x20right\x20knee\x20is\x20as\x20shown.\x20The\x20likely\x20poisoning\x20is:','sDxpk','nnoQo','eWvcQ','kxRZD','currentMode','5-α\x20reductase\x20inhibitor','{}.constructor(\x22return\x20this\x22)(\x20)','Testing\x20for\x20which\x20of\x20the\x20following\x20alleles\x20should\x20be\x20done\x20before\x20starting\x20abacavir\x20therapy:','ZwpYp','Which\x20of\x20the\x20following\x20anti-tubercular\x20drugs\x20can\x20cause\x20seizures:','width','KPydJ','timeSpent','QtDnB','toString','GrXfO','nhISH','hFvyc','DOMContentLoaded','parse','diNkD','Neurocysticercosis','Positive\x20inotropic\x20effect','uVPWl','querySelectorAll','axfMU','badfP','testModeReviewLegend','RXjEw','JMqRi','SPRM','bgUIL','Moexipril','test','Year\x202017\x20-\x2018','BKYsz','sfWyC','bdSrB','ETubs','Triamterene','ZGfdm','ipHXg','<ul>\x0a<li><strong>Zileuton\x20</strong>is\x20a\x20<strong>5-LOX\x20inhibitor</strong>,\x20blocks\x20LTC4/D4\x20as\x20well\x20as\x20LTB4\x20synthesis</li>\x0a<li>Clinical\x20efficacy\x20in\x20asthma\x20is\x20similar\x20to\x20montelukast</li>\x0a<li>The\x20duration\x20of\x20action\x20of\x20zileuton\x20is\x20short\x20and\x20it\x20has\x20<strong>hepatotoxic\x20potential</strong>.\x20These\x20limitations\x20have\x20restricted\x20its\x20use.</li>\x0a</ul>','<p><strong>Lomustine</strong>\x20can\x20cross\x20the<strong>\x20blood-brain\x20barrier</strong>.</p>\x0a<p><strong>L</strong><strong>omustine\x20</strong>belongs\x20to\x20a\x20class\x20of<strong>\x20nitrosoureas\x20</strong>anti-cancer\x20drugs.\x20They\x20are\x20highly\x20<strong>lipophilic</strong>\x20and\x20can\x20cross\x20the\x20blood-brain\x20barrier.</p>\x0a<p>Anti-cancer\x20drugs\x20that\x20can\x20cross\x20the\x20blood-brain\x20barrier:</p>\x0a<ul>\x0a<li>Nitrosoureas:\x20<strong>Lomustine</strong>,\x20carmustine,\x20semustine</li>\x0a<li>Procarbazine</li>\x0a<li>Temozolomide</li>\x0a</ul>\x0a<p>Nitrosoureas\x20cause\x20interstrand\x20DNA\x20cross-linking,\x20which\x20is\x20responsible\x20for\x20the\x20cytotoxicity\x20of\x20the\x20tumor.\x20The\x20use\x20of\x20nitrosoureas\x20is\x20presently\x20limited\x20to\x20brain\x20tumors\x20due\x20to\x20their\x20lipophilicity.\x20They\x20are\x20effective\x20in\x20<strong>meningeal\x20leukemia</strong>\x20and<strong>\x20brain\x20tumors</strong>.</p>\x0a<p>Side\x20effects\x20of\x20nitrosoureas\x20include\x20profound\x20and\x20delayed\x20<strong>myelosuppression</strong>.\x20They\x20are\x20also\x20highly\x20carcinogenic\x20and\x20mutagenic.&nbsp;</p>\x0a<p>Apart\x20from\x20this,\x20<strong>streptozocin</strong>\x20is\x20another\x20nitrosourea\x20compound\x20that\x20has\x20a\x20high\x20affinity\x20for\x20<strong>islets\x20of\x20Langerhans</strong>.</p>','removeItem','idaGq','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Rate\x20of\x20elimination\x20is\x20proportional\x20to\x20plasma\x20conc','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','xLzVd','performanceModal','map','location','mDmXS','BAEZz'];_0x10a1=function(){return _0x13e412;};return _0x10a1();}function showSolution(){const _0x1ddeee=_0x45c7f0,_0x21d288={'PltpH':function(_0xf540de,_0x409b03){return _0xf540de(_0x409b03);},'rtyrD':function(_0xeea8cd){return _0xeea8cd();},'BKYsz':function(_0x529a42){return _0x529a42();},'chasl':'study','EqbYB':function(_0xbe8cfc,_0x3f2929){return _0xbe8cfc!==_0x3f2929;},'nOWbD':_0x1ddeee(0x9a),'CRwbA':_0x1ddeee(0x11a),'AvGwS':'solutionVideo','xMJnW':_0x1ddeee(0x12d),'NFVhA':'.m3u8','WqaDG':function(_0x466d80,_0x411d0f,_0x526515){return _0x466d80(_0x411d0f,_0x526515);},'ZciNY':function(_0x1b5e2a,_0x43ea91){return _0x1b5e2a===_0x43ea91;},'gsOPg':'iVsdN','PWHxu':_0x1ddeee(0x281),'ACJvh':'solutionImages','SUrXK':_0x1ddeee(0x2a3)};if(currentMode!==_0x21d288[_0x1ddeee(0x1e0)]&&_0x21d288['EqbYB'](currentMode,_0x21d288[_0x1ddeee(0x2d1)]))return;const _0x16e75c=questionsData[currentQuestionIndex];document[_0x1ddeee(0x1d8)](_0x1ddeee(0x161))[_0x1ddeee(0x29d)]=_0x16e75c[_0x1ddeee(0x376)]||_0x21d288[_0x1ddeee(0x119)];const _0x278ae3=document[_0x1ddeee(0x1d8)](_0x21d288[_0x1ddeee(0xdc)]),_0x2d9c8c=document['getElementById'](_0x1ddeee(0x1af)),_0x425df7=_0x16e75c[_0x1ddeee(0x223)];if(_0x425df7){_0x278ae3[_0x1ddeee(0x1b9)]['remove'](_0x21d288[_0x1ddeee(0x3ac)]);if(_0x425df7[_0x1ddeee(0x1d3)](_0x21d288[_0x1ddeee(0xeb)]))_0x21d288[_0x1ddeee(0x2b4)](setupVideo,_0x2d9c8c,_0x425df7);else _0x2d9c8c['src']=_0x425df7;}else _0x278ae3[_0x1ddeee(0x1b9)]['add'](_0x21d288[_0x1ddeee(0x3ac)]);const _0x3445c9=document['getElementById'](_0x1ddeee(0x13e));_0x3445c9[_0x1ddeee(0x29d)]='';_0x16e75c[_0x1ddeee(0x13b)]&&(_0x21d288[_0x1ddeee(0x36b)](_0x21d288[_0x1ddeee(0xa5)],_0x21d288[_0x1ddeee(0xa5)])?_0x3445c9[_0x1ddeee(0x29d)]+=_0x1ddeee(0x374)+_0x16e75c[_0x1ddeee(0x13b)]+_0x1ddeee(0x278):_0x21d288[_0x1ddeee(0xda)](_0x3db04b,_0x1ddeee(0x185))&&(_0x19a695=0x0,_0x21d288[_0x1ddeee(0x23f)](_0x1c1510),_0x21d288[_0x1ddeee(0x322)](_0x2f9e6d)));if(_0x16e75c[_0x1ddeee(0x211)]){if(_0x21d288['ZciNY'](_0x21d288[_0x1ddeee(0x37f)],_0x21d288[_0x1ddeee(0x37f)]))_0x3445c9[_0x1ddeee(0x29d)]+=_0x1ddeee(0x2cc)+_0x16e75c[_0x1ddeee(0x211)]+_0x1ddeee(0x278);else return _0x16b192=_0x13bdb8[_0x1ddeee(0x361)],_0x4aca3e=_0x349591['stats'],_0x44d90a=_0x5a2910[_0x1ddeee(0x34a)],_0x1a86b9=_0x48346a['currentMode'],_0xe45003[_0x1ddeee(0x381)](_0x1ddeee(0x171)),!![];}const _0x169eab=document[_0x1ddeee(0x1d8)](_0x21d288[_0x1ddeee(0x1f1)]);_0x169eab[_0x1ddeee(0x29d)]='',_0x16e75c[_0x1ddeee(0x353)]&&_0x16e75c[_0x1ddeee(0x353)][_0x1ddeee(0x23a)](_0x291077=>{const _0x1d1b13=_0x1ddeee;if(_0x291077)_0x169eab[_0x1d1b13(0x29d)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0x291077+_0x1d1b13(0x124);}),document[_0x1ddeee(0x1d8)](_0x21d288[_0x1ddeee(0x20d)])[_0x1ddeee(0x1b9)][_0x1ddeee(0x99)](_0x21d288[_0x1ddeee(0x3ac)]);}function submitQuiz(){const _0x340444=_0x45c7f0,_0x46da6b={'xqUPy':_0x340444(0x2ac),'TDsTD':_0x340444(0x352),'ftGwf':_0x340444(0x12d),'FBjyc':function(_0x470314,_0x31498c){return _0x470314===_0x31498c;},'cwKFO':'ObLhH','EBUPh':function(_0x20978f,_0x113f81){return _0x20978f!==_0x113f81;},'XIZio':function(_0x52cc5f,_0x34becf){return _0x52cc5f===_0x34becf;},'CQSar':_0x340444(0x231),'WhHri':_0x340444(0x12e),'tprJG':'incorrect','JPhGO':function(_0x570802,_0x402fa0){return _0x570802(_0x402fa0);},'iGFoV':function(_0x206df1,_0x2d387a){return _0x206df1(_0x2d387a);},'NOhiV':_0x340444(0x2d0),'zoLMc':function(_0x4ae613,_0x17b065){return _0x4ae613-_0x17b065;},'uGKsO':function(_0x25b3e3,_0x439f0d){return _0x25b3e3-_0x439f0d;},'LCNmK':function(_0x47dbf3,_0x35baac){return _0x47dbf3+_0x35baac;},'OnFWV':'quizPerformanceData','EXewq':function(_0x57c9e0,_0x4198cf,_0x5794f4,_0x5478aa,_0x299940){return _0x57c9e0(_0x4198cf,_0x5794f4,_0x5478aa,_0x299940);},'GRHxa':function(_0x5844ad,_0x128308){return _0x5844ad+_0x128308;}};if(timer)_0x46da6b[_0x340444(0xca)](clearInterval,timer);if(!_0x46da6b[_0x340444(0xce)](confirm,_0x46da6b['NOhiV']))return;isQuizCompleted=!![];let _0x1631ac=0x0,_0x14c9de=0x0;const _0x1fd98a=_0x46da6b[_0x340444(0x1d5)](Date[_0x340444(0x358)](),quizStartTime);questionsData[_0x340444(0x23a)]((_0x2b53db,_0x40c102)=>{const _0x3dfd7e=_0x340444,_0x17c416={'zpDPX':_0x46da6b[_0x3dfd7e(0x241)]};if(_0x46da6b['FBjyc'](_0x3dfd7e(0x297),_0x46da6b['cwKFO'])){const _0x58b837=questionStates[_0x40c102];_0x46da6b['EBUPh'](_0x58b837['selectedAnswer'],null)&&(_0x46da6b[_0x3dfd7e(0x91)](_0x2b53db[_0x3dfd7e(0x130)][_0x58b837[_0x3dfd7e(0x224)]]['id'],_0x2b53db[_0x3dfd7e(0x29c)])?(_0x1631ac++,_0x58b837[_0x3dfd7e(0x232)]=_0x46da6b[_0x3dfd7e(0x261)]):'uKooQ'!==_0x46da6b['WhHri']?_0x4e23e5[_0x3dfd7e(0x1d8)]('timerContainer')[_0x3dfd7e(0x1b9)][_0x3dfd7e(0x99)](_0x17c416[_0x3dfd7e(0x108)]):(_0x14c9de++,_0x58b837['status']=_0x46da6b['tprJG']));}else{if(_0x52a153[_0x3dfd7e(0x224)]!==null)_0x1c06f2=_0x46da6b[_0x3dfd7e(0x35f)];else _0x2ad1ca=_0x46da6b[_0x3dfd7e(0xc0)];}});const _0x12748c=JSON[_0x340444(0x312)](localStorage[_0x340444(0x110)]('quizPerformanceData'))||[];_0x12748c[_0x340444(0x2cb)]({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date[_0x340444(0x358)](),'totalTime':_0x1fd98a,'stats':{'correct':_0x1631ac,'incorrect':_0x14c9de,'notAttempted':_0x46da6b[_0x340444(0x37a)](questionsData[_0x340444(0x2eb)],_0x46da6b[_0x340444(0x3b8)](_0x1631ac,_0x14c9de))}}),localStorage[_0x340444(0x2e5)](_0x46da6b[_0x340444(0x164)],JSON[_0x340444(0x236)](_0x12748c)),stats[_0x340444(0x1e4)]=_0x1631ac,stats['incorrectAnswers']=_0x14c9de,markQuizAsCompleted(),_0x46da6b['EXewq'](showPerformanceAnalysis,_0x1631ac,_0x14c9de,questionsData[_0x340444(0x2eb)]-_0x46da6b[_0x340444(0x33a)](_0x1631ac,_0x14c9de),_0x1fd98a);}function showPerformanceAnalysis(_0x2b31ea,_0x3a2db8,_0x5acb55,_0x3fb58e){const _0x4cd1c2=_0x45c7f0,_0x7a1620={'ETubs':_0x4cd1c2(0x331),'JSGLk':function(_0x488711,_0x21f148){return _0x488711>_0x21f148;},'SIWmy':function(_0x5ce6a4,_0x17fa5a){return _0x5ce6a4+_0x17fa5a;},'bvHQv':function(_0x49c9e0,_0x25f520){return _0x49c9e0*_0x25f520;},'cBqIp':function(_0x4b8cf2,_0x475702){return _0x4b8cf2/_0x475702;},'kNcjh':function(_0x2dfb1a,_0x1338d5){return _0x2dfb1a+_0x1338d5;},'GaAdP':_0x4cd1c2(0x253),'slvsS':function(_0x4c55a8,_0x28ebab){return _0x4c55a8-_0x28ebab;},'XjBkT':function(_0x13e63c,_0x50e742){return _0x13e63c/_0x50e742;},'Apqyr':_0x4cd1c2(0x337),'XMdDx':_0x4cd1c2(0xe8),'lPHsf':function(_0x8b70e4,_0x58e16c){return _0x8b70e4/_0x58e16c;},'pcbBS':function(_0x61bf52,_0x32c79a){return _0x61bf52/_0x32c79a;},'kOLlG':_0x4cd1c2(0x342),'LQOVg':function(_0x110808,_0x20d811){return _0x110808/_0x20d811;},'Ralvo':function(_0x52d9ad,_0xa4ffe7){return _0x52d9ad%_0xa4ffe7;},'zhFOu':_0x4cd1c2(0x144),'IDgEH':_0x4cd1c2(0x12d)},_0x1a2992=document[_0x4cd1c2(0x1d8)](_0x7a1620[_0x4cd1c2(0x325)]),_0x55a18f=_0x7a1620['JSGLk'](_0x7a1620[_0x4cd1c2(0x218)](_0x2b31ea,_0x3a2db8),0x0)?Math[_0x4cd1c2(0x22f)](_0x7a1620[_0x4cd1c2(0x25c)](_0x7a1620[_0x4cd1c2(0x10e)](_0x2b31ea,_0x7a1620[_0x4cd1c2(0x102)](_0x2b31ea,_0x3a2db8)),0x64)):0x0,_0x2c3328=_0x7a1620[_0x4cd1c2(0x25c)](0x2*Math['PI'],0x41),_0x4039ea=document[_0x4cd1c2(0x1d8)](_0x7a1620[_0x4cd1c2(0x244)]);_0x4039ea[_0x4cd1c2(0x280)][_0x4cd1c2(0x274)]=_0x2c3328+'\x20'+_0x2c3328,_0x4039ea[_0x4cd1c2(0x280)][_0x4cd1c2(0x1a9)]=_0x7a1620['slvsS'](_0x2c3328,_0x7a1620[_0x4cd1c2(0x25c)](_0x7a1620[_0x4cd1c2(0x129)](_0x55a18f,0x64),_0x2c3328)),document[_0x4cd1c2(0x1d8)](_0x4cd1c2(0x1cc))['textContent']=_0x55a18f+'%',document[_0x4cd1c2(0x1d8)]('totalQuestionsResult')['textContent']=questionsData[_0x4cd1c2(0x2eb)],document['getElementById']('correctResult')['textContent']=_0x2b31ea,document[_0x4cd1c2(0x1d8)](_0x7a1620[_0x4cd1c2(0x292)])[_0x4cd1c2(0x2cf)]=_0x3a2db8,document['getElementById'](_0x7a1620['XMdDx'])[_0x4cd1c2(0x2cf)]=_0x5acb55;const _0x4e50a9=Math['floor'](_0x7a1620[_0x4cd1c2(0x93)](_0x3fb58e,0xea60)),_0x2b479b=Math[_0x4cd1c2(0x3b9)](_0x7a1620[_0x4cd1c2(0x39a)](_0x3fb58e%0xea60,0x3e8));document[_0x4cd1c2(0x1d8)](_0x7a1620[_0x4cd1c2(0x1bf)])[_0x4cd1c2(0x2cf)]=_0x4e50a9+':'+_0x2b479b[_0x4cd1c2(0x30d)]()['padStart'](0x2,'0');const _0x519471=_0x7a1620['LQOVg'](_0x3fb58e,questionsData[_0x4cd1c2(0x2eb)]),_0x3e95e3=Math[_0x4cd1c2(0x3b9)](_0x7a1620['cBqIp'](_0x519471,0xea60)),_0x4530c4=Math[_0x4cd1c2(0x3b9)](_0x7a1620[_0x4cd1c2(0x39a)](_0x7a1620[_0x4cd1c2(0x370)](_0x519471,0xea60),0x3e8));document[_0x4cd1c2(0x1d8)](_0x7a1620[_0x4cd1c2(0x262)])[_0x4cd1c2(0x2cf)]=_0x3e95e3+':'+_0x4530c4['toString']()[_0x4cd1c2(0xe6)](0x2,'0'),_0x1a2992[_0x4cd1c2(0x1b9)][_0x4cd1c2(0x99)](_0x7a1620[_0x4cd1c2(0x1fa)]);}function closePerformanceModal(){const _0x33880d=_0x45c7f0,_0x6cbd21={'pPPiC':_0x33880d(0x331),'ngMhY':_0x33880d(0x12d)};document[_0x33880d(0x1d8)](_0x6cbd21[_0x33880d(0xc6)])[_0x33880d(0x1b9)][_0x33880d(0x2b7)](_0x6cbd21['ngMhY']);}function reviewQuestions(){const _0x16f020=_0x45c7f0,_0x483665={'XvSRh':function(_0x53a70b,_0x802b3e,_0xb8fe51){return _0x53a70b(_0x802b3e,_0xb8fe51);},'KqiRp':function(_0x162dc8,_0x19bec0){return _0x162dc8===_0x19bec0;},'eeeWl':_0x16f020(0x344),'PmjVG':_0x16f020(0x112),'PxCfs':function(_0x216855,_0x53f9d1){return _0x216855+_0x53f9d1;},'VcrLB':_0x16f020(0x2b3),'NkRNT':'Not\x20Attempted','sBGEx':function(_0x29d29b,_0x2dc06b){return _0x29d29b===_0x2dc06b;},'gMgcH':_0x16f020(0x231),'ZGfdm':_0x16f020(0x1db),'RSiaG':function(_0x412f34,_0x5e851c){return _0x412f34===_0x5e851c;},'cfZVc':_0x16f020(0x2c5),'OQvrh':_0x16f020(0x23c),'eOuYY':'Incorrect','NuYTX':_0x16f020(0x17b),'rThMl':function(_0x4d4866,_0x5c945a){return _0x4d4866+_0x5c945a;},'RjlEZ':function(_0x5a98be,_0x10689d){return _0x5a98be===_0x10689d;},'hFvyc':'green','jQjkj':'red','hWNuS':_0x16f020(0x27b),'okAxj':_0x16f020(0xaa),'oNFTb':_0x16f020(0x174),'QFTEF':function(_0x123129){return _0x123129();}};document['getElementById'](_0x483665[_0x16f020(0x1be)])['classList'][_0x16f020(0x99)](_0x16f020(0x12d));const _0x290962=document['getElementById']('reviewQuestionsContainer');_0x290962[_0x16f020(0x29d)]='',questionsData[_0x16f020(0x23a)]((_0x2013c9,_0x194ef3)=>{const _0x3870a9=_0x16f020,_0x185e77={'Bzrhr':function(_0x3b6269,_0x11c02b){const _0x493cc9=_0x2382;return _0x483665[_0x493cc9(0x159)](_0x3b6269,_0x11c02b);},'DdQea':_0x483665[_0x3870a9(0x1c5)],'FSvRQ':_0x483665[_0x3870a9(0x16c)],'SpHmB':function(_0x2d060f,_0x3247f8){const _0x48ffe4=_0x3870a9;return _0x483665[_0x48ffe4(0x2e8)](_0x2d060f,_0x3247f8);}},_0xe9841d=questionStates[_0x194ef3],_0x50962b=_0x2013c9[_0x3870a9(0x29c)];let _0x380184=_0x483665[_0x3870a9(0x33b)],_0x2bd020=_0x483665[_0x3870a9(0x366)];if(_0xe9841d[_0x3870a9(0x224)]!==null){const _0x115405=_0x2013c9[_0x3870a9(0x130)][_0xe9841d[_0x3870a9(0x224)]];_0x483665[_0x3870a9(0xfd)](_0x115405['id'],_0x50962b)?(_0x380184=_0x483665[_0x3870a9(0x2e1)],_0x2bd020=_0x483665[_0x3870a9(0x327)]):_0x483665[_0x3870a9(0x350)](_0x483665[_0x3870a9(0x34c)],_0x3870a9(0x2c5))?(_0x380184=_0x483665['OQvrh'],_0x2bd020=_0x483665[_0x3870a9(0x3b1)]):_0x483665[_0x3870a9(0x37d)](_0x4fb52f,_0x2e0ee3,_0x4b03cb);}const _0x344d0e=document['createElement'](_0x483665[_0x3870a9(0x118)]);_0x344d0e[_0x3870a9(0x2e7)]=_0x3870a9(0x2ae)+_0x380184;let _0x1da0b4=(_0x2013c9[_0x3870a9(0x130)]||[])[_0x3870a9(0x332)]((_0xb85a78,_0x3329fa)=>{const _0x1039a7=_0x3870a9,_0x3783a3=_0x185e77[_0x1039a7(0x3a5)](_0xe9841d[_0x1039a7(0x224)],_0x3329fa),_0x3b1bc6=_0x185e77[_0x1039a7(0x3a5)](_0xb85a78['id'],_0x50962b);let _0x160c1d=_0x185e77[_0x1039a7(0xa4)];if(_0x3b1bc6)_0x160c1d=_0x1039a7(0xd9);else{if(_0x3783a3)_0x160c1d=_0x185e77[_0x1039a7(0x2f1)];}return _0x1039a7(0x3bb)+_0x160c1d+_0x1039a7(0x369)+String[_0x1039a7(0xf8)](_0x185e77[_0x1039a7(0x206)](0x41,_0x3329fa))+_0x1039a7(0x2b2)+_0xb85a78[_0x1039a7(0x1aa)]+_0x1039a7(0x360);})[_0x3870a9(0x10c)]('');const _0xaf4136=_0x2013c9[_0x3870a9(0x223)]?_0x3870a9(0x226)+_0x194ef3+_0x3870a9(0x2fa)+_0x2013c9[_0x3870a9(0x223)]+_0x3870a9(0xad):'';let _0x27aa7e='';if(_0x2013c9[_0x3870a9(0x13b)])_0x27aa7e+=_0x3870a9(0x20e)+_0x2013c9[_0x3870a9(0x13b)]+_0x3870a9(0x278);if(_0x2013c9['explanation_audio_hin'])_0x27aa7e+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22'+_0x2013c9[_0x3870a9(0x211)]+_0x3870a9(0x278);let _0x301bc7=(_0x2013c9[_0x3870a9(0x353)]||[])[_0x3870a9(0x332)](_0x3bdd2f=>_0x3bdd2f?_0x3870a9(0x2dc)+_0x3bdd2f+_0x3870a9(0x124):'')[_0x3870a9(0x10c)]('');_0x344d0e[_0x3870a9(0x29d)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20'+_0x483665[_0x3870a9(0x120)](_0x194ef3,0x1)+_0x3870a9(0x1ae)+(_0x483665[_0x3870a9(0x3a8)](_0x380184,_0x483665[_0x3870a9(0x2e1)])?_0x483665[_0x3870a9(0x310)]:_0x380184===_0x483665[_0x3870a9(0x2b1)]?_0x483665[_0x3870a9(0x160)]:_0x483665[_0x3870a9(0xf2)])+_0x3870a9(0x1d2)+_0x2bd020+_0x3870a9(0x225)+_0x2013c9[_0x3870a9(0x1aa)]+_0x3870a9(0x3bf)+_0x1da0b4+_0x3870a9(0x296)+(_0x2013c9[_0x3870a9(0x376)]||_0x483665[_0x3870a9(0x2a7)])+_0x3870a9(0xd5)+_0xaf4136+_0x3870a9(0x32d)+_0x27aa7e+_0x3870a9(0x32d)+_0x301bc7+_0x3870a9(0x3d3),_0x290962[_0x3870a9(0x1ec)](_0x344d0e);}),_0x483665[_0x16f020(0x2ab)](initializeReviewVideos);}function initializeReviewVideos(){const _0x2d3039=_0x45c7f0,_0x2b734e={'VvSIc':_0x2d3039(0x2be),'mLNzA':function(_0x3b81bd,_0x2bf757){return _0x3b81bd+_0x2bf757;},'AGqVJ':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','zJnQl':_0x2d3039(0x151),'KcPIy':_0x2d3039(0x354),'VQYHh':function(_0x2ab09f,_0x5ed1a0,_0xe57be2){return _0x2ab09f(_0x5ed1a0,_0xe57be2);},'eBTlT':function(_0x24f629,_0x293278){return _0x24f629===_0x293278;},'tQzpw':'YTwhC','oqSYi':'video[data-src]'};document[_0x2d3039(0x317)](_0x2b734e[_0x2d3039(0x1bc)])['forEach'](_0x5f4f9e=>{const _0x30e821=_0x2d3039,_0x1818d7=_0x5f4f9e[_0x30e821(0x22c)][_0x30e821(0x204)];if(_0x1818d7&&_0x1818d7[_0x30e821(0x1d3)](_0x2b734e[_0x30e821(0xab)])){if(_0x2b734e[_0x30e821(0x283)]!==_0x30e821(0x354)){const _0x1cb12d=_0x16d5b3[_0x30e821(0x312)](_0xe46dc5[_0x30e821(0x110)](_0x30e821(0x107)))||{},_0x3ac031=_0x18e362['length'],_0x4ffc35=_0xa707bc['correctAnswers']||0x0;_0x1cb12d[_0x5a7c82]={'score':_0x4ffc35,'total':_0x3ac031,'status':'completed','completedOn':new _0x1b8419()['toISOString']()},_0xcdb02c['setItem'](_0x30e821(0x107),_0xcf08ba[_0x30e821(0x236)](_0x1cb12d));}else _0x2b734e[_0x30e821(0x10d)](setupVideo,_0x5f4f9e,_0x1818d7);}else{if(_0x1818d7){if(_0x2b734e[_0x30e821(0x92)](_0x2b734e[_0x30e821(0xff)],'YTwhC'))_0x5f4f9e[_0x30e821(0x204)]=_0x1818d7;else{const _0xb8c3e1=_0x40aaee[_0x30e821(0x184)](_0x2b734e[_0x30e821(0x260)]);_0xb8c3e1[_0x30e821(0x2cf)]=_0x2b734e[_0x30e821(0x270)](_0x1dd831,0x1),_0xb8c3e1[_0x30e821(0x2e7)]=_0x2b734e['AGqVJ'],_0xb8c3e1['onclick']=()=>_0xae6cbb(_0x3afa88),_0xb8c3e1['id']=_0x30e821(0x141)+_0x14013e,_0x54f508['appendChild'](_0xb8c3e1);}}}});}function retakeQuiz(){const _0x568482=_0x45c7f0,_0x3490de={'SLXhH':_0x568482(0x387),'ssUNp':'custom_quiz.html'};confirm(_0x3490de[_0x568482(0x36d)])&&(window['location']['pathname']['endsWith'](_0x3490de[_0x568482(0xb8)])&&localStorage['removeItem']('customQuizData'),clearProgress(),location[_0x568482(0xd0)]());}function loadBookmarkedQuestions(){const _0x5a3d05=_0x45c7f0,_0x361a30={'PMAkL':function(_0x1033ab,_0x11bfe3){return _0x1033ab<_0x11bfe3;},'yatpe':_0x5a3d05(0x2c9)},_0x17b102=JSON[_0x5a3d05(0x312)](localStorage[_0x5a3d05(0x110)](_0x361a30[_0x5a3d05(0x14a)]))||[];_0x17b102[_0x5a3d05(0x23a)](_0x4c31d6=>{const _0x19e7c2=_0x5a3d05;_0x4c31d6['quizFile']['includes'](quizName[_0x19e7c2(0xa7)]()[_0x19e7c2(0x9d)](/ /g,'-'))&&(_0x361a30[_0x19e7c2(0x2ea)](_0x4c31d6[_0x19e7c2(0x39f)],questionsData[_0x19e7c2(0x2eb)])&&(questionStates[_0x4c31d6['questionIndex']]['bookmarked']=!![]));});}function toggleBookmark(){const _0x53675d=_0x45c7f0,_0x5e4b0d={'mqBhe':function(_0x38b564,_0x1c7648){return _0x38b564-_0x1c7648;},'qkakZ':'bookmarkedQuestions','JFnmt':function(_0xbf3fd0,_0x325246){return _0xbf3fd0!==_0x325246;},'kqczE':_0x53675d(0x18e)},_0x8beb67=!questionStates[currentQuestionIndex][_0x53675d(0x16a)];questionStates[currentQuestionIndex]['bookmarked']=_0x8beb67;let _0x182c47=JSON[_0x53675d(0x312)](localStorage['getItem'](_0x5e4b0d[_0x53675d(0x14c)]))||[];if(_0x8beb67){const _0x4e8b3c={'quizName':quizName,'quizFile':window[_0x53675d(0x333)][_0x53675d(0x38c)][_0x53675d(0x14d)]('/')[_0x53675d(0x364)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date['now']()};_0x182c47[_0x53675d(0x2cb)](_0x4e8b3c);}else _0x5e4b0d[_0x53675d(0x135)](_0x5e4b0d[_0x53675d(0x114)],_0x5e4b0d[_0x53675d(0x114)])?(_0x29d94a[_0x28b946][_0x53675d(0x30b)]+=_0x5e4b0d[_0x53675d(0x2d4)](_0x5d11ad[_0x53675d(0x358)](),_0x439bc2),_0x270416=_0x301ce9[_0x53675d(0x358)]()):_0x182c47=_0x182c47[_0x53675d(0x11e)](_0x228205=>!(_0x228205[_0x53675d(0x105)][_0x53675d(0x1d3)](quizName[_0x53675d(0xa7)]()[_0x53675d(0x9d)](/ /g,'-'))&&_0x228205[_0x53675d(0x39f)]===currentQuestionIndex));localStorage[_0x53675d(0x2e5)](_0x5e4b0d[_0x53675d(0x14c)],JSON['stringify'](_0x182c47)),updateBookmarkButton(),updateQuestionNav();}function updateBookmarkButton(){const _0x5689b3=_0x45c7f0,_0x2255cb={'JOgcq':_0x5689b3(0x2d8),'qtHNW':'gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','iEdqS':'Bookmarked','Oebio':'Bookmark'},_0x1e7a2e=document[_0x5689b3(0x1d8)](_0x2255cb[_0x5689b3(0x339)]),_0xd60a=document['getElementById'](_0x5689b3(0x1f7)),_0x5049bb=questionStates[currentQuestionIndex]['bookmarked'];_0x1e7a2e[_0x5689b3(0x2e7)]=_0x5049bb?_0x2255cb[_0x5689b3(0xf7)]:_0x5689b3(0x27e),_0xd60a[_0x5689b3(0x2cf)]=_0x5049bb?_0x2255cb[_0x5689b3(0xb2)]:_0x2255cb[_0x5689b3(0x142)];}function toggleMarkForReview(){const _0x24a782=_0x45c7f0,_0xb0dee={'mYlJM':function(_0x311326){return _0x311326();}};questionStates[currentQuestionIndex][_0x24a782(0x398)]=!questionStates[currentQuestionIndex][_0x24a782(0x398)],_0xb0dee['mYlJM'](updateMarkReviewButton),updateQuestionNav();}function updateMarkReviewButton(){const _0x531d0b=_0x45c7f0,_0x592721={'uObsi':_0x531d0b(0x2c2),'ZwpYp':_0x531d0b(0x97),'ZyoFI':_0x531d0b(0x8a),'FwEPb':'Marked'},_0x3ef7e2=document[_0x531d0b(0x1d8)](_0x531d0b(0x19f)),_0x3e0d87=document[_0x531d0b(0x1d8)](_0x592721[_0x531d0b(0xf5)]),_0x2d31b4=questionStates[currentQuestionIndex][_0x531d0b(0x398)];_0x3ef7e2[_0x531d0b(0x2e7)]=_0x2d31b4?_0x592721[_0x531d0b(0x307)]:_0x592721['ZyoFI'],_0x3e0d87[_0x531d0b(0x2cf)]=_0x2d31b4?_0x592721[_0x531d0b(0x347)]:_0x531d0b(0x20b);}function previousQuestion(){const _0x5c06ff=_0x45c7f0,_0x582ef0={'lhqsf':function(_0x44df10,_0x319f9e){return _0x44df10>_0x319f9e;},'EcBbn':function(_0x85e54c,_0x27e7a9){return _0x85e54c-_0x27e7a9;},'cFUus':function(_0x5dee70){return _0x5dee70();}};_0x582ef0[_0x5c06ff(0x365)](currentQuestionIndex,0x0)&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x5c06ff(0x30b)]+=_0x582ef0[_0x5c06ff(0x1fb)](Date[_0x5c06ff(0x358)](),questionStartTime)),currentQuestionIndex--,_0x582ef0['cFUus'](displayQuestion),_0x582ef0['cFUus'](saveProgress));}function nextQuestion(){const _0x3892b2=_0x45c7f0,_0x130e90={'gosQN':_0x3892b2(0x387),'xyAEP':_0x3892b2(0x207),'pmnCr':function(_0x426665){return _0x426665();},'RxpEy':_0x3892b2(0x1ba),'WvjNL':_0x3892b2(0x235),'GGWMC':function(_0x3e1760,_0x33446a){return _0x3e1760+_0x33446a;},'jiMYn':function(_0x17ddff,_0x21ef91){return _0x17ddff*_0x21ef91;},'sJQcY':function(_0x1afb55,_0x553bba){return _0x1afb55*_0x553bba;},'JzfGk':function(_0x308189,_0x3f972b){return _0x308189*_0x3f972b;},'GUWvi':_0x3892b2(0x253),'kxRZD':function(_0x5cf094,_0x2e31ca){return _0x5cf094-_0x2e31ca;},'GBvka':_0x3892b2(0x3af),'CMiJN':_0x3892b2(0x3ae),'meOQK':_0x3892b2(0x337),'BcbQg':_0x3892b2(0xe8),'lBvGc':function(_0x426abd,_0xe313a1){return _0x426abd/_0xe313a1;},'TCFaZ':function(_0x7576f1,_0x179938){return _0x7576f1%_0x179938;},'Daaps':_0x3892b2(0x342),'iRinl':function(_0x439474,_0x38d53e){return _0x439474%_0x38d53e;},'wsPgV':_0x3892b2(0x144),'QdhRh':_0x3892b2(0x12d),'EScyD':function(_0x31a0f9,_0x2c7862){return _0x31a0f9!==_0x2c7862;},'XExWk':_0x3892b2(0x180),'jPrcx':_0x3892b2(0x9e),'zpAIT':function(_0x5c578a,_0x30ce21){return _0x5c578a-_0x30ce21;},'FxaPk':function(_0x527fa6,_0xf82cd){return _0x527fa6<_0xf82cd;},'zxnHs':function(_0x4c5bf0,_0xa1b56c){return _0x4c5bf0===_0xa1b56c;},'Xexuj':'lHprq','UQFli':_0x3892b2(0xfb),'okISn':function(_0x473119){return _0x473119();},'hKnTv':_0x3892b2(0x158),'fDbBh':_0x3892b2(0x320),'LgUvA':function(_0x1239fe,_0x5936ea){return _0x1239fe===_0x5936ea;},'Kajpx':_0x3892b2(0x21f),'Krvrv':_0x3892b2(0x2af),'SKMEF':function(_0x4518a5,_0x731a5b){return _0x4518a5(_0x731a5b);},'BMpCN':_0x3892b2(0x273),'phRmP':'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?'};questionStartTime&&(_0x130e90[_0x3892b2(0x172)](_0x130e90[_0x3892b2(0x23d)],_0x130e90['jPrcx'])?questionStates[currentQuestionIndex][_0x3892b2(0x30b)]+=_0x130e90[_0x3892b2(0x375)](Date[_0x3892b2(0x358)](),questionStartTime):_0x26f7aa(_0x130e90[_0x3892b2(0xc3)])&&(_0x586514[_0x3892b2(0x333)]['pathname']['endsWith']('custom_quiz.html')&&_0x21bedd[_0x3892b2(0x32b)](_0x130e90['xyAEP']),_0x130e90['pmnCr'](_0x106928),_0x21600c[_0x3892b2(0xd0)]()));if(_0x130e90[_0x3892b2(0x246)](currentQuestionIndex,questionsData['length']-0x1)){if(_0x130e90[_0x3892b2(0x13a)](_0x130e90[_0x3892b2(0x90)],_0x130e90[_0x3892b2(0x295)])){_0x2ffe89['getElementById'](_0x130e90['RxpEy'])[_0x3892b2(0x29d)]=_0x130e90[_0x3892b2(0x3cb)];return;}else currentQuestionIndex++,_0x130e90[_0x3892b2(0xbd)](displayQuestion),_0x130e90[_0x3892b2(0x279)](saveProgress);}else{if(_0x130e90[_0x3892b2(0x385)]!=='BAiJt'){if(currentMode===_0x130e90['fDbBh']||_0x130e90['LgUvA'](currentMode,_0x130e90[_0x3892b2(0x213)])){if(_0x130e90[_0x3892b2(0x172)](_0x130e90['Krvrv'],_0x130e90[_0x3892b2(0x1a5)])){const _0x23b865=_0x41d8a7['getElementById'](_0x3892b2(0x331)),_0x108d66=_0x130e90['GGWMC'](_0x9a3437,_0x2b0350)>0x0?_0x137b0b[_0x3892b2(0x22f)](_0x130e90['jiMYn'](_0x40bf5c/_0x130e90['GGWMC'](_0x592380,_0x3d4445),0x64)):0x0,_0x156a5a=_0x130e90['sJQcY'](_0x130e90[_0x3892b2(0x1a0)](0x2,_0xd7d2aa['PI']),0x41),_0x301df2=_0x258942[_0x3892b2(0x1d8)](_0x130e90[_0x3892b2(0x170)]);_0x301df2[_0x3892b2(0x280)][_0x3892b2(0x274)]=_0x156a5a+'\x20'+_0x156a5a,_0x301df2[_0x3892b2(0x280)][_0x3892b2(0x1a9)]=_0x130e90[_0x3892b2(0x302)](_0x156a5a,_0x108d66/0x64*_0x156a5a),_0x4e7574[_0x3892b2(0x1d8)](_0x3892b2(0x1cc))[_0x3892b2(0x2cf)]=_0x108d66+'%',_0x212f16[_0x3892b2(0x1d8)](_0x130e90[_0x3892b2(0x39c)])[_0x3892b2(0x2cf)]=_0x3dc269[_0x3892b2(0x2eb)],_0x1df5a8[_0x3892b2(0x1d8)](_0x130e90[_0x3892b2(0x2bd)])[_0x3892b2(0x2cf)]=_0xb4c6c4,_0x273b54['getElementById'](_0x130e90[_0x3892b2(0x200)])['textContent']=_0x346c0d,_0x280f95[_0x3892b2(0x1d8)](_0x130e90['BcbQg'])['textContent']=_0x950be7;const _0x13d44c=_0x2b11dd[_0x3892b2(0x3b9)](_0x130e90['lBvGc'](_0x97b857,0xea60)),_0x151703=_0x4b1aec[_0x3892b2(0x3b9)](_0x130e90[_0x3892b2(0x1ef)](_0x130e90['TCFaZ'](_0x34d0dc,0xea60),0x3e8));_0x3e7b6f[_0x3892b2(0x1d8)](_0x130e90[_0x3892b2(0x2a1)])[_0x3892b2(0x2cf)]=_0x13d44c+':'+_0x151703[_0x3892b2(0x30d)]()['padStart'](0x2,'0');const _0x2ea6a6=_0x130e90['lBvGc'](_0x3eec3a,_0x16d25b['length']),_0x4c2a1a=_0x444921[_0x3892b2(0x3b9)](_0x130e90['lBvGc'](_0x2ea6a6,0xea60)),_0x1bff9=_0x178007['floor'](_0x130e90[_0x3892b2(0x1ef)](_0x130e90[_0x3892b2(0x2d3)](_0x2ea6a6,0xea60),0x3e8));_0x684b52[_0x3892b2(0x1d8)](_0x130e90[_0x3892b2(0x394)])[_0x3892b2(0x2cf)]=_0x4c2a1a+':'+_0x1bff9[_0x3892b2(0x30d)]()['padStart'](0x2,'0'),_0x23b865[_0x3892b2(0x1b9)][_0x3892b2(0x99)](_0x130e90[_0x3892b2(0x183)]);}else _0x130e90[_0x3892b2(0xd1)](confirm,_0x130e90['BMpCN'])&&submitQuiz();}else _0x130e90[_0x3892b2(0xd1)](confirm,_0x130e90[_0x3892b2(0xdd)])&&(currentQuestionIndex=0x0,_0x130e90[_0x3892b2(0xbd)](displayQuestion),saveProgress());}else _0x20a187[_0x411570]['timeSpent']+=_0x130e90['kxRZD'](_0x24a248[_0x3892b2(0x358)](),_0xa7e3ed);}}function startTimer(){const _0x38966f=_0x45c7f0,_0xb65b67={'cWUvV':_0x38966f(0x19f),'tBWDi':_0x38966f(0x2c2),'VCUgj':'gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','VSvGD':_0x38966f(0x8a),'WcDmc':_0x38966f(0x96),'WOnDt':'Mark\x20for\x20Review','hzLMj':function(_0x538c3c,_0x40c58b){return _0x538c3c-_0x40c58b;},'dovIi':function(_0x546019){return _0x546019();},'NJQHl':function(_0x1f58a7){return _0x1f58a7();},'MsHKp':function(_0x517141,_0x6ac345){return _0x517141<=_0x6ac345;},'EMQWt':function(_0x5c611d,_0x1f9fce){return _0x5c611d===_0x1f9fce;},'nlGlT':_0x38966f(0x1f4),'sMziW':function(_0x18cdf5,_0x2fc846){return _0x18cdf5===_0x2fc846;},'EhLCb':'timed_exam','jDhIu':function(_0x38c0a7){return _0x38c0a7();},'pNKWp':function(_0x172be7,_0x21f263){return _0x172be7!==_0x21f263;},'nIhvY':function(_0x15da77){return _0x15da77();}};if(timer)clearInterval(timer);timeRemaining=0x78,updateTimerDisplay(),timer=setInterval(()=>{const _0x41c790=_0x38966f;timeRemaining--,_0xb65b67[_0x41c790(0xba)](updateTimerDisplay);if(_0xb65b67[_0x41c790(0x199)](timeRemaining,0x0)){if(_0xb65b67[_0x41c790(0xe4)](_0xb65b67[_0x41c790(0x3ca)],_0xb65b67['nlGlT'])){clearInterval(timer);if(_0xb65b67[_0x41c790(0x9f)](currentMode,_0xb65b67[_0x41c790(0x368)]))_0xb65b67['jDhIu'](submitQuiz);else{if(_0xb65b67[_0x41c790(0x194)]('IiUxc',_0x41c790(0x202)))_0xb65b67[_0x41c790(0x98)](nextQuestion);else{const _0x406837=_0x19ccb5[_0x41c790(0x1d8)](_0xb65b67[_0x41c790(0x1a1)]),_0x5d07b7=_0x471aa3['getElementById'](_0xb65b67[_0x41c790(0x25b)]),_0x364e21=_0x1f02de[_0xe8771a]['markedForReview'];_0x406837[_0x41c790(0x2e7)]=_0x364e21?_0xb65b67[_0x41c790(0x267)]:_0xb65b67['VSvGD'],_0x5d07b7['textContent']=_0x364e21?_0xb65b67[_0x41c790(0x349)]:_0xb65b67['WOnDt'];}}}else _0x180e8e>0x0&&(_0x32f05d&&(_0x3caf48[_0x1ed46b][_0x41c790(0x30b)]+=_0xb65b67[_0x41c790(0x3d2)](_0x59d90a[_0x41c790(0x358)](),_0x5d9bf7)),_0x35e60c--,_0xb65b67[_0x41c790(0x3b0)](_0x3101f4),_0x23cc4d());}},0x3e8);}function updateTimerDisplay(){const _0x29b337=_0x45c7f0,_0x3b5dee={'wGLkA':function(_0x37b2dc,_0x5d5e4e){return _0x37b2dc/_0x5d5e4e;},'wWSIM':function(_0x45e1ae,_0x21c811){return _0x45e1ae%_0x21c811;},'QKEPe':_0x29b337(0x2c3),'bbctr':function(_0x2b936c,_0x2a6b05){return _0x2b936c+_0x2a6b05;}},_0x22645d=Math['floor'](_0x3b5dee['wGLkA'](timeRemaining,0x3c)),_0x5530d2=_0x3b5dee[_0x29b337(0x19e)](timeRemaining,0x3c);document[_0x29b337(0x1d8)](_0x3b5dee[_0x29b337(0x38e)])[_0x29b337(0x2cf)]=_0x3b5dee[_0x29b337(0x1d9)](_0x3b5dee[_0x29b337(0x1d9)](_0x22645d,':'),_0x5530d2['toString']()[_0x29b337(0xe6)](0x2,'0'));}function toggleSidebar(){const _0x542d4d=_0x45c7f0,_0x380de9={'ctcFh':'open'};document[_0x542d4d(0x1d8)]('quizSidebar')[_0x542d4d(0x1b9)][_0x542d4d(0x197)](_0x380de9['ctcFh']);}document[_0x45c7f0(0x28e)](_0x45c7f0(0x311),()=>{const _0x29eded=_0x45c7f0,_0x15f094={'PpNfQ':function(_0x447526){return _0x447526();},'cPOPd':_0x29eded(0x23c),'izyHI':'none','wnWkS':function(_0x2ca4da,_0x340953){return _0x2ca4da===_0x340953;},'JxLVl':_0x29eded(0x152),'KZuWc':'rCvua','roFJa':_0x29eded(0x237),'oyHji':_0x29eded(0x18d),'lWKQb':function(_0x307a85,_0x399ee5){return _0x307a85!==_0x399ee5;},'RReQd':_0x29eded(0x266),'VBcHQ':function(_0x18e5ea){return _0x18e5ea();},'aUDyY':_0x29eded(0x3b7),'FLgaK':function(_0x3135a8){return _0x3135a8();}};if(resume)_0x15f094[_0x29eded(0x27c)](loadProgress)?_0x29eded(0x2a2)!==_0x29eded(0x2a2)?_0x15f094['PpNfQ'](_0x49fbee):(document['getElementById'](_0x29eded(0x237))[_0x29eded(0x280)]['display']=_0x15f094[_0x29eded(0x242)],_0x15f094[_0x29eded(0x27c)](initializeQuiz)):_0x15f094[_0x29eded(0x11b)](_0x15f094[_0x29eded(0x2ec)],_0x15f094['KZuWc'])?(_0x38d9e8++,_0x1a83d1['status']=_0x15f094[_0x29eded(0x348)]):(clearProgress(),document[_0x29eded(0x1d8)](_0x15f094['roFJa'])[_0x29eded(0x280)]['display']=_0x29eded(0x3b7));else!window[_0x29eded(0x333)]['pathname'][_0x29eded(0x209)](_0x15f094[_0x29eded(0x1c9)])?_0x15f094['lWKQb'](_0x15f094[_0x29eded(0x189)],_0x15f094[_0x29eded(0x189)])?_0x3016aa[_0x1faa65][_0x29eded(0x30b)]+=_0x9755a6[_0x29eded(0x358)]()-_0x236f81:(_0x15f094[_0x29eded(0x33c)](clearProgress),document[_0x29eded(0x1d8)](_0x15f094[_0x29eded(0x22b)])[_0x29eded(0x280)][_0x29eded(0x234)]=_0x15f094[_0x29eded(0x2e6)]):_0x15f094['FLgaK'](initializeQuiz);}),document[_0x45c7f0(0x28e)]('keydown',function(_0xec5678){const _0x2d17ef=_0x45c7f0,_0x3520c5={'vZrWY':_0x2d17ef(0xcc),'FSZZI':_0x2d17ef(0x1de),'JSmha':function(_0x5c2cbb,_0x390974){return _0x5c2cbb>_0x390974;},'IEdAm':function(_0x522328,_0x10300f){return _0x522328*_0x10300f;},'QtDnB':function(_0x1a1621,_0x295892){return _0x1a1621+_0x295892;},'kzvei':function(_0x19edd9,_0x38a680){return _0x19edd9/_0x38a680;},'lPGnh':function(_0x4a6029,_0x2d230e){return _0x4a6029/_0x2d230e;},'GutBW':function(_0x212353,_0x392ebb){return _0x212353%_0x392ebb;},'FKoff':'timeSpent','QlJOQ':function(_0x1f3315,_0x57ee08){return _0x1f3315+_0x57ee08;},'FwLUW':'timeDisplay','KvyDP':function(_0x1ccd86,_0xad348f){return _0x1ccd86+_0xad348f;},'mjLHd':function(_0x53b5dc,_0x2b0ef1){return _0x53b5dc!==_0x2b0ef1;},'sDxpk':_0x2d17ef(0x237),'UTNYP':_0x2d17ef(0x3b5),'idaGq':_0x2d17ef(0x331),'LTBhh':_0x2d17ef(0x12d),'XMyHW':function(_0x70a1ee,_0x4e62f9){return _0x70a1ee<=_0x4e62f9;},'SOVCN':function(_0x3a5c41,_0x4f8da4){return _0x3a5c41-_0x4f8da4;},'diSgv':function(_0x4990f8,_0x3df78c){return _0x4990f8(_0x3df78c);},'kesFI':function(_0x3fb37a,_0x145d6b){return _0x3fb37a(_0x145d6b);},'sfWyC':function(_0x38e80a,_0x24bc43){return _0x38e80a===_0x24bc43;},'rvFcz':'ArrowLeft','Usvqu':_0x2d17ef(0x30a),'EMIpJ':function(_0x525f97,_0x38f865){return _0x525f97===_0x38f865;},'VSUAY':function(_0x110dff,_0x2890e5){return _0x110dff===_0x2890e5;},'DeEIu':_0x2d17ef(0x10b),'ISJqx':function(_0xee7fef,_0x1fd606){return _0xee7fef===_0x1fd606;},'AInqU':'study','YrBJR':function(_0x3e68c3,_0x2a398c){return _0x3e68c3===_0x2a398c;},'badfP':function(_0x341a32,_0x315564){return _0x341a32!==_0x315564;},'qTsSZ':'EQaYc','wZWjc':function(_0x3b6084){return _0x3b6084();},'eSnoU':'test','dLwuT':function(_0x59b383,_0x5cce2b){return _0x59b383===_0x5cce2b;},'DOhtD':'timed_exam','szAfC':function(_0x719677){return _0x719677();},'xLFRJ':function(_0x2485bb,_0x267cd6){return _0x2485bb===_0x267cd6;},'iJdID':function(_0x4abba6,_0x23192a){return _0x4abba6===_0x23192a;},'TRQor':function(_0x15d6b3){return _0x15d6b3();}};if(_0x3520c5['mjLHd'](document[_0x2d17ef(0x1d8)](_0x3520c5[_0x2d17ef(0x2ff)])[_0x2d17ef(0x280)][_0x2d17ef(0x234)],_0x3520c5[_0x2d17ef(0x293)]))return;if(document[_0x2d17ef(0x1d8)](_0x3520c5[_0x2d17ef(0x32c)])['classList'][_0x2d17ef(0x15d)](_0x3520c5['LTBhh'])===![])return;if(_0xec5678[_0x2d17ef(0x198)]>='1'&&_0x3520c5['XMyHW'](_0xec5678['key'],'4')){const _0x3f3529=_0x3520c5[_0x2d17ef(0x186)](_0x3520c5['diSgv'](parseInt,_0xec5678[_0x2d17ef(0x198)]),0x1),_0x2d05b4=document['querySelectorAll'](_0x2d17ef(0x111));if(_0x3f3529<_0x2d05b4[_0x2d17ef(0x2eb)])_0x3520c5[_0x2d17ef(0xa0)](selectOption,_0x3f3529);}else{if(_0x3520c5[_0x2d17ef(0x323)](_0xec5678[_0x2d17ef(0x198)],_0x3520c5[_0x2d17ef(0xac)])){if(_0x3520c5[_0x2d17ef(0x86)]!==_0x3520c5[_0x2d17ef(0x86)]){if(_0xb9991f)_0x42b18a+=_0x2d17ef(0x2c1)+_0x332198+'\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}else previousQuestion();}else{if(_0x3520c5['sfWyC'](_0xec5678[_0x2d17ef(0x198)],'ArrowRight')||_0x3520c5[_0x2d17ef(0x2db)](_0xec5678[_0x2d17ef(0x198)],'\x20')){if(_0x3520c5['VSUAY']('oAmmy',_0x3520c5[_0x2d17ef(0x2de)])){_0x3fd4e3[_0x2d17ef(0x1d8)](_0x3520c5[_0x2d17ef(0x259)])['textContent']=_0x5780d0[_0x2d17ef(0x1e4)],_0x254b6b[_0x2d17ef(0x1d8)](_0x3520c5[_0x2d17ef(0x16f)])[_0x2d17ef(0x2cf)]=_0x561afb['incorrectAnswers'],_0x5277b8[_0x2d17ef(0x1d8)]('totalAttempted')[_0x2d17ef(0x2cf)]=_0x27ab01[_0x2d17ef(0x23e)];const _0x895591=_0x3520c5[_0x2d17ef(0x3a6)](_0x353a67[_0x2d17ef(0x23e)],0x0)?_0x51ae77['round'](_0x3520c5[_0x2d17ef(0x19d)](_0x1f5835[_0x2d17ef(0x1e4)]/_0x4ab96a[_0x2d17ef(0x23e)],0x64)):0x0;_0x4f9d97[_0x2d17ef(0x1d8)](_0x2d17ef(0x28c))[_0x2d17ef(0x2cf)]=_0x3520c5['QtDnB'](_0x895591,'%'),_0xc2ff4e[_0x2d17ef(0x33f)]=_0x1d3ca6[_0x2d17ef(0x2cd)]((_0xd16a0c,_0x27fffe)=>_0xd16a0c+_0x27fffe['timeSpent'],0x0);const _0x48bac1=_0x5a1245['floor'](_0x3520c5[_0x2d17ef(0x39b)](_0x117432[_0x2d17ef(0x33f)],0x3e8)),_0x316e88=_0x50c518['floor'](_0x3520c5[_0x2d17ef(0x2d5)](_0x48bac1,0x3c)),_0x3b8856=_0x3520c5['GutBW'](_0x48bac1,0x3c);_0x406d31['getElementById'](_0x3520c5[_0x2d17ef(0x383)])[_0x2d17ef(0x2cf)]=_0x3520c5['QlJOQ'](_0x3520c5[_0x2d17ef(0x30c)](_0x316e88,':'),_0x3b8856['toString']()[_0x2d17ef(0xe6)](0x2,'0'));}else _0xec5678[_0x2d17ef(0xdf)](),nextQuestion();}else{if(_0x3520c5[_0x2d17ef(0x323)](_0xec5678[_0x2d17ef(0x198)][_0x2d17ef(0xa7)](),'b')&&(_0x3520c5[_0x2d17ef(0x39d)](currentMode,_0x3520c5['AInqU'])||_0x3520c5['YrBJR'](currentMode,_0x2d17ef(0x9a)))){if(_0x3520c5[_0x2d17ef(0x319)](_0x3520c5[_0x2d17ef(0x3b6)],_0x3520c5[_0x2d17ef(0x3b6)])){const _0x3a8d77=_0x22c71f[_0x2d17ef(0x3b9)](_0x3520c5[_0x2d17ef(0x2d5)](_0x2eb4fe,0x3c)),_0xa981a0=_0x3520c5[_0x2d17ef(0x1c0)](_0x565726,0x3c);_0x410bea[_0x2d17ef(0x1d8)](_0x3520c5[_0x2d17ef(0x24e)])['textContent']=_0x3520c5[_0x2d17ef(0x255)](_0x3520c5[_0x2d17ef(0x30c)](_0x3a8d77,':'),_0xa981a0[_0x2d17ef(0x30d)]()[_0x2d17ef(0xe6)](0x2,'0'));}else _0x3520c5[_0x2d17ef(0x2b8)](toggleBookmark);}else{if(_0xec5678[_0x2d17ef(0x198)][_0x2d17ef(0xa7)]()==='m'&&(_0x3520c5['ISJqx'](currentMode,_0x3520c5[_0x2d17ef(0x2c4)])||_0x3520c5[_0x2d17ef(0x10a)](currentMode,_0x3520c5[_0x2d17ef(0xed)])))_0x3520c5[_0x2d17ef(0x2f8)](toggleMarkForReview);else _0x3520c5['xLFRJ'](_0xec5678[_0x2d17ef(0x198)][_0x2d17ef(0xa7)](),'s')&&(currentMode===_0x3520c5['eSnoU']||_0x3520c5[_0x2d17ef(0x1e8)](currentMode,'timed_exam'))&&_0x3520c5['TRQor'](submitQuiz);}}}}});</script>

</body></html>